
<html lang="en"     class="pb-page"  data-request-id="d4cc13af-b2b7-405b-829e-968e277d9fae"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2009.52.issue-22;wgroup:string:ACHS website Group;article:article:10.1021/jm901188v;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors" /></meta><meta name="dc.Creator" content="Philip  Jones" /></meta><meta name="dc.Creator" content="Sergio  Altamura" /></meta><meta name="dc.Creator" content="Julia  Boueres" /></meta><meta name="dc.Creator" content="Federica  Ferrigno" /></meta><meta name="dc.Creator" content="Massimiliano  Fonsi" /></meta><meta name="dc.Creator" content="Claudia  Giomini" /></meta><meta name="dc.Creator" content="Stefania  Lamartina" /></meta><meta name="dc.Creator" content="Edith  Monteagudo" /></meta><meta name="dc.Creator" content="Jesus M.  Ontoria" /></meta><meta name="dc.Creator" content="Maria Vittoria  Orsale" /></meta><meta name="dc.Creator" content="Maria Cecilia  Palumbi" /></meta><meta name="dc.Creator" content="Silvia  Pesci" /></meta><meta name="dc.Creator" content="Giuseppe  Roscilli" /></meta><meta name="dc.Creator" content="Rita  Scarpelli" /></meta><meta name="dc.Creator" content="Carsten  Schultz-Fademrecht" /></meta><meta name="dc.Creator" content="Carlo  Toniatti" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Description" content="We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellula..." /></meta><meta name="Description" content="We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellula..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 29, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901188v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901188v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901188v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901188v" /></link>
        
    
    

<title>Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901188v" /></meta><meta property="og:title" content="Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0011.jpeg" /></meta><meta property="og:description" content="We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1 and 1A2 was identified as a metabolic concern, and strategies to improve pharmacokinetic properties are reported. These efforts culminated in the identification of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide 56 (MK-4827), which displays good pharmacokinetic properties and is currently in phase I clinical trials. This compound displays excellent PARP 1 and 2 inhibition with IC50 = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibited PARP activity with EC50 = 4 nM and inhibited proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10−100 nM range. Compound 56 was well tolerated in vivo and demonstrated efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901188v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901188v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901188v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901188v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901188v&amp;href=/doi/10.1021/jm901188v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7170-7185</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901230r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901149c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Jones">Philip Jones</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Altamura">Sergio Altamura</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julia++Boueres">Julia Boueres</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Ferrigno">Federica Ferrigno</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimiliano++Fonsi">Massimiliano Fonsi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Giomini">Claudia Giomini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Lamartina">Stefania Lamartina</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edith++Monteagudo">Edith Monteagudo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jesus+M.++Ontoria">Jesus M. Ontoria</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Vittoria++Orsale">Maria Vittoria Orsale</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Cecilia++Palumbi">Maria Cecilia Palumbi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Pesci">Silvia Pesci</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Roscilli">Giuseppe Roscilli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Scarpelli">Rita Scarpelli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carsten++Schultz-Fademrecht">Carsten Schultz-Fademrecht</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlo++Toniatti">Carlo Toniatti</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Current address: Department of Medicinal Chemistry, Merck Research Labs Boston, Avenue Louis Pasteur 33, Boston, MA 02115-5727. Phone: +1-617-992-2292. Fax: +1-617-992-2405. E-mail: <a href="/cdn-cgi/l/email-protection#52223a3b3e3b220d383d3c3721123f372031397c313d3f"><span class="__cf_email__" data-cfemail="09796160656079566366676c7a49646c7b6a62276a6664">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901188v&amp;href=/doi/10.1021%2Fjm901188v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7170–7185</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 29, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 August 2009</li><li><span class="item_label"><b>Published</b> online</span>29 October 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901188v" title="DOI URL">https://doi.org/10.1021/jm901188v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7170%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPhilip%2BJones%252C%2BSergio%2BAltamura%252C%2BJulia%2BBoueres%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D22%26contentID%3Djm901188v%26title%3DDiscovery%2Bof%2B2-%257B4-%255B%25283S%2529-Piperidin-3-yl%255Dphenyl%257D-2H-indazole-7-carboxamide%2B%2528MK-4827%2529%253A%2BA%2BNovel%2BOral%2BPoly%2528ADP-ribose%2529polymerase%2B%2528PARP%2529%2BInhibitor%2BEfficacious%2Bin%2BBRCA-1%2Band%2B-2%2BMutant%2BTumors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7185%26publicationDate%3DNovember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901188v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7342</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">190</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901188v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Jones&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Altamura&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;Boueres&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Ferrigno&quot;},{&quot;first_name&quot;:&quot;Massimiliano&quot;,&quot;last_name&quot;:&quot;Fonsi&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Giomini&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Lamartina&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Monteagudo&quot;},{&quot;first_name&quot;:&quot;Jesus&quot;,&quot;last_name&quot;:&quot;M. Ontoria&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Vittoria Orsale&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Cecilia Palumbi&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Pesci&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Roscilli&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Scarpelli&quot;},{&quot;first_name&quot;:&quot;Carsten&quot;,&quot;last_name&quot;:&quot;Schultz-Fademrecht&quot;},{&quot;first_name&quot;:&quot;Carlo&quot;,&quot;last_name&quot;:&quot;Toniatti&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;7170-7185&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901188v&quot;},&quot;abstract&quot;:&quot;We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1 and 1A2 was identified as a metabolic concern, and strategies to improve pharmacokinetic properties are reported. These efforts culminated in the identification of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide 56 (MK-4827), which displays good pharmacokinetic properties and is currently in phase I clinical trials. This compound displays excellent PARP 1 and 2 inhibition with IC50 = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibited PARP activity with EC50 = 4 nM and inhibited proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10−100 nM range.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901188v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901188v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901188v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901188v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901188v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901188v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901188v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901188v&amp;href=/doi/10.1021/jm901188v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901188v" /></input><a href="/doi/pdf/10.1021/jm901188v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901188v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901188v%26sid%3Dliteratum%253Aachs%26pmid%3D19873981%26genre%3Darticle%26aulast%3DJones%26date%3D2009%26atitle%3DDiscovery%2Bof%2B2-%257B4-%255B%25283S%2529-Piperidin-3-yl%255Dphenyl%257D-2H-indazole-7-carboxamide%2B%2528MK-4827%2529%253A%2BA%2BNovel%2BOral%2BPoly%2528ADP-ribose%2529polymerase%2B%2528PARP%2529%2BInhibitor%2BEfficacious%2Bin%2BBRCA-1%2Band%2B-2%2BMutant%2BTumors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D22%26spage%3D7170%26epage%3D7185%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We disclose the development of a novel series of 2-phenyl-2<i>H</i>-indazole-7-carboxamides as poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1 and 1A2 was identified as a metabolic concern, and strategies to improve pharmacokinetic properties are reported. These efforts culminated in the identification of 2-{4-[(3<i>S</i>)-piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide <b>56</b> (MK-4827), which displays good pharmacokinetic properties and is currently in phase I clinical trials. This compound displays excellent PARP 1 and 2 inhibition with IC<sub>50</sub> = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibited PARP activity with EC<sub>50</sub> = 4 nM and inhibited proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC<sub>50</sub> in the 10−100 nM range. Compound <b>56</b> was well tolerated in vivo and demonstrated efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Poly(ADP-ribose) polymerase (PARP)-1 is the founding and most abundant member of poly(ADP-ribosyl)ating proteins, a family of some 18 proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Several of the PARP<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: BER, base excision repair; BRCA, breast cancer susceptibility gene; DSB, double strand break; HLM, human liver microsomes; HR, homologous recombination; NAD<sup>+</sup>, nicotinamide adenine dinucleotide; PAR, poly(ADP)ribose; PARP, poly(ADP-ribose)polymerase; RLM, rat liver microsomes; SFC, supercritical fluid chromatography; shRNA, short hairpin interfering RNA; SSB, single strand break; TANK, tankyrase; V-PARP, vault PARP; WT, wild type.</p></div> family of enzymes share a catalytic PARP homology domain and are characterized by the ability to catalyze the transfer of ADP-ribose units to proteins using nicotinamide adenine dinucleotide (NAD<sup>+</sup>) as the substrate, resulting in the formation of long and branched poly(ADP)ribose (PAR) chains.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> More recent characterization suggests that while PARPs 1−5 function as poly(ADP-ribosyl)ating proteins, some of the other family members may indeed be mono-ADP-ribosyltransferases and other members of the family may be catalytically inactive.<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> PARP-1 and the closely related PARP-2 are nuclear proteins and possess DNA binding domains.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> These DNA binding domains serve to localize and rapidly bind these PARPs to the sites of DNA single- and double-strand breaks (SSB and DSB, respectively). With binding at sites of lesion, the catalytic activity of these enzymes is stimulated more than 500-fold, which results in the addition of PAR chains on several proteins associated with chromatin, including histones, p53, topoisomerases, and PARP itself, plus various DNA repair proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This results in chromatin relaxation and fast recruitment of DNA repair factors which access the DNA breaks and repair them by a process known as base excision repair (BER).</div><div class="NLM_p">The knockout of PARP-1 significantly impairs repair of DNA damage following exposure to radiation or cytotoxic insult,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> with the residual PARP dependent repair activity being due to PARP-2, which contributes about 10% to nuclear PARP activity.<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4, 7)</a> Similarly, PARP 1 and 2 inhibition with small molecule inhibitors has been demonstrated to sensitize tumor cells to cytotoxic agents that induce DNA damage that would normally be repaired by BER, notably alkylating agents (like temozolomide and cyclophosphamide) and topoisomerase I poisons (irinotecan and topotecan).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Sensitization of platins, like cisplatin and carboplatin, has also been demonstrated, as has the use of PARP inhibitors as radiopotentiators, whereby the cellular damage caused by ionizing radiation is enhanced.</div><div class="NLM_p">In addition, hyperactivation of PARP activity has been reported, caused by excessive DNA damage following oxidative insult upon ischemia reperfusion.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The subsequent extensive PARylation of substrates results in depletion of cellular NAD<sup>+</sup> pools and energy stores, leading to acute neuronal and myocardial cell death by necrosis. Indeed several classes of PARP inhibitors have already been developed<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and have demonstrated efficacy in animal models of these diseases.<a onclick="showRef(event, 'ref2 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref2 ref12 ref13">(2, 12, 13)</a> These PARP inhibitors have also shown applicability in models of inflammation,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> cardiovascular disease,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and neurodegenerative disorders.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">PARP-1 is also known to participate in a range of other cellular processes including regulation of apoptosis, cell division, transcriptional regulation, and differentiation, as well as chromosome stability.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Despite PARP-1 being identified over 40 years ago, the biology of the other family members is still being elucidated,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> although PARP-4/vault PARP is known to be the catalytic component of the vault particles, which are ribonucleoprotein complexes that are involved in multidrug resistance of tumors. Tankyrases I and II are known to regulate telomere homeostasis and also to play key roles during mitotic segregation.</div><div class="NLM_p">Recently, data have emerged suggesting that targeting more than one DNA repair pathway in tumor cells could induce “synthetic lethality”.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Specifically, publications have appeared that described the selective killing of BRCA-1 or BRCA-2 deficient tumor cells by PARP inhibitors.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> In contrast, normal cells with an intact BRCA pathway when treated with a PARP inhibitor are viable and minimal cytotoxicity is seen. BRCA-1 and -2 are known tumor suppressors and are key components involved in the repair of DNA double strand breaks by the homologous recombination (HR) pathway, and mutations in these genes predispose individuals to hereditary breast and ovarian cancer and also prostate and pancreatic cancer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Every day cells are faced by an onslaught of DNA damage, through metabolic processes and/or exogenous damage, and in the presence of a PARP inhibitor this attack results in persistent DNA SSB. During replication, these SSBs cause stalled replication forks and subsequently develop into DSB. In BRCA-1 and -2 deficient cells, these lesions are not repaired by the alternative DSB repair pathway of homologous recombination, resulting in gross genomic instability, cell cycle arrest, and apoptosis. Cells that are deficient in BRCA-1 and -2 have been demonstrated to be acutely sensitive to killing by PARP inhibitors in vitro and in vivo.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> In a genetically engineered mouse model for BRCA-1 associated breast cancer treatment of tumor bearing mice with the PARP inhibitor 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>1</b> (olaparib, KU-0059436, AZD-2281) resulted in inhibition of tumor growth without signs of toxicity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Furthermore, clinical proof-of-concept for the use of a PARP inhibitor for the treatment of cancers with known BRCA mutations has been demonstrated, with <b>1</b> showing clinical responses in patients with breast and ovarian cancers with known BRCA 1 or 2 mutations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Besides <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), other PARP inhibitors in clinical development include Abbott’s orally available 2-[(<i>R</i>)-2-methylpyrrolidin-2-yl]-1<i>H</i>-benzimidazole-4-carboxamide <b>2</b> (ABT-888) which is being investigated as a chemo- and radiosensitizer;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and Pfizer’s 8-fluoro-2-(4-methylaminomethylphenyl)-1,3,4,5-tetrahydroazepino[5,4,3-<i>cd</i>]indol-6-one <b>3</b> (AG014699).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Another two agents that are being investigated in the clinic are Inotek Pharmaceuticals’ INO-1001<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and BiPar Science’s BS-201;<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> neither structure has been disclosed. The latter is currently in phase II studies for the treatment of triple-negative breast cancer.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PARP inhibitors currently undergoing clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article the development of a novel series of 2-phenyl-2<i>H</i>-indazole-7-carboxamides as PARP 1 and 2 inhibitors for the treatment of BRCA-1 and -2 deficient cancers is reported. The introduction of a (di)alkylaminomethyl substituent on the pendent aryl moiety of this scaffold resulted in compounds with improved cellular activity, although at the expense of metabolic liabilities in the form of extrahepatic oxidation by CYP450 1A1 and 1A2. Strategies to improve pharmacokinetic properties are reported, culminating in the discovery of 2-{4-[(3<i>S</i>)-piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide <b>56</b> (MK-4827) which is currently in human phase I clinical trials. This compound displays excellent potency against both the PARP-1 and PARP-2 enzymes with IC<sub>50</sub> = 3.8 and 2.1 nM, respectively, and in a whole cell assay it inhibits PARP activity with EC<sub>50</sub> = 4.0 nM and EC<sub>90</sub> = 45 nM. This indazole-7-carboxamide inhibits proliferation of cancer cell lines with mutant BRCA-1 and BRCA-2 in vitro and is efficacious in xenograft models following oral dosing.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Synthetic routes for the preparations of diverse [6,5]-bicyclic heterocyclic systems <b>8</b>, <b>22</b>, <b>27</b>, and <b>30</b> bearing pendent primary carboxamide and phenyl groups are described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Indazole PARP inhibitors were prepared from methyl 3-formyl-2-nitrobenzoate (<b>5</b>), itself available from oxidation of methyl 3-methyl-2-nitrobenzoate. Condensation with substituted anilines in refluxing EtOH gave azomethines <b>6a</b>−<b>j</b> that could then be treated with NaN<sub>3</sub> in DMF at 90 °C, and initial substitution of the ortho-nitro group and subsequent cyclization gave the corresponding indazoles <b>7a</b>−<b>j</b> as described by Kuvshinov.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Amide formation using ammonia in MeOH in a sealed tube furnished the desired compounds <b>8</b>−<b>17</b>. The 1,2,3-benzotriazole <b>22</b> was prepared from methyl 2,3-diaminobenzoate (<b>19</b>) by condensation with nitrosobenzene in AcOH to give <b>20</b>, followed by oxidation cyclization using stoichiometric Cu(OAc)<sub>2</sub> under an O<sub>2</sub> atmosphere. Functional group interconversion then yielded <b>22</b>. The synthesis of the pyrazolo[1,5-<i>a</i>]pyridine <b>27</b> started from ethyl 2-picolinate (<b>23</b>) which upon treatment with <i>O</i>-mesitylenesulfonylhydroxylamine gave the <i>N</i>-aminopyridinium salt <b>24</b>. The key bicycle <b>25</b> was then prepared by a [3 + 2] cycloaddition of the <i>N</i>-aminopyridinium salt with an alkynoic ester.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Hydrogenation of the benzyl ester <b>25</b>, followed by decarboxylation in 48% HBr, gave the required 2-phenylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxamide (<b>27</b>) after amide formation. A similar synthetic strategy was employed for the formation of 2-phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxamide (<b>30</b>), in which case the <i>N</i>-aminopyridinium salt was condensed with benzaldehyde to elaborate the key heterocyclic intermediate <b>29</b> that was subsequently transformed to <b>30</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HCl, MeOH, Δ; (b) NBS, (BzO)<sub>2</sub>, CCl<sub>4</sub>, Δ; (c) NMMO, MeCN; (d) RNH<sub>2</sub>, EtOH, Δ; (e) NaN<sub>3</sub>, DMF, 90 °C; (f) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (g) H<sub>2</sub>, Pd/C, MeOH; (h) nitrosobenzene, AcOH; (i) Cu(OAc)<sub>2</sub>, O<sub>2</sub>, DMF, 80 °C; (j) NaOH, then HATU, NH<sub>3</sub>, DIPEA, DMF; (k) H<sub>2</sub>N-OMes, DCM; (l) PhCCCO<sub>2</sub>Bn, K<sub>2</sub>CO<sub>3</sub>, THF; (m) H<sub>2</sub>, Pd/C, EtOH, EtOAc; (n) 48% HBr, Δ; (o) H<sub>2</sub>N-OMes, dioxane; (p) PhCHO, Δ; (q) KOH, MeOH.</p></p></figure><div class="NLM_p">Substituted 2-arylindazole-7-carboxamides were prepared using the previously described route from the appropriately substituted aniline, or alternatively methyl-2<i>H</i>-indazole-7-carboxylate (<b>31</b>) and indazole-7-carboxamide (<b>34</b>) can undergo microwave assisted S<sub>N</sub>Ar substitution of <i>p</i>-fluorobenzaldehyde or fluoroacetophenone in DMF in the presence of K<sub>2</sub>CO<sub>3</sub> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reductive amination using ZnCl<sub>2</sub> and NaBH<sub>3</sub>(CN) together with the appropriate amines gave derivatives <b>37</b>−<b>48</b>. The corresponding <i>gem</i>-dimethyl analogue <b>50</b> was prepared by conversion of methyl ketone <b>36</b> to the corresponding tertiary alcohol <b>49</b>. This alcohol underwent a Ritter rearrangement to yield the corresponding formamide,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> which was in turn reduced to give <b>50</b>. Homologation to the corresponding phenethylamine <b>52</b> was achieve by treating aldehyde <b>35</b> with methoxymethyltriphenylphosphonium chloride and KO<i><sup>t</sup></i>Bu followed by mild acid treatment to yield phenacetaldehyde <b>51</b>, followed by reductive amination. The isomeric benzylamine <b>54</b> was prepared utilizing 3-aminobenzaldehyde ethylene acetal in the cyclization to form the indazole followed by functional group interconversion.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>p</i>-FC<sub>6</sub>H<sub>4</sub>COR, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave; (b) R′R′′NH, NaBH<sub>3</sub>(CN), ZnCl<sub>2</sub>, MeOH, DCE; (c) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (d) MeMgBr, THF; (e) NaCN, H<sub>2</sub>SO<sub>4</sub>, DCM; (f) BH<sub>3</sub>.THF, THF; (g) MeOCH<sub>2</sub>P<sup>+</sup>Ph<sub>3</sub> Cl<sup>−</sup>, KO<sup><i>t</i></sup>Bu, Et<sub>2</sub>O/THF, −78 °C to room temp, then HCl, Et<sub>2</sub>O; (h) formaldehyde, NaBH<sub>3</sub>(CN), then H<sub>2</sub>, Pd/C, MeOH; (i) ArNH<sub>2</sub>, EtOH, Δ; (j) NaN<sub>3</sub>, DMF, 90 °C; (k) TFA, DCM, H<sub>2</sub>O.</p></p></figure><div class="NLM_p">Derivatives bearing the 4-[(3<i>S</i>)-piperidin-3-yl]phenyl moiety were prepared by one of two routes illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Racemic <i>N</i>-Boc-3-(4-aminophenyl)piperidine was condensed with methyl 3-formyl-2-nitrobenzoate (<b>5</b>) and cyclized using NaN<sub>3</sub> in DMF as described previously to subsequently yield <b>7i</b>. Separation of <b>16</b> by chiral SFC gave the enantiomers <b>56</b> and <b>57</b>. Alternatively, 4-piperidin-3-ylaniline (<b>60</b>), readily available from Suzuki coupling of 1-iodo-4-nitrobenzene and pyridine-3-boronic acid followed by PtO<sub>2</sub> hydrogenation, was resolved using <span class="smallcaps smallerCapital">l</span>-tartaric acid to yield the <i>S</i>-enantiomer <b>61</b> in high enantiomeric excess following four recrystallizations. Subsequent elaboration to <b>56</b> proceeded in high yield with no erosion of the stereochemistry to give <b>56</b> in 30% yield over five steps.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) ArNH<sub>2</sub>, EtOH, Δ; (b) NaN<sub>3</sub>, DMF, 90 °C; (c) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (d) HCl, dioxane; (e) SFC separation; (f) 3-pyridyl-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, Δ; (g) 50 psi of H<sub>2</sub>, PtO<sub>2</sub>, MeOH; (h) resolution <span class="smallcaps smallerCapital">l</span>-tartaric acid, EtOH; (i) Boc<sub>2</sub>O, DCM; (j) <b>5</b>, EtOH, Δ.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biology</h3><div class="NLM_p">Given the interest in PARP-1 inhibition in a wide variety of therapeutic areas, a significant number of industrial and academic groups have worked on developing inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Most of inhibitors developed to date bind to the nicotinamide binding site, where they compete with the natural substrate nicotinamide adenine dinucleotide (NAD<sup>+</sup>). X-ray crystal structures and molecular modeling studies have indicated that the amide of nicotinamide makes three key hydrogen bonds to the hydroxyl group of Ser904 and the amide backbone of Gly863.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Moreover, the pyridyl ring is engaged in π−π stacking with Tyr907. The majority of the inhibitors developed to date are close structural mimics of nicotinamide, and attempts to improve the affinity of these derivatives have been made by trying to lock the carboxamide group, which is usually free to rotate, into the desired anti-conformation. On the basis of this knowledge, four [6,5]-bicyclic heteroaromatic carboxamide derivatives <b>8</b>, <b>22</b>, <b>27</b>, and <b>30</b> were designed, all of which incorporate a nitrogen atom within the heteroaromatic ring to lock the carboxamide group into a six-membered intramolecular hydrogen bond. All four novel scaffolds were demonstrated to be modest PARP inhibitors, with the indazole derivative <b>8</b> with IC<sub>50</sub> = 24 nM displaying higher affinity than the benzotriazole <b>22</b>, pyrazolo[1,5-<i>a</i>]pyridine <b>27</b>, and the [1,2,4]triazolo[1,5-<i>a</i>]pyridine <b>30</b> in a PARP-1 SPA assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The indazole <b>8</b> was also demonstrated to inhibit PARP activity in cells, being able to inhibit the formation of PAR polymers following the induction of DNA damage with hydrogen peroxide. In HeLa cervical cancer cells <b>8</b> displayed EC<sub>50</sub> = 3.7 μM and EC<sub>90</sub> = 6.2 μM. The pharmacokinetics of <b>8</b> were also encouraging, displaying moderate stability in both rat and human microsomes (Cl<sub>int</sub> = 123 and 138 (μL/min)/mgP, respectively), and in vivo in rats <b>8</b> displayed acceptable plasma clearance (Cl = 30 (mL/min)/kg), volume of distribution of 1.8 L/kg, and terminal half-life of 5.1 h. This indazole also showed acceptable oral bioavailability, <i>F</i> = 41%.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity of PARP Inhibitor Scaffolds<a class="ref internalNav" href="#t1fn2" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">R</th><th align="center" char=".">PARP-1 IC<sub>50</sub> (nM)</th><th align="center" char=".">PARylation EC<sub>50</sub> (nM)</th><th align="center" char=".">PARylation EC<sub>90</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>8</b></td><td align="left">Ph</td><td align="char" char=".">24</td><td align="char" char=".">3700</td><td align="char" char=".">6200</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">benzyl</td><td align="char" char=".">130</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left"><i>o</i>-Cl-C<sub>6</sub>H<sub>4</sub>-</td><td align="char" char=".">100</td><td align="char" char=".">ND</td><td align="char" char=".">ND</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left"><i>m</i>-Cl-C<sub>6</sub>H<sub>4</sub>-</td><td align="char" char=".">14</td><td align="char" char=".">450</td><td align="char" char=".">5600</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left"><i>p</i>-Cl-C<sub>6</sub>H<sub>4</sub>-</td><td align="char" char=".">24</td><td align="char" char=".">720</td><td align="char" char=".">6700</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left"> </td><td align="char" char=".">71</td><td align="char" char=".">ND</td><td align="char" char=".">ND</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left"> </td><td align="char" char=".">55</td><td align="char" char=".">ND</td><td align="char" char=".">ND</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left"> </td><td align="char" char=".">270</td><td align="char" char=".">ND</td><td align="char" char=".">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>a</sup><p class="last">Values are the mean of at least four experiments (standard deviations were within 25% of the mean values). ND = not determined.</p></div></div></div><div class="NLM_p">On the basis of these results, a more detailed exploration of the indazole lead <b>8</b> was undertaken in order to optimize potency, as well as pharmaceutical properties. In an effort to improve the activity, substituents were introduced at the ortho, meta, and para positions of the pendent phenyl ring, as well as the insertion of a methylene spacer between the indazole core and the phenyl moiety. Substituents were well tolerated at the distal meta and para positions, resulting in an improvement in at least 5-fold in cellular activity, with <b>11</b> and <b>12</b> displaying EC<sub>50</sub> = 450 and 720 nM in the PARylation assay, respectively. However, substitution adjacent to the indazole was detrimental, with <b>10</b> displaying a 5-fold loss of enzyme activity, IC<sub>50</sub> = 100 nM. Similarly, homologation to the benzyl derivative <b>9</b> resulted in a similar loss of enzymatic activity.</div><div class="NLM_p">Knowing that substitution was tolerated at the remote positions, alternative groups were introduced in the hope of picking up additional binding interactions in the adenosine binding pocket to improve the affinity and cellular activity, Efforts concentrated on the addition of polar groups with a view to improve the solubility of these lipophilic compounds, given that the prototype <b>8</b> was only sparingly soluble in phosphate buffer, 26 μg/mL.</div><div class="NLM_p">The addition of a dimethylaminomethyl group to give <b>37</b> resulted in a 6-fold improvement in enzymatic activity, IC<sub>50</sub> = 3.7 nM, and further improved the cellular activity, inhibiting the formation of poly-ADP-ribose chains following DNA damage with EC<sub>50</sub> = 110 nM and EC<sub>90</sub> = 630 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Given the submicromolar activity of this compound, its ability to inhibit the growth of cervical cancer HeLa cells where BRCA-1 had been silenced with a lentivirus expressing a short hairpin interfering RNA (shRNA) targeting BRCA-1 was tested. In parallel, the cytotoxicity against a matched pair cell line expressing an empty lentivector was also measured. In 7-day proliferation assays <b>37</b> displayed CC<sub>50</sub> = 520 nM against the BRCA-1 deficient cells and 10-fold selectivity over the BRCA-1 proficient HeLa cells where CC<sub>50</sub> = 5.6 μM, thereby confirming the previous literature reports that PARP inhibitors are capable of selectively killing BRCA-1 deficient cells.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The addition of the basic amine also improved the physicochemical properties, with <b>37</b> displaying solubility in excess of 3 mg/mL in phosphate buffer.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity and Antiproliferation Activity of 2-Phenyl-2<i>H</i>-indazole-7-carboxamide PARP Inhibitors<a class="ref internalNav" href="#t2fn2" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0005.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0006.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0007.gif" alt="" id="_i8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup>a</sup><p class="last">Values are the mean of at least four experiments (standard deviations were within 25% of the mean values).</p></div></div></div><div class="NLM_p">Subsequent SAR studies confirmed these results with pyrrolidine <b>38</b> and piperidine <b>39</b> displaying similar PARP inhibitory activity in vitro and in cells, inhibiting the growth of BRCA-1 silenced HeLa cells with CC<sub>50</sub> = 1.2 and 0.88 μM, respectively, and showing at least 5-fold selective cytotoxicity versus HeLa BRCA-1 wild-type cells. The less basic derivatives such as morpholine <b>40</b> displayed inferior PARP inhibition, with EC<sub>90</sub> = 6.2 μM in the PARylation assay and CC<sub>50</sub> = 5.3 μM against BRCA-1 silenced cells. Cellular activity could be improved by the incorporation of the <i>N</i>-methylpiperazine, and <b>41</b> displayed CC<sub>50</sub> = 2.7 μM in the BRCA-1 deficient cells, despite this compound displaying weaker enzyme activity, IC<sub>50</sub> = 31 nM. However, <b>41</b> showed only 3-fold selective cytotoxicity between BRCA-1 silenced and wild-type cells, suggesting some underlying toxicity. Similar micromolar activity was also seen with the trimethylethylenediamine derivative <b>42</b>, although with at least a 5-fold selectivity between BRCA-1 deficient and wild-type cells. Secondary amines were also tolerated, with the methylamine <b>43</b> displaying slightly improved activity compared to dimethylamino analogue <b>37</b> in cells, with CC<sub>50</sub> = 460 nM and more than 10-fold selectivity for BRCA-1 deficient cells. In contrast, more lipophilic ethylamine <b>44</b>, although displaying comparable enzymatic activity, was 3-fold less active in cells, and further substitution was detrimental, as the isopropylamine <b>47</b> lost both enzyme and cellular activity, with IC<sub>50</sub> = 6.7 nM and CC<sub>50</sub> = 2.0 μM in BRCA-1 deficient cells. Introduction of mono- and difluoro groups to the ethylamine, in <b>45</b> and <b>46</b>, reduced the basicity of the amine and reduced cellular activity as seen with the morpholine <b>40</b>. In general, there was good correlation between the extent of PARP inhibition in cells and the concentrations needed to inhibit growth of BRCA-1 silenced HeLa cells. In most cases EC<sub>90</sub> for inhibition of PARylation correlated with the CC<sub>50</sub> for inhibition of the proliferation of BRCA-1 silenced HeLa cells. This suggests that strong sustained PARP inhibition is required to inhibit growth in this context.</div><div class="NLM_p">Exploration was also conducted in the isomeric series, where the methylaminomethyl group was introduced in the meta position of the phenyl ring, resulting in <b>54</b>, and although this was tolerated, inhibiting PARP activity with IC<sub>50</sub> = 5.3 nM, this derivative displayed only weak cellular activity, BRCA-1 deficient CC<sub>50</sub> = 10 μM. A loss of activity was also observed in the para regioisomer if the amine was homologated to the corresponding phenethylamine, with <b>52</b> losing almost 2 orders of magnitude in activity, PARP-1 IC<sub>50</sub> = 200 nM.</div><div class="NLM_p">Encouraged by these results and the selective growth inhibition caused by these PARP inhibitors in BRCA-1 deficient cells, a number of compounds were profiled in microsomal stability studies and in vivo in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The dimethylamino derivative <b>37</b> displayed relatively high turnover in rat liver microsomes (RLM), Cl<sub>int</sub> = 177 (μL/min)/mgP, and in vivo high plasma clearance was observed in rats, in excess of hepatic blood flow. In contrast, the monomethylamine <b>43</b> showed improved stability in vitro (RLM Cl<sub>int</sub> = 28 (μL/min)/mgP), yet in vivo in rats similar high plasma clearance was measured, Cl = 220 (mL/min)/kg. The plasma clearance value in excess of rat liver blood flow suggested extrahepatic metabolism. Similar observations were seen with the piperidine <b>39</b> and the isopropyl <b>47</b> derivatives, all of which displayed good stability in rat liver microsomes but plasma clearances in excess of 100 (mL/min)/kg in vivo in rats. Plasma stability studies were conducted on a number of derivatives, and no metabolism was seen in rat or human plasma. Furthermore, blood/plasma partitioning experiments revealed B/P ratios in the range 1.2−1.6, thereby failing to explain the blood clearance in excess of hepatic blood flow.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro and in Vivo Pharmacokinetic Parameters for 2-Phenyl-2<i>H</i>-indazole-7-carboxamide PARP Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">RLM Cl<sub>int</sub><br /></br>((μL/min)/mgP)</th><th align="center" char=".">HLM Cl<sub>int</sub><br /></br>((μL/min)/mgP)</th><th align="center">CYP1A1 Cl<sub>int</sub><br /></br>((μL/min)/mgP)</th><th align="center">rat Cl<br /></br>((mL/min)/kg)</th><th align="center" char="."><i>F</i><br /></br>(%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>8</b></td><td align="char" char=".">123</td><td align="char" char=".">138</td><td align="left">ND</td><td align="left">30</td><td align="char" char=".">41</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="char" char=".">177</td><td align="char" char=".">1</td><td align="left">8.7</td><td align="left">450</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="char" char=".">29</td><td align="char" char=".">3</td><td align="left">3.8</td><td align="left">107</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="char" char=".">34</td><td align="char" char=".">2</td><td align="left"><0.1</td><td align="left">8</td><td align="char" char=".">11</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">28</td><td align="char" char=".">3</td><td align="left">6</td><td align="left">220</td><td align="char" char=".">23</td></tr><tr valign="top"><td align="left"><b>47</b></td><td align="char" char=".">18</td><td align="char" char=".">1</td><td align="left">0.8</td><td align="left">131</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>54</b></td><td align="char" char=".">32</td><td align="char" char=".">5</td><td align="left">5.4</td><td align="left">69</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>48</b></td><td align="char" char=".">9</td><td align="char" char=".">1</td><td align="left">2.2</td><td align="left">58</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="char" char=".">11</td><td align="char" char="."><1</td><td align="left">0.4</td><td align="left">30</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="char" char=".">52</td><td align="char" char=".">4</td><td align="left">0.7</td><td align="left">87</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="char" char=".">36</td><td align="char" char=".">3</td><td align="left">0.7</td><td align="left">30</td><td align="char" char=".">22</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="char" char=".">22</td><td align="char" char=".">4</td><td align="left">2.5</td><td align="left">ND</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="char" char=".">11</td><td align="char" char=".">1</td><td align="left">0.3</td><td align="left">47</td><td align="char" char=".">74</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="char" char=".">15</td><td align="char" char=".">5</td><td align="left"><0.1</td><td align="left">ND</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>56</b></td><td align="char" char=".">16</td><td align="char" char=".">4</td><td align="left">0.3</td><td align="left">28</td><td align="char" char=".">65</td></tr><tr valign="top"><td align="left"><b>57</b></td><td align="char" char=".">7</td><td align="char" char=".">3</td><td align="left"><0.1</td><td align="left">24</td><td align="char" char=".">47</td></tr></tbody></table></div></div><div class="NLM_p">A [<sup>3</sup>H]-radiolabeled version of <b>43</b> was prepared<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and administered iv to rats, and 80% of the radioactivity was recovered in the urine and bile within 24 h of dosing, being equally distributed between the two fluids (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In urine, one significant metabolite was detected corresponding to the benzoic acid <b>63</b>, probably arising from oxidation of the benzylic position to the corresponding aldehyde <b>35</b> followed by further oxidation to the carboxylic acid. In contrast, in bile, both the carboxylic acid <b>63</b> and the corresponding glucuronide <b>64</b> were detected. In total the formation of <b>63</b> accounted for 50% of the radioactivity dosed and 60% of that recovered between 0 and 24 h.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolite profiles were obtained by radiochromatography of urine and bile following dosing of [<sup>3</sup>H]<b>43</b> (300 μCi/kg).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Separation was by RP-HPLC, using a Ace Act RP C18 150 mm × 2.1 mm column (Mac Mod Analytical Inc., Chadds Ford, PA) coupled to a Packard 515TR radiodetector (Perkin-Elmer Life and Analytical Sciences, Boston, MA) equipped with a 500 μL liquid scintillation flow cell.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Knowing the identity of the primary route of metabolism, CYP phenotyping was undertaken with recombinant CYP450 isoforms, which revealed that CYPs 1A1 and 1A2 are primarily responsible for the metabolism of <b>43</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). CYP1A1 is expressed at only very low levels in the liver and is predominantly an extrahepatic CYP, although it can be induced via the aryl hydrocarbon receptor.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> CYP1A2 is expressed mainly in the liver but is also expressed extrahepatically in rats.<a onclick="showRef(event, 'ref34 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref36">(34, 36)</a> Incubations of <b>43</b> with CYPs 1A1 and 1A2 revealed that formation of <b>63</b> correlated with disappearance of <b>43</b>, and only minor levels of the aldehyde <b>35</b> were seen in vitro. Knowing that these CYP450 isoforms are expressed extrahepatically, stability studies were undertaken with microsomes isolated from different organs (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b), which revealed that <b>43</b> was degraded by lung and kidney microsomes in the presence of NADPH, in addition to liver microsomes, with intrinsic clearance of 22, 22, and 28 (μL/min)/mgP. In contrast, <b>43</b> was stable in heart microsomes and showed only modest metabolism in intestinal microsomes Cl<sub>int</sub> = 5 (μL/min)/mgP.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Stability of <b>43</b> in the presence of rat rCYP isoforms. (b) Metabolic stability of <b>43</b> in liver, lung, kidney, intestine microsomes and heart homogenate in the presence of NADPH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With this information analogues were screened using recombinant CYP1A1; <b>43</b>, the dimethylamino <b>37</b>, the piperidine <b>39</b>, and the isopropyl <b>47</b> derivatives were all degraded rapidly, with Cl<sub>int</sub> = 6, 8.7, 3.8, and 0.8 (μL/min)/mgP. This is in good agreement with the high clearances seen in vivo in rats. On the other hand, the <i>N</i>-methylpiperazine derivative <b>41</b>, which showed modest stability in RLM, showed improved stability in the presence of CYP1A1 Cl<sub>int</sub> < 0.1 (μL/min)/mgP, and when this compound was dosed iv to rats, it displayed low plasma clearance Cl = 8 (mL/min)/kg, with long terminal half-life <i>t</i><sub>1/2</sub> = 9.7 h.</div><div class="NLM_p">A strategy to improve the PK properties was to block the methylene group through steric crowding; therefore, the corresponding mono- and <i>gem</i>-dimethyl derivatives, <b>48</b> and <b>50</b>, were prepared. Both compounds maintained PARP inhibitory activity with IC<sub>50</sub> = 3.7 and 16 nM, respectively, and were capable of blocking PARP activity in cells as revealed by EC<sub>90</sub> = 680 and 900 nM. This level of PARP inhibition resulted in the inhibition of proliferation of BRCA-1 deficient HeLa cells with CC<sub>50</sub> = 3.1 and 0.92 μM, respectively, albeit with only a modest selectivity over wild type cells. Both derivatives showed good stability in rat liver microsomes as seen previously with <b>43</b>, with <b>48</b> and <b>50</b> having intrinsic clearances of 9 and 11 (μL/min)/mgP, respectively. The introduction of the steric crowding on the benzylic methylene served to protect these derivatives from oxidation by CYP1A1 as demonstrated by improved stability compared to <b>43</b> against this recombinant CYP, with Cl<sub>int</sub> = 2.2 and 0.4 (μL/min)/mgP for <b>48</b> and <b>50</b>, respectively. Moreover, this improved stability was recapitulated in vivo where the addition of a single methyl group reduced the rat plasma clearance to 58 (mL/min)/kg, while the <i>gem</i>-dimethyl group reduced plasma clearance still further to 30 (mL/min)/kg.</div><div class="NLM_p">Despite the improvement in PK properties, the activity of these derivatives was still suboptimal, and accordingly attempts were undertaken to increase the activity by restricting the rotational freedom of the amines, either by closing the methylamine back onto the phenyl ring as in <b>13</b> and <b>14</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) or through cyclization onto the benzylic methylene, as in <b>15</b>−<b>17</b>. Locking the amine into a tetrahydroisoquinoline system like <b>13</b> or <b>14</b> resulted in a modest improvement in enzymatic activity, and both analogues displayed around a 2-fold improvement in activity, with EC<sub>90</sub> = 310 and 140 nM in the PARylation assay and antiproliferative activities of 130 and 270 nM, respectively, in BRCA-1 silenced cells. Both analogues showed excellent selectivity for the BRCA-1 silenced cells, with 16- and 20-fold higher concentrations required to cause antiproliferative effects in wild-type cells. Despite the encouraging profile, <b>13</b> was still characterized by high plasma clearance in rats, with Cl = 87 (mL/min)/kg, reflecting the moderate stability in both rat microsomes and CYP1A1, Cl<sub>int</sub> = 52 and 0.7 (μL/min)/mgP, respectively. In contrast, the isomer <b>14</b> showed slightly better microsomal stability with Cl<sub>int</sub> = 36 (μL/min)/mgP, and lower plasma clearance in vivo where Cl = 30 (mL/min)/kg. This compound also displayed modest oral bioavailability, <i>F</i> = 22%.</div><div class="NLM_p">Unfortunately cellular activity was still suboptimal and efforts focused on the other cyclization strategy (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Accordingly, pyrrolidine <b>15</b> and piperidine derivatives <b>16</b> and <b>17</b> were prepared. These three analogues bore the basic amine at increasing distances from the aromatic ring. The first two analogues displayed similar enzyme activities, although the piperidine <b>16</b> was characterized by 2-fold improvement in cellular activity, with EC<sub>90</sub> = 220 nM in the PARylation assay. This analogue was the first compound from this series to display double digit antiproliferation activity, CC<sub>50</sub> = 72 nM, in BRCA-1 deficient cells and displayed >25-fold selectivity for BRCA-1 silenced cells compared to their wild type counterparts. In contrast, the 4-piperidinyl isomer <b>17</b> displayed around a 3-fold weaker enzyme activity, and this was reflected in weaker cellular activity with CC<sub>50</sub> = 410 nM in BRCA-1 deficient cells. Unsurprisingly, the pyrrolidine <b>15</b> with the amine in a benzylic position was a substrate of CYP1A1 (Cl<sub>int</sub> = 2.5 (μL/min)/mgP), but the 3-piperidinyl <b>16</b> derivative bearing a phenethylamine showed good stability both in rat liver microsomes and in recombinant CYP1A1, Cl<sub>int</sub> = 11 and 0.3 (μL/min)/mgP, respectively. When dosed to rats, <b>16</b> displayed moderate plasma clearance Cl = 47 (mL/min)/kg and excellent oral bioavailability, <i>F</i> = 74%. The 4-piperidinyl derivative <b>17</b> showed similar in vitro properties, but given the weaker cellular activity with BRCA-1, CC<sub>50</sub> = 410 nM.</div><div class="NLM_p">Given the encouraging properties of <b>16</b>, the two enantiomers were separated and profiled, and although only marginal differences in activity between <b>56</b> and <b>57</b> were seen on the enzyme (PARP-1 IC<sub>50</sub> = 3.2 and 2.4 nM, respectively), the <i>S</i>-enantiomer <b>56</b> proved to be around an order of magnitude more active in cells with EC<sub>50</sub> = 4 nM and EC<sub>90</sub> = 45 nM in the PARylation assay, compared to EC<sub>50</sub> = 30 nM and EC<sub>90</sub> = 280 nM for the enantiomer <b>57</b>. Similarly, the <i>S</i>-enantiomer <b>56</b> displayed improved antiproliferation effects in the BRCA-1 silenced cells with CC<sub>50</sub> = 33 nM, compared to 470 nM for the <i>R</i>-enantiomer <b>57</b>. As seen previously for the racemate, excellent selectivity was seen between BRCA-1 silenced and wild-type cells with <b>56</b> displaying a 23-fold window. The absolute stereochemistry of the piperidine was determined by Mosher’s amide analysis (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), as well as through comparison to a synthetic intermediate prepared by nitration and reduction of (<i>S</i>)-3-phenylpiperidine prepared by enantioselectively as described by Bosch.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The pharmacokinetics of the <i>S</i>-enantiomer <b>56</b> both in vitro and in vivo in rats were slightly inferior to those of the <b>57</b>, but nevertheless, <b>56</b> was characterized by acceptable pharmacokinetics in rats with plasma clearance of 28 (mL/min)/kg, very high volume of distribution (Vd<sub>ss</sub> = 6.9 L/kg), long terminal half-life (<i>t</i><sub>1/2</sub> = 3.4 h), and excellent bioavailability, <i>F</i> = 65%.</div><div class="NLM_p">Given the interest in <b>56</b>, it was profiled against several other PARP family members in a trichloroacetic acid precipitation assay looking at the incorporation of [<sup>3</sup>H]NAD into the growing PAR polymers (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). It was demonstrated to be a potent and selective PARP-1 and PARP-2 inhibitor with IC<sub>50</sub> = 3.8 and 2.1 nM, respectively. Furthermore, it displayed at least a 100-fold selectivity over PARP-3, V-PARP, and tankyrase-1, with IC<sub>50</sub> = 1300, 330, and 570 nM, respectively. As well as inhibiting the growth of HeLa cell lacking BRCA-1 because of silencing by RNA interference, this derivative is able to inhibit the proliferation of cancer cell lines carrying natural BRCA-1 or BRCA-2 mutations (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In MDA-MB-436 human mammary gland adenocarcinoma cells carrying BRCA-1 mutations, <b>56</b> displayed CC<sub>50</sub> = 18 nM, while in CAPAN-1 human pancreatic adenocarcinoma cells, which are BRCA-2 mutant, <b>56</b> displayed CC<sub>50</sub> = 90 nM. The latter result substantiates the evidence that potent PARP inhibitors are capable of killing BRCA-2 deficient cells.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In contrast, normal human prostate and mammary epithelial cells are resistant to <b>56</b>, displaying antiproliferative effects in the micromolar range, thereby demonstrating the very high selective cytotoxicity from these PARP inhibitors in BRCA-1 and -2 mutant cancer cells compared to surrounding tissue.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity of <b>56</b> on Individual PARP Isoform<a class="ref internalNav" href="#t4fn2" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left">PARP-1</td><td align="char">3.8</td></tr><tr valign="top"><td align="left">PARP-2</td><td align="char">2.1</td></tr><tr valign="top"><td align="left">PARP-3</td><td align="char">1300</td></tr><tr valign="top"><td align="left">V-PARP</td><td align="char">330</td></tr><tr valign="top"><td align="left">TANK-1</td><td align="char">570</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn2"><div class="footnote" id="t4fn2"><sup>a</sup><p class="last">Values are the mean of at least four experiments (standard deviations were within 25% of the mean values).</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Antiproliferation Activity of <b>56</b><a class="ref internalNav" href="#t5fn2" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">cell line</th><th class="rowsep1" align="center">tumor type</th><th class="rowsep1" align="center">mutation</th><th class="rowsep1" align="center" char=".">CC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left">MDA-MB-436</td><td align="left">mammary gland adenocarcinoma</td><td align="left">BRCA1 5396 + 1G > A mutation and loss of wt allele</td><td align="char" char=".">18</td></tr><tr valign="top"><td align="left">CAPAN-1 cells</td><td align="left">pancreas adenocarcinoma</td><td align="left">BRCA2 6174delT mutation and loss of wt allele</td><td align="char" char=".">90</td></tr><tr valign="top"><td align="left">human prostate epithelial</td><td align="left"> </td><td align="left"> </td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left">human mammary epithelial</td><td align="left"> </td><td align="left"> </td><td align="char" char=".">>5000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn2"><div class="footnote" id="t5fn2"><sup>a</sup><p class="last">Values are the mean of at least four experiments (standard deviations were within 25% of the mean values).</p></div></div></div><div class="NLM_p">The in vivo efficacy of the compound was demonstrated preclinically in a BRCA-1 mutant MDA-MB-436 xenograft model (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), and 2 × 10<sup>6</sup> cells were injected subcutaneously in the right flank of 6-week-old nude CD1 female mice. When tumors reached an average volume of 150 mm<sup>3</sup>, mice were randomized to form homogeneous groups and treated with <b>56</b>, dosing orally at either 100 mg/kg q.d. or 50 mg/kg b.i.d. Tumor regression was observed with both dosing regimes, and both were well tolerated, with no mortality. Less than 10% body weight loss was seen during the experiment.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of <b>56</b> in MDA-MB-436 (BRCA-1 mutant) xenograft bearing mice when dosed orally at 100 mg/kg q.d. or 50 mg/kg b.i.d. for 33 days. For each group, <i>n</i> = 7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further characterization of the preclinical profile of <b>56</b> will be described elsewhere in due course, and <b>56</b> is currently undergoing clinical evaluation in a phase 1 clinical trial in cancer patients.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel series of 2-phenyl-2<i>H</i>-indazole-7-carboxamide PARP inhibitors has been developed. Introduction of a <i>p</i>-alkylaminomethyl group improved cellular activity but resulted in detrimental PK properties as a result of oxidation by CYP1A enzymes. Subsequent optimization culminated in the identification of <b>56</b> which is a potent and selective PARP 1 and 2 inhibitor, displaying more than 100-fold selectivity over the other PARP family members. This compound has a double digit nanomolar antiproliferative activity on a range of BRCA mutant tumor cells and displays high selectivity over normal epithelial cells. In a mouse xenograft model using BRCA-1 mutant cells, <b>56</b> is efficacious at well tolerated doses when administered orally. These preclinical findings have supported the transition of <b>56</b> into clinical development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Experimental Details</h3><div class="NLM_p last">Solvents and reagents were obtained from commercial suppliers and were used without further purification. HPLC−MS and UPLC−MS analyses were performed on either a Waters Alliance 2795 apparatus or an Acquity UPLC. Nuclear magnetic resonance spectra were obtained on Bruker AMX spectrometers and are referenced in ppm relative to TMS. High resolving power accurate mass measurement electrospray (ES) and atmospheric pressure chemical ionization (APCI) mass spectral data were acquired by use of a Bruker Daltonics 7T Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR MS). All final compounds displayed ≥95% purity as determined by analytical RP-HPLC on an Acquity Waters UPLC using three different methods.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> PARP-1 SPA Assay</h3><div class="NLM_p">Enzyme assay was conducted in buffer containing 25 mM Tris, pH 8.0, 1 mM DTT, 1 mM spermine, 50 mM KCl, 0.01% Nonidet P-40, and 1 mM MgCl<sub>2</sub>. PARP reactions contained 0.1 μCi [<sup>3</sup>H]NAD<sup>+</sup> (200 000 DPM), 1.5 μM NAD<sup>+</sup>, 150 nM biotinylated NAD<sup>+</sup>, 1 μg/mL activated calf thymus, and 1−5 nM PARP-1. Autoreactions utilizing SPA bead-based detection were carried out in 50 μL volumes in white 96-well plates.</div><div class="NLM_p last">Compounds were prepared in 11-point serial dilution in 96-well plate, 5 μL/well in 5% DMSO/H<sub>2</sub>O (10× concentrated). Reactions were initiated by adding first 35 μL of PARP-1 enzyme in buffer and incubating for 5 min at room temperature and then 10 μL of NAD<sup>+</sup> and DNA substrate mixture. After 3 h at room temperature, these reactions were terminated by the addition of 50 μL of streptavidin-SPA beads (2.5 mg/mL in 200 mM EDTA, pH 8). After 5 min, they were counted using a TopCount microplate scintillation counter. IC<sub>50</sub> data was determined from inhibition curves at various substrate concentrations.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> PARP Isoform TCA Assays</h3><div class="NLM_p">The enzymatic reaction was conducted in the presence of 25 mM Tris-HCl pH 8.0, 1 mM MgCl<sub>2</sub>, 50 mM KCl, 1 mM spermine, 0.01% Nonidet P-40, and 1 mM DTT. PARP reactions contained 0.1 μCi [<sup>3</sup>H]NAD (200 000 DPM), 1.5 μM NAD<sup>+</sup>, 1 μg/mL activated calf thymus, and 0.2−1 nM human PARP-1 enzyme. Assays were carried out in 50 μL volumes in white 96-well polypropylene microplate.</div><div class="NLM_p last">A 96-well plate was prepared with serial dilutions over 10 points over a 0.1−50 nM concentration range 5% DMSO/H<sub>2</sub>O, 5 μL. Reactions were initiated by adding first 35 μL of PARP-1 enzyme in buffer and incubating for 5 min at room temperature, then 10 μL of NAD<sup>+</sup> and DNA substrate mixture. After 2 h incubation at room temperature, the reaction was stopped by the addition of TCA (50 μL/well, 20% in 20 mM NaPPi solution) and incubated for 10 min over ice. The resulting precipitate was filtered on a Unifilter GF/B microplate and washed four times with 2.5% TCA. After addition of 50 μL/well of scintillation liquid the amount of radioactivity incorporated into the PAR polymers was determined using a TopCount microplate scintillation counter. IC<sub>50</sub> data were determined from inhibition curves at various substrate concentrations. The protocols for the other PARP family members are very similar with subtle changes as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> PARylation Assay</h3><div class="NLM_p">HeLa cells were seeded into a 96-well Viewplate black microplate at an initial concentration of 10 000 cells/well in culture medium (100 μL of DMEM containing 10% FCS, 0.1 mg/mL penicillin−streptomycin, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine). The plates were incubated for 4 h at 37 °C under 5% CO<sub>2</sub> atmosphere, and then compounds were added with serial dilutions over nine points over a 0.3−100 nM concentration range in 5% DMSO/H<sub>2</sub>O, 10 μL/well. The plate was then incubated for 18 h at 37 °C in 5% CO<sub>2</sub>, and then DNA damage was provoked by addition of 5 μL of H<sub>2</sub>O<sub>2</sub> solution in H<sub>2</sub>O (final concentration 200 μM). As a negative control, cells untreated with H<sub>2</sub>O<sub>2</sub> were used. The plate was kept at 37 °C for 5 min. Then the medium was gently removed by plate inversion, and the cells were fixed by addition of ice-cold MeOH (100 μL/well) and kept at −20 °C for 20 min.</div><div class="NLM_p last">After removal of the fixative by plate inversion and washing 10 times with PBS (300 μL), the detection buffer (100 μL/well, containing PBS, Tween (0.05%), and BSA (1 mg/mL)) together with the primary PAR mAb (Alexis ALX-804-220, 1:2000), the secondary antimouse Alexa Fluor 488 antibody (Molecular Probes A11029, 1:3000), and nuclear dye Draq5 (Alexis Bos 889001R200, 5 μM) were added. Following 3 h incubation at room temperature in the dark, removal of the solution, and washing 10 times with PBS (300 μL), the plate was read on an InCell1000. Monitoring for PAR polymer was by detection of Alexa488 at Ex. S 475_20X, Em. HQ 535_50, exposure time of 600 ms, and identification of the nuclei was by tracking Draq5 with Ex. HQ 620_60X, Em. HQ 700_75M, exposure time of 300 ms. The % PAR-positive cells was calculated by measuring the ratio between the numbers of PAR-positive nuclei over the total number of Draq5-labeled nuclei. The IC<sub>50</sub> was determined on the basis of the residual enzyme activity in the presence of increasing PARPi concentration.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Proliferation Assay in BRCA-1 Silenced and Wild Type HeLa Cells</h3><div class="NLM_p">HeLa BRCA1-silenced cells were generated by transducing HeLa cells at an MOI of 100 with a lentivirus containing an H1-derived expression cassette for a shRNA against BRCA-1 and an expression cassette for GFP (GFP under the control of EF1-a promoter). Silencing of BRCA1 was more than 80% as assessed by Taqman analysis. Control BRCA wild type HeLa cells were generated by transducing them with a lentivirus expressing GFP only.</div><div class="NLM_p last">Proliferation assays were conducted in 96-well black viewplates, and 300 cells/well (250 cell/well for BRCA-1 wt) in culture medium, 190 μL/well (DMEM containing 10% FCS, 0.1 mg/mL penicillin−streptomycin, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine), were plated and incubated for 4 h at 37 °C under 5% CO<sub>2</sub> atmosphere. Inhibitors were then added with serial dilutions, 10 μL/well to obtain the desired final compound concentration in 0.5% DMSO. The cells were then incubated for 7 days at 37 °C in 5% CO<sub>2</sub> after which time viability was assessed. Briefly, with CellTiter-Blue (Promega) solution prediluted 1:10 in medium, 100 μL/well was added and the cells left for 45 min at 37 °C under 5% CO<sub>2</sub> and then a further 15 min at room temperature in the dark. The number of living cells was determined by reading the plate at fluorimeter, excitation at 550 nm and emission at 590 nm. Cell growth was expressed as the percentage growth with respect to vehicle treated cells. The concentration required to inhibit cell growth by 50% (CC<sub>50</sub>) was determined. The protocols for the other cell lines are very similar and are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Xenograft Model</h3><div class="NLM_p last">The MDA-MB-436 human breast cancer cells (ATCC) were grown in RPMI 1640 medium with <span class="smallcaps smallerCapital">l</span>-glutamine supplemented with 10% FCS, penicillin (100 U/mL), and streptomycin (100 μg/mL) in standard adherent culture conditions at 37 °C and 5% CO<sub>2</sub>. For establishment of xenograft tumors, cells were harvested from subconfluent cultures using EDTA/trypsin, washed in serum free-medium, and injected (2 × 10<sup>6</sup> cells) subcutaneously in the right flank of 6-week-old nude CD1 female mice in 100 μL total volume of 1:1 mix of cell suspension in serum-free media and RGF-Matrigel. When tumor reached an average volume of 150 mm<sup>3</sup>, mice were randomized to form homogeneous groups and treatment started, dosing orally. Mice were dosed orally in water (10 mL/kg) with 100 mg/kg q.d. or 50 mg/kg b.i.d. for 33 days, with tumor growth and body weight measurements done at least once a week.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods for the Synthesis of Indazole PARP Inhibitors</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Preparation of Imines <b>6a</b>−<b>k</b> (Method A)</h4><div class="NLM_p last">A mixture of methyl 3-formyl-2-nitrobenzoate (<b>5</b>) (1.0 equiv) and the corresponding aniline (1.05 equiv) in EtOH (0.2 M) was stirred at reflux under N<sub>2</sub> atmosphere for 2 h until TLC revealed completion of the reaction. Evaporation of the solvent gave a white solid which was used in the next step without further purification.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Preparation of Methyl 2<i>H</i>-Indazole-7-carboxylate Esters <b>7a</b>−<b>k</b> (Method B)</h4><div class="NLM_p last">A mixture of the imine (<b>6a</b>−<b>k</b>) (1.0 equiv) and NaN<sub>3</sub> (1.05 equiv) in dry DMF (0.3 M) was stirred at 90 °C overnight under N<sub>2</sub> atmosphere. The crude was concentrated under reduced pressure and the residue purified by flash column chromatography on silica.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Preparation of 2<i>H</i>-Indazole-7-carboxamides <b>8</b>−<b>17</b> (Method C)</h4><div class="NLM_p last">A solution of the corresponding carboxylic ester (<b>7a</b>−<b>k</b>) in NH<sub>3</sub> (7 N solution in MeOH, 200 equiv) in a sealed tube was heated to 60 °C for 36 h. After the mixture was cooled, solvent was evaporated under reduced pressure and the residue purified by flash column chromatography.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Preparation of Methyl 2-(4-Formylphenyl)-2<i>H</i>-indazole-7-carboxylate <b>32</b> (Method D)</h4><div class="NLM_p last">To a solution of methyl 2<i>H</i>-indazole-7-carboxylate (<b>31</b>) (1.0 equiv) in DMF (0.8 M) were added K<sub>2</sub>CO<sub>3</sub> (1.1 equiv) and 4-fluorobenzaldehyde (1.3 equiv), and the reaction mixture was heated under microwave conditions at 200 °C for 10 min. The reaction mixture was cooled to room temperature and diluted with EtOAc. The organic phase was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave (<b>32</b>) which was purified by flash column chromatography.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Preparation of Methyl 2-{4-[(Alkylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxylate <b>33a</b>−<b>k</b> (Method E)</h4><div class="NLM_p last">Methyl 2-(4-formylphenyl)-2<i>H</i>-indazole-7-carboxylate (<b>32</b>) (1.0 equiv) was suspended in MeOH (0.1 M), and the amine (8 equiv) was added. To this solution was added a solution of NaBH<sub>3</sub>(CN) (1.1 equiv) and ZnCl<sub>2</sub> (0.5 equiv) in MeOH (0.5 mL). The pH was adjusted to 6 with 1.25 M HCl in MeOH, and the mixture stirred at room temperature for 3 h. Then 6 N HCl (0.1 mL) was added and the solvent was reduced in vacuo. Saturated aqueous NaHCO<sub>3</sub> solution was added, the product was extracted with DCM and dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvents were reduced under reduced pressure.</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 3-Formyl-2-nitrobenzoate (<b>5</b>)</h4><div class="NLM_p">To a suspension of 3-methyl-2-nitrobenzoic acid (13.5 g, 74 mmol) in MeOH (200 mL) at 0 °C was added dropwise AcCl (15.9 mL, 224 mmol). The reaction mixture was stirred for 20 h at reflux. The solvent was reduced under reduced pressure, and the residue was dissolved in EtOAc, washed several times with saturated aqueous NaHCO<sub>3</sub> solution and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave methyl 3-methyl-2-nitrobenzoate (<b>4</b>) (12.4 g, 85%) as a white solid which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 7.86 (1H, d, <i>J =</i> 7.5 Hz), 7.53−7.42 (2H, m), 3.89 (3H, s), 2.36 (3H, s). MS (ES) C<sub>9</sub>H<sub>9</sub>NO<sub>4</sub> requires 195, found 218 (M + Na)<sup>+</sup>.</div><div class="NLM_p">A mixture of methyl 3-methyl-2-nitrobenzoate (12.4 g, 63.3 mmol), (BzO)<sub>2</sub> (0.92 g, 3.8 mmol), and NBS (13.3 g, 74.7 mmol) in CCl<sub>4</sub> (320 mL) was heated at reflux under N<sub>2</sub> atmosphere for 12 h. The mixture was cooled to room temperature, diluted with DCM, concentrated under reduced pressure while dry loading onto silica gel. The residue was purified by flash column chromatography on silica gel using 10% EtOAc/petroleum ether to yield methyl 3-(bromomethyl)-2-nitrobenzoate (6.94 g, 40%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300K) δ 7.93 (1H, d, <i>J =</i> 7.7 Hz), 7.72 (1H, d, <i>J =</i> 7.7 Hz), 7.57 (1H, t, <i>J =</i> 7.7 Hz), 4.43 (2H, s), 3.88 (3H, s). MS (ES) C<sub>9</sub>H<sub>8</sub>BrNO<sub>4</sub> requires 273/275, found 242/244 (M − MeO)<sup>+</sup>, 227/229 (M − NO<sub>2</sub>)<sup>+</sup>.</div><div class="NLM_p last">To a mixture of methyl 3-(bromomethyl)-2-nitrobenzoate (6.94 g, 25.3 mmol) and 4 Å molecular sieves (35 g) in MeCN (125 mL) at room temperature was added <i>N</i>-methylmorpholine <i>N</i>-oxide (5.93 g, 50.6 mmol), and the reaction mixture was stirred for 1.5 h under N<sub>2</sub> atmosphere. Then the mixture was diluted with EtOAc and filtered and the filtrate was washed with H<sub>2</sub>O, 1 N HCl, brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave methyl 3-formyl-2-nitrobenzoate (<b>5</b>) as a white solid (3.92 g, 74%) which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 9.96 (1H, s), 8.26 (1H, d, <i>J</i> = 7.9 Hz), 8.18 (1H, d, <i>J =</i> 7.9 Hz), 7.77 (1H, t, <i>J =</i> 7.9 Hz), 3.93 (3H, s). MS (ES) C<sub>9</sub>H<sub>7</sub>NO<sub>5</sub> requires 209, found 208 (M − H)<sup>−</sup>.</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-Nitro-3-[(phenylimino)methyl]benzoate (<b>6a</b>)</h4><div class="NLM_p last"><b>6a</b> was prepared according to general method A, using <b>5</b> (0.4 g, 1.9 mmol) and aniline (0.18 g, 2.0 mmol) to afford methyl 2-nitro-3-[(phenylimino)methyl]benzoate (<b>6a</b>) which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 8.51 (1H, d, <i>J =</i> 7.3 Hz), 8.41 (1H, s), 8.11 (1H, d, <i>J =</i> 7.3 Hz), 7.67 (1H, t, <i>J =</i> 7.8 Hz), 7.43 (2H, t, <i>J =</i> 7.8 Hz), 7.31 (1H, t, <i>J =</i> 7.3 Hz), 7.16 (2H, d, <i>J =</i> 7.8 Hz), 3.94 (3H, s).</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 2-Phenyl-2<i>H</i>-indazole-7-carboxylate (<b>7a</b>)</h4><div class="NLM_p last"><b>7a</b> was prepared according to general method B using <b>6a</b> (0.54 g, 1.9 mmol) to give, after purification by flash column chromatography on silica using a gradient of 10−40% EtOAc/petroleum, ether methyl 2-phenyl-2<i>H</i>-indazole-7-carboxylate (<b>7a</b>) (0.18 g, 37% over two steps) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 8.50 (1H, s), 8.12 (1H, d, <i>J =</i> 7.0 Hz), 7.96−7.90 (3H, m), 7.49 (2H, t, <i>J =</i> 7.6 Hz), 7.38 (1H, t, <i>J =</i> 7.4 Hz), 7.15 (1H, t, <i>J =</i> 7.4 Hz), 4.03 (3H, s). MS (ES) C<sub>15</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> requires 252, found 253 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Phenyl-2<i>H</i>-indazole-7-carboxamide (<b>8</b>)</h4><div class="NLM_p last"><b>8</b> was prepared according to general method C using <b>7a</b> (0.18 g, 0.7 mmol) to afford, after purification by flash column chromatography on silica using a gradient of 30−50% EtOAc/petroleum ether, <b>8</b> (47 mg, 28%) as white solid. <sup>1</sup>H NMR (400 MHz, DMSO, 300 K) δ 9.33 (1H, s), 8.56 (1H, br s), 8.16 (2H, d, <i>J =</i> 7.9 Hz), 8.08−8.00 (2H, m), 7.88 (1H, br s), 7.63 (2H, t, <i>J =</i> 7.7 Hz), 7.50 (1H, t, 7.4 Hz), 7.27 (1H, t, <i>J =</i> 7.9 Hz). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>12</sub>N<sub>3</sub>O 238.0975, found 238.0977. MS (ES) C<sub>14</sub>H<sub>11</sub>N<sub>3</sub>O requires 237, found 238 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2,3-Diaminobenzoate (<b>19</b>)</h4><div class="NLM_p last">A mixture of 2-amino-3-nitrobenzoic acid methyl ester (<b>18</b>) (6 g, 30 mmol) and Pd/C (0.6 g, 10% w/w) in MeOH (100 mL) was stirred for 3 days at room temperature under H<sub>2</sub> atmosphere (1 atm). The mixture was filtered through Celite, and then the solvent was evaporated under reduced pressure. The red solid of crude methyl 2,3-diaminobenzoate (<b>19</b>) (4.88 g, 96%) was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3,</sub> 300 K) δ 7.46 (1H, dd, <i>J =</i> 8.1 and 1.4 Hz), 6.84 (1H, dd, <i>J =</i> 7.5 and 1.4 Hz), 6.59 (1H, dd, <i>J =</i> 8.1 and 7.5 Hz), 3.87 (3H, s). MS (ES) C<sub>8</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> requires 166, found 167 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 3-Amino-2-[phenyldiazenyl]benzoate (<b>20</b>)</h4><div class="NLM_p last">A mixture of methyl 2,3-diaminobenzoate (<b>19</b>) (400 mg, 2.4 mmol) and nitrosobenzene (284 mg, 2.6 mmol) in AcOH (25 mL) was stirred for 3 h at room temperature. Evaporation of the solvent gave methyl 3-amino-2-[phenyldiazenyl]benzoate (<b>20</b>) as a yellow solid which was used in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 8.00 (1H, dd, <i>J =</i> 8.0 and 1.6 Hz), 7.96 (1H, dd, <i>J =</i> 7.6 and 1.6 Hz), 7.83 (2H, d, <i>J =</i> 7.6 Hz), 7.45−7.35 (4H, m), 6.71 (1H, t, <i>J =</i> 8.0 Hz), 3.89 (3H, s). MS (ES<sup>+</sup>) C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub> requires 255, found 256 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 2-Phenyl-2<i>H</i>-1,2,3-benzotriazole-4-carboxylate (<b>21</b>)</h4><div class="NLM_p last">A mixture of the crude methyl 3-amino-2-[phenyldiazenyl]benzoate (<b>20</b>) (1.2 mmol) and Cu(OAc)<sub>2</sub> (218 mg, 1.2 mmol) in DMF (4.5 mL) was stirred for 90 min at 80 °C while O<sub>2</sub> was bubbled through this solution. The mixture was cooled to room temperature and diluted with EtOAc. The organic phase was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave methyl 2-phenyl-2<i>H</i>-1,2,3-benzotriazole-4-carboxylate (<b>21</b>) as a yellow oil which was used in the next step without purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3,</sub> 300 K) δ 8.45 (1H, d, <i>J =</i> 7.8 Hz), 8.29 (2H, d, <i>J =</i> 7.2 Hz), 8.17 (2H, d, <i>J =</i> 7.8 Hz), 7.41−7.33 (3H, m), 4.05 (3H, s). MS (ES<sup>+</sup>) C<sub>14</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub> requires 253, found 276 (M + Na)<sup>+</sup>.</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Phenyl-2<i>H</i>-1,2,3-benzotriazole-4-carboxamide (<b>22</b>)</h4><div class="NLM_p last">A mixture of the crude methyl 2-phenyl-2<i>H</i>-1,2,3-benzotriazole-4-carboxylate (<b>21</b>) (1.2 mmol) and NaOH (72 mg, 1.8 mmol) in dioxane/water (4:1) (25 mL) was stirred overnight at room temperature. Then 1 N HCl was added until pH 5 was obtained. Evaporation of the solvents under reduced pressure gave the crude carboxylic acid which was dissolved in DMF (5 mL), and HATU (684 mg, 1.8 mmol) was added. After the mixture was stirred for 15 min, DIPEA (0.42 mL, 2.4 mmol) and ammonia (0.5 M in THF, 7.2 mL, 3.6 mmol) were added, and the reaction mixture was stirred for 36 h. The mixture was diluted with EtOAc, and the organic phase was washed with saturated aqueous NaHCO<sub>3</sub> solution and brine and dried. Evaporation of the solvent gave a crude which was purified by preparative RP-HPLC (column, C<sub>18</sub>), using H<sub>2</sub>O (0.1% TFA) and MeCN (+0.1% TFA) as eluents, to afford 2-phenyl-2<i>H</i>-1,2,3-benzotriazole-4-carboxamide (<b>22</b>) (70 mg, 12% over three steps) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.44 (2H, d, <i>J =</i> 7.8 Hz), 8.25 (1H, d, <i>J =</i> 8.4 Hz), 8.12 (2H, d, <i>J =</i> 7.1 Hz), 8.03 (1H, br s), 7.72−7.56 (4H, m). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>N<sub>4</sub>O 239.0927, found 239.0929. MS (ES) C<sub>13</sub>H<sub>10</sub>N<sub>4</sub>O requires 238, found 239 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-Amino-2-(ethoxycarbonyl)pyridinium 2,4,6-Trimethylbenzenesulfonate (<b>24</b>)</h4><div class="NLM_p last">Ethyl 2-picolinate (<b>23</b>) (500 mg, 3.3. mmol) in DCM (10 mL) was treated with <i>O</i>-mesitylenesulfonylhydroxylamine (1.07 g, 5.0 mmol) at room temperature. After 15 min a further portion of <i>O</i>-mesitylenesulfonylhydroxylamine (1.07 g, 5.0 mmol) was added and stirring continued for 2 h. The resulting solution was diluted with Et<sub>2</sub>O (100 mL) and the resulting precipitate removed by filtration and dried under reduced pressure to yield the desired compound (1.15 g, 95%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.91 (1H, d, <i>J =</i> 5.5 Hz), 8.48 (1H, d, <i>J =</i> 5.5 Hz), 8.36 (1H, t, <i>J =</i> 5.5 Hz), 8.16 (1H, t, <i>J =</i> 5.5 Hz), 6.71 (2H, s), 4.48 (2H, q, <i>J =</i> 7.2 Hz), 2.52 (6H, s), 2.29 (3H, s), 1.39 (3H, q, <i>J =</i> 7.2 Hz).</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Benzyl 7-Carbamoyl-2-phenylpyrazolo[1,5-<i>a</i>]pyridine-3-carboxylate (<b>25</b>)</h4><div class="NLM_p last">1-Amino-2-(ethoxycarbonyl)pyridinium 2,4,6-trimethylbenzenesulfonate (<b>24</b>) (1.15 g, 3.1 mmol), benzyl 3-phenylpropiolate (0.74 g, 3.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (434 mg, 3.1 mmol) in THF (30 mL) were stirred at room temperature for 18 h. The inorganics were removed by filtration, and the filtrate was concentrated under reduced pressure. The crude residue was dissolved in toluene (50 mL) and heated at reflux for 4 h and then concentrated under reduced pressure and purified by column chromatography on silica eluting with 20% EtOAc/petroleum ether to yield the desired material (<b>25</b>) (184 mg, 15%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.36 (1H, d, <i>J =</i> 5.5 Hz), 7.78−7.63 (4H, m), 7.59 (1H, d, <i>J =</i> 5.5 Hz), 7.48−7.27 (7H, m), 5.32 (2H, s), 4.47 (2H, q, <i>J =</i> 7.2 Hz), 1.19 (3H, t, <i>J =</i> 7.2 Hz). MS (ES) C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub> requires 400 found 401 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl 2-Phenylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylate (<b>26</b>)</h4><div class="NLM_p last">The substrate <b>25</b> (184 mg, 0.46 mmol) was taken up in EtOH (20 mL) and EtOAc (20 mL) and hydrogenated in the presence of 10% Pd/C (75 mg) under an H<sub>2</sub> atmosphere for 4 h. The catalyst was filtered off and the solvent concentrated under reduced pressure to yield 7-(ethoxycarbonyl)-2-phenylpyrazolo[1,5-<i>a</i>]pyridine-3-carboxylic acid (130 mg, 91%). MS (ES) C<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub> requires 310 found 311 (M + H)<sup>+</sup>. The residue (130 mg, 0.42 mmol) was taken up in 48% HBr solution (2 mL) and heated at reflux for 75 min. The reaction mixture was concentrated under reduced pressure azeotroping with toluene, then taken up in MeCN/H<sub>2</sub>O and lyophilized. The crude residue (178 mg) was used in the next step without purification. MS (ES) C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> requires 266 found 267 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Phenylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Ethyl 2-phenylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylate (<b>26</b>) was converted to 2-phenylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxamide according to general method C and then purified by column chromatography on silica eluting with 50% EtOAc/petroleum ether to yield the titled compound (34 mg, 34%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.38 (1H, s), 8.44 (1H, s), 8.06 (2H, d, <i>J =</i> 6.0 Hz), 7.97 (1H, d, <i>J =</i> 6.9 Hz, 7.76 (1H, d, <i>J =</i> 6.9 Hz), 7.55−7.47 (2H, m), 7.46−7.37 (2H, m), 7.31 (1H, s). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>12</sub>N<sub>3</sub>O 238.0975, found 238.0976. MS (ES) C<sub>14</sub>H<sub>11</sub>N<sub>3</sub>O requires 237 found 238 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 2-Phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxylate (<b>29</b>)</h4><div class="NLM_p last"><i>O</i>-Mesitylenesulfonylhydroxylamine (236 mg, 1.1 mmol) was added to a stirred solution of methyl 2-aminopyridine-3-carboxylate (<b>28</b>) (152 mg, 1 mmol) in dioxane (10 mL) at room temperature. The reaction mixture was stirred at room temperature for 2 h. Then benzaldehyde (134 μL, 1.3 mmol) was added and the reaction mixture was heated to reflux for 2 h. After the mixture was cooled, KOH (1 N in MeOH, 1 mL, 1 mmol) was added and the resulting dark-brown mixture was stirred at room temperature overnight. The reaction mixture was diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent under reduced pressure gave methyl 2-phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxylate (<b>29</b>) as a brown oil which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.25 (1H, d, <i>J =</i> 6.4 Hz), 8.28 (1H, d, <i>J =</i> 7.2 Hz), 9.25 (2H, dd, <i>J =</i> 8.0 and 2.0 Hz), 7.94−7.89 (2H, m), 7.31 (2H, d, <i>J =</i> 5.6 Hz), 3.97 (3H, s). MS (ES) C<sub>14</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub> requires 253, found 254 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Methyl 2-phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxylate <b>(29)</b> (1 mmol) was converted according to method C to give 2-phenyl[1,2,4]triazolo[1,5-<i>a</i>]pyridine-8-carboxamide (<b>30</b>) (63 mg, 26% over two steps) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.20 (1H, d, <i>J =</i> 6.0 Hz), 8.96 (1H, br s), 8.33−8.28 (3H, m), 8.21 (1H, br s), 7.60−7.55 (3H, m), 7.38 (1H, t, <i>J =</i> 7.2 Hz). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>N<sub>4</sub>O 239.0927, found 239.0928. MS (ES) C<sub>13</sub>H<sub>10</sub>N<sub>4</sub>O requires 238, found 239 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 2-(4-Formylphenyl)-2<i>H</i>-indazole-7-carboxylate (<b>32</b>)</h4><div class="NLM_p last"><b>32</b> was prepared according to general method D using methyl 2<i>H</i>-indazole-7-carboxylate (<b>31</b>) (0.3 g, 1.7 mmol) and 4-fluorobenzaldehyde (235 μL, 2.2 mmol) to give, after purification by flash column chromatography on silica using a gradient of 30−40% EtOAc/petroleum ether, methyl 2-(4-formylphenyl)-2<i>H</i>-indazole-7-carboxylate (<b>32</b>) (185 mg, 39%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 10.08 (1H, s), 8.64 (1H, s), 8.20 (2H, d, <i>J =</i> 8.6 Hz), 8.16 (1H, d, <i>J =</i> 7.2 Hz), 8.05 (2H, d, <i>J =</i> 8.6 Hz), 7.96 (1H, d, <i>J =</i> 7.2 Hz), 7.21 (1H, t, <i>J =</i> 7.2 Hz), 4.06 (3H, s). MS (ES) C<sub>16</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub> requires 280, found 281 (M + H) <sup>+</sup>.</div></div><div id="sec4_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(4-Formylphenyl)-2<i>H</i>-indazole-7-carboxamide (<b>35</b>)</h4><div class="NLM_p last"><b>35</b> was prepared according to general method D using 2<i>H</i>-indazole-7-carboxamide (<b>34</b>) (0.8 g, 5.0 mmol) and 4-fluorobenzaldehyde (685 μL, 6.4 mmol) to yield, after purification by flash column chromatography on silica with 10% MeOH/DCM, 2-(4-formylphenyl)-2<i>H</i>-indazole-7-carboxamide (<b>35</b>) (0.59 g, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 10.10 (1H, s), 9.50 (1H, s), 8.52 (1H, br s), 8.45 (2H, d, <i>J =</i> 8.6 Hz), 8.15 (2H, d, <i>J =</i> 8.6 Hz), 8.08 (1H, d, <i>J =</i> 7.2 Hz), 8.04 (1H, d, <i>J =</i> 7.2 Hz), 7.92 (1H, br s), 7.30 (1H, t, <i>J =</i> 7.2 Hz). MS (ES) C<sub>15</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub> requires 265, found 266 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(4-Acetylphenyl)-2<i>H</i>-indazole-7-carboxamide (<b>36</b>)</h4><div class="NLM_p last"><b>36</b> was prepared following general method D using 2<i>H</i>-indazole-7-carboxamide (<b>34</b>) (322 mg, 2 mmol) and 1-(4-fluorophenyl)ethanone (0.19 mL, 2 mmol). The product (<b>36</b>) (540 mg, 97%) was obtained as a white solid by precipitation from the reaction mixture by adding MeOH/EtOAc (5:1) and was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.48 (1H, s), 8.53 (1H, br s), 8.36 (2H, d, <i>J =</i> 8.8 Hz), 8.20 (2H, d, <i>J =</i> 8.8 Hz), 8.09 (1H, dd, <i>J =</i> 7.0 and 0.8 Hz), 8.05 (1H, dd, <i>J =</i> 8.4 and 0.8 Hz), 7.92 (1H, br s), 7.30 (1H, dd, <i>J =</i> 8.4 and 7.0 Hz), 2.66 (3H, s). MS (ES<sup>+</sup>) C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub> requires 279, found 280 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-{4-[(Dimethylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxamide (<b>37</b>)</h4><div class="NLM_p last"><b>37</b> was prepared according to general method E, with methyl 2-(4-formylphenyl)-2<i>H</i>-indazole-7-carboxylate (<b>32</b>) (50 mg, 0.18 mmol) and 2.0 M Me<sub>2</sub>NH in MeOH (0.71 mL, 1.4 mmol) to give methyl 2-{4-[(dimethylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>33a</b>) which was used in the next step without further purification. MS (ES) C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> requires 309, found 310 (M + H)<sup>+</sup>. Methyl 2-{4-[(dimethylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>33a</b>) (55 mg, 0.18 mmol) was treated according to general method C to give, after purification by flash column chromatography on silica with 10% MeOH/DCM, 2-{4-[(dimethylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxamide (<b>37</b>) (40 mg, 76%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>CN, 300 K) δ 8.85 (1H, s), 8.78 (1H, br s), 8.17 (1H, d, <i>J =</i> 8.0 Hz), 8.05−8.00 (3H, m), 7.56 (2H, d, <i>J =</i> 8.4 Hz), 7.28 (1H, t, <i>J =</i> 8.0 Hz), 6.36 (1H, br s), 3.56 (2H, s), 2.28 (6H, s). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>4</sub>O 295.1553, found 295.1554. MS (ES) C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O requires 294, found 295 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> {4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}<i>-N-</i>methylmethanaminium Chloride (<b>43</b>)</h4><div class="NLM_p last">Methyl 2-{4-[(methylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>33g</b>) was prepared according to general method E using methyl 2-(4-formylphenyl)-2<i>H</i>-indazole-7-carboxylate (<b>32</b>) (80 mg, 0.28 mmol) and MeNH<sub>2</sub>·HCl (308 mg, 4.6 mmol) in a mixture DCE/MeOH (4:1, 5 mL), and AcOH was used to adjust the pH to 6. The crude product was used in the next step without further purification. MS (ES) C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> requires 295, found 296 (M + H)<sup>+</sup>. 2-{4-[(Methylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxamide was prepared according to general method C using methyl 2-{4-[(methylamino)methyl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>33g</b>). The residue was purified by flash column chromatography on silica using a gradient of 0−20% DCM/MeOH (+1% Et<sub>3</sub>N) to afford a yellow powder (62 mg, 78%). The free base (21 mg, 0.08 mmol) was then dissolved in a solution of CH<sub>3</sub>CN/H<sub>2</sub>O (1:1, 0.025 M), concentrated HCl (81 μL, 0.08 mmol) was added and the solution was lyophilized, affording <b>43</b> (23 mg, quant) as a yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6,</sub> 300 K) δ 9.30 (1H, s), 9.26 (2H, br s), 8.47 (1H, br s), 8.19 (2H, d, <i>J =</i> 8.4 Hz), 8.00 (1H, d, <i>J =</i> 6.8 Hz), 7.96 (1H, d, <i>J =</i> 8.2 Hz), 7.81 (1H, br s), 7.71 (2H, d, <i>J =</i> 8.4 Hz), 7.21 (1H, app t, <i>J =</i> 7.6 Hz), 4.14 (2H, s), 2.43 (3H, s). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>4</sub>O 281.1397, found 281.1403. MS (ES) C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O requires 280, found 281 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}<i>-N-</i>methylethanaminium Chloride (<b>48</b>)</h4><div class="NLM_p last"><b>48</b> was prepared according to general method E using 2-(4-acetylphenyl)-2<i>H</i>-indazole-7-carboxamide (<b>36</b>) (0.1 g, 0.36 mmol) which, after purification by IST ISOLUTE SPE column SCX, gave 2-{4-[1-(methylamino)ethyl]phenyl}-2<i>H</i>-indazole-7-carboxamide (78 mg, 74%). The free base (78 mg, 0.26 mmol) was then dissolved in a solution of CH<sub>3</sub>CN/H<sub>2</sub>O (1:1) and 37% HCl<sub>(aq)</sub> (0.26 mmol) and the solution was lyophilized, affording 1-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}<i>-N-</i>methylethanaminium chloride (<b>48</b>) as a yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.79 (1H, br s), 9.43−9.38 (1H, m), 9.38−9.35 (1H, m), 8.55 (1H, s), 8.26 (1H, d, <i>J =</i> 8.4 Hz), 8.07 (1H, d, <i>J =</i> 6.8 Hz), 8.03 (2H, d, <i>J =</i> 8.2 Hz), 7.88 (1H, br s), 7.81 (2H, d, <i>J =</i> 8.2 Hz), 7.28 (1H, app. t, <i>J =</i> 7 Hz), 4.44−4.40 (1H, m), 2.42 (3H, s), 1.62 (3H, d, <i>J =</i> 6.8 Hz). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>4</sub>O 295.1553, found 295.1556. MS (ES<sup>+</sup>) C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O requires 294, found 295 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-[4-(1-Hydroxy-1-methylethyl)phenyl]-2<i>H</i>-indazole-7-carboxamide (<b>49</b>)</h4><div class="NLM_p last">To a solution of 2-(4-acetylphenyl)-2<i>H</i>-indazole-7-carboxamide (<b>36</b>) (2.0 g, 7.2 mmol) in THF (150 mL) at 0 °C, MeMgBr (3 M in THF, 3.6 mL, 10.7 mmol) was added dropwise. The mixture was stirred overnight at room temperature, then quenched with H<sub>2</sub>O and extracted with EtOAc. The combined organic phase was dried over MgSO<sub>4</sub>. Evaporation of the solvent under reduced pressure gave 2-[4-(1-hydroxy-1-methylethyl)phenyl]-2<i>H</i>-indazole-7-carboxamide (<b>49</b>) (1.6 g, 76%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>, 300 K) δ 9.27 (1H, s), 8.57 (1H, br s), 8.07−8.00 (4H, m), 7.87 (1H, br s), 7.68 (2H, d, <i>J =</i> 8.6 Hz), 7.28−7.24 (1H, m), 1.48 (6H, s). MS (ES<sup>+</sup>) C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> requires 295, found 296 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}<i>-N-</i>methylpropan-2-aminium Trifluoroacetate (<b>50</b>)</h4><div class="NLM_p">In a well ventilated fume hood, to a solution of 2-[4-(1-hydroxy-1-methylethyl)phenyl]-2<i>H</i>-indazole-7-carboxamide (<b>49</b>) (0.5 g, 1.7 mmol) and NaCN (0.41 g, 8.5 mmol) in DCM (10 mL) was added concentrated H<sub>2</sub>SO<sub>4</sub> (0.45 mL, 8.5 mmol), and the mixture was stirred for 24 h at room temperature. The reaction mixture was quenched by addition of saturated aqueous NaHCO<sub>3</sub> solution, and the mixture was extracted with EtOAc. The combined organic phase was dried (MgSO<sub>4</sub>) and evaporation of the solvent under reduced pressure gave a residue that was purified by flash chromatography column using 0−10% MeOH/DCM to afford 2-{4-[1-(formylamino)-1-methylethyl]phenyl}-2<i>H</i>-indazole-7-carboxamide (120 mg, 22%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.27 (1H, s), 8.57 (1H, br s), 8.43 (1H, br s), 8.07−8.01 (4H, m), 7.99 (1H, d, <i>J =</i> 1.6 Hz), 7.88 (1H, br s), 7.57 (2H, d, <i>J =</i> 8.6 Hz), 7.26 (1H, dd, <i>J =</i> 8.1 and 7.0 Hz), 1.61 (6H, s). MS (ES<sup>+</sup>) C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> requires 322, found 323 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of 2-{4-[1-(formylamino)-1-methylethyl]phenyl}-2<i>H</i>-indazole-7-carboxamide (60 mg, 0.19 mmol) in THF (6 mL) was added BH<sub>3</sub>·THF (1 M in THF, 0.28 mL, 0.28 mmol), and the mixture was stirred for 24 h at room temperature. Then saturated aqueous NaHCO<sub>3</sub> solution was added and the mixture was extracted with EtOAc. The combined organic phase was dried over MgSO<sub>4</sub>. Evaporation of the solvent under reduced pressure gave a residue that was purified by RP-HPLC (column, C<sub>18</sub>), using H<sub>2</sub>O (0.1% TFA) and MeCN (+0.1% TFA) as eluents, to afford 2-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}<i>-N-</i>methylpropan-2-aminium trifluoroacetate (<b>50</b>) (8 mg, 10%) as a yellow solid . <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.38 (s, 1H), 9.14 (1H, br s), 8.53 (1H, br s), 8.27 (2H, d, <i>J =</i> 8.7 Hz), 8.08−8.01 (2H, m), 7.88 (1H, br s), 7.79 (2H, d, <i>J =</i> 8.7 Hz), 7.28 (1H, t, <i>J =</i> 8.2 Hz), 2.36 (3H, s), 1.73 (6H, s). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>21</sub>N<sub>4</sub>O 309.1710, found 309.1712. MS (ES<sup>+</sup>) C<sub>18</sub>H<sub>20</sub>N<sub>4</sub>O requires 308, found 309 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 2-{4-[1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>7i</b>)</h4><div class="NLM_p last"><b>7i</b> was prepared following the general methods A and B using methyl 3-formyl-2-nitrobenzoate (<b>5</b>) (1.0 g, 4.8 mmol) and <i>N</i>-Boc-3-(4-aminophenyl)piperidine (1.45 g, 5.3 mmol). The crude residue was purified by flash column chromatography on silica using a gradient of 20−40% EtOAc/petroleum ether to yield the desired <b>7i</b> (0.95 g, 46%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.51 (1H, s), 8.13 (1H, d, <i>J =</i> 7.1 Hz), 7.95 (1H, d, <i>J =</i> 8.3 Hz), 7.91 (2H, d, <i>J =</i> 8.4 Hz), 7.39 (2H, d, <i>J =</i> 8.4 Hz), 7.18 (1H, app t, <i>J =</i> 7.2 Hz), 4.30−4.10 (2H, m), 4.00 (3H, s), 2.85−2.70 (3H, m), 2.11−2.03 (1H, m), 1.83−1.75 (1H, m), 1.73−1.53 (2H, m), 1.48 (9H, s). MS (ES) C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> requires 435, found 436 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 3-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidine-1-carboxylate (<b>55</b>)</h4><div class="NLM_p last">The title compound was prepared according to general method C from <b>7i</b> (0.95 g, 2.18 mmol), and the crude product was purified by trituration with Et<sub>2</sub>O to give the desired product (<b>55</b>) (0.75 g, 82%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 9.04 (1H, br s), 8.51 (1H, s), 8.31 (1H, d, <i>J =</i> 6.8 Hz), 7.91 (1H, d, <i>J =</i> 8.3 Hz), 7.84 (2H, d, <i>J =</i> 8.2 Hz), 7.42 (2H, d, <i>J =</i> 8.2 Hz), 7.31−7.22 (1H, m), 5.95 (1H, br s), 4.40−4.05 (2H, m), 2.90−2.70 (3H, m), 2.15−2.00 (1H, m), 1.85−1.75 (1H, m), 1.75−1.50 (2H, m), 1.48 (9H, s). MS (ES) C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> requires 420, found 421 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidinium Chloride (<b>16</b>)</h4><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 3-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidine-1-carboxylate (<b>55</b>) (0.75 g, 1.78 mmol) in EtOAc (8.9 mL) was added HCl (4 N in dioxane, 6.67 mL, 26.7 mmol), and the reaction mixture was stirred at room temperature for 3 h. Solvent was evaporated under reduced pressure and the crude product purified by trituration with Et<sub>2</sub>O to yield the desired (<b>16</b>) (0.59 g, 93%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.32 (1H, s), 9.12 (1H, br s), 8.87 (1H, br s), 8.55 (1H, br s), 8.13 (2H, d, <i>J =</i> 8.6 Hz), 8.06 (1H, d, <i>J =</i> 7.0 Hz), 8.02 (1H, d, <i>J =</i> 8.4 Hz), 7.89 (1H, br s), 7.55 (2H, d, <i>J =</i> 8.6 Hz), 7.27 (1H, dd, <i>J =</i> 8.4 and 7.0 Hz), 3.43−3.27 (2H, m), 3.17−3.03 (2H, m), 3.00−2.85 (1H, m), 2.00−1.70 (4H, m). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O 321.1710, found 321.1720. MS (ES) C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O requires 320, found 321 (M + H)<sup>+</sup>.</div></div><div id="sec4_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (3<i>R</i>)-3-[4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl]piperidinium Chloride (<b>57</b>) and (3<i>S</i>)-3-[4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl]piperidinium Chloride (<b>56</b>)</h4><div class="NLM_p last">The racemate <b>16</b> was separated by chiral SFC purification using CO<sub>2</sub> as supercritic eluent: column, Chiralpak AS-H, 1 mm × 25 mm.; flow = 10 mL/min; <i>T</i><sub>col</sub> = 35 °C; <i>P</i><sub>col</sub> = 100 bar; modifier, 55% <i><sup>i</sup></i>PrOH containing 4% Et<sub>2</sub>NH. Retention time of the first eluting enantiomer was 4.80 min. Evaporation of the solvent followed by lyophilization gave 2-{4-[(3<i>R</i>)-piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide as a white powder (99.0% ee). Retention time of the second eluting enantiomer was 6.51 min. Evaporation of the solvent followed by lyophilization gave 2-{4-[(3<i>S</i>)-piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide as a white powder (99.2% ee). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.28 (1H, s), 8.57 (1H, br s), 8.06 (2H, d, <i>J =</i> 7.2 Hz), 8.04 (2H, d, <i>J =</i> 8.4 Hz), 7.88 (1H, br s), 7.49 (2H, d, <i>J =</i> 8.4 Hz), 7.27 (1H, dd, <i>J =</i> 8.4, 7.2 Hz), 3.08−2.94 (2H, m), 2.77−2.67 (1H, m), 2.64−2.52 (1H, m), 1.98−1.90 (1H, m), 1.75−1.47 (4H, m). MS (ES) C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O requires 320, found 321 (M + H)<sup>+</sup>. The chlorohydrate salts of both enantiomers were prepared by stirring a solution of the free base in 1 N HCl for 15 min and lyophylization of the resulting solution, affording the corresponding hydrochloride salts as a pale-yellow solids.</div></div><div id="sec4_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (3<i>R</i>)-3-[4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl]piperidinium Chloride (<b>57</b>)</h4><div class="NLM_p last">[α]<sub class="stack">Na</sub><sup class="stack">20</sup> +133.3 (<i>c</i> 0.004, MeOH). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O 321.1710, found 321.1711.</div></div><div id="sec4_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (3<i>S</i>)-3-[4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl]piperidinium Chloride (<b>56</b>)</h4><div class="NLM_p last">[α]<sub class="stack">Na</sub><sup class="stack">20</sup> −137.9 (<i>c</i> 0.004, MeOH). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub><i>6</i></sub>, 300 K) δ 9.32 (1H, s), 9.30 (1H, br d, <i>J =</i> 10.7 Hz), 9.10 (1H, dt, <i>J</i> = 10.7, 10.3 Hz), 8.56 (1H, br s), 8.13 (2H, d, <i>J =</i> 8.5 Hz), 8.06 (1H, dd, <i>J =</i> 7.0, 0.8 Hz), 8.02 (1H, dd, <i>J =</i> 8.3, 0.8 Hz), 7.90 (1H, br s), 7.55 (2H, d, <i>J =</i> 8.5 Hz), 7.27 (1H, dd, <i>J =</i> 8.3, 7.0 Hz), 3.35−3.29 (2H, m), 3.16−3.06 (2H, m), 2.92 (1H, m), 1.95−1.74 (4H, m). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 165.5, 146.1, 142.2, 138.2, 129.7, 128.5, 125.3, 123.5, 123.4, 121.9, 121.5, 120.9, 47.5, 42.8, 38.7, 29.4, 22.1. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O 321.1710, found 321.1712. MS (ES) C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O requires 320, found 321 (M + H)<sup>+</sup>.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Alternative preparation of (3<i>S</i>)-3-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidinium Chloride (<b>56</b>)</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-(4-Nitrophenyl)pyridine (<b>59</b>)</h4><div class="NLM_p last">A mixture of 1-iodo-4-nitrobenzene (40.6 g, 0.16 mol) and pyridine-3-boronic acid (30 g, 0.24 mmol) in THF (0.82 L) together with 2 M solution Na<sub>2</sub>CO<sub>3</sub> (0.24 L) was degassed with a stream of N<sub>2</sub> for 1 h. Pd(PPh<sub>3</sub>)<sub>4</sub> (9.5 g, 8.2 mmol) was added, and the reaction mixture was heated at reflux for 72 h. After the mixture was cooled, solvents were concentrated and then EtOAc (500 mL) was added. The aqueous phase was separated and extracted with DCM (2 × 250 mL). The combined organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and solvent evaporated, giving a residue that was purified by flash chromatography column on silica gel 20−100% EtOAc/petroleum ether. The solid obtained after evaporation of the solvent was recrystallized in EtOH and filtered to give 3-(4-nitrophenyl)pyridine (<b>59</b>) (23.2 g, 71%) as a pale-beige solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.87 (1H, s), 8.69 (1H, d, <i>J =</i> 4.6 Hz), 8.34 (2H, d, <i>J =</i> 8.4 Hz), 7.95 (1H, d, <i>J =</i> 8.0 Hz), 7.74 (2H, d, <i>J =</i> 8.4 Hz), 7.46 (1H, dd, <i>J =</i> 8.0, 4.6 Hz). MS (ES) C<sub>11</sub>H<sub>8</sub>N<sub>2</sub>O<sub>2</sub> requires 200, found 201 (M + H<sup>+</sup>).</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-Piperidin-3-ylaniline (<b>60</b>)</h4><div class="NLM_p last">PtO<sub>2</sub> (0.5 g) was added to a solution of 3-(4-nitrophenyl)pyridine (<b>59</b>) (5 g, 25 mmol) and HCl (1.0 N solution in water, 25 mL, 25 mmol) in MeOH (250 mL). The reaction mixture was stirred for 24 h at room temperature under H<sub>2</sub> atmosphere (50 psi) in a Parr hydrogenation apparatus. The mixture was filtered through Celite, and then the solvent was evaporated under reduced pressure. The resulting white solid was dissolved in EtOAc (250 mL) and washed with 1 N NaOH (100 mL). The aqueous phase was extracted with EtOAc (3 × 250 mL), and the combined organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave 4-piperidin-3-ylaniline (<b>60</b>) (4.27 g, 97%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 6.98 (2H, d, <i>J =</i> 8.0 Hz), 6.61 (2H, d, <i>J =</i> 8.0 Hz), 3.55 (2H, br s), 3.15−3.09 (2H, m), 3.15−3.09 (3H, m), 1.98−1.91(1H, m), 1.79−1.75 (1H, m), 1.66−1.52 (2H, m). MS (ES) C<sub>11</sub>H<sub>16</sub>N<sub>2</sub> requires 176, found 177 (M + H)<sup>+</sup>.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (3<i>S</i>)-3-(4-Aminophenyl)piperidinium (2<i>R</i>,3<i>R</i>)-3-Carboxy-2,3-dihydroxypropanoate (<b>61</b>)</h4><div class="NLM_p last">To a solution of 4-piperidin-3-ylaniline (<b>60</b>) (19.2 g, 0.109 mol) in EtOH (4.0 L) was added a 1.0 M solution of <span class="smallcaps smallerCapital">l</span>-tartaric acid in EtOH (109 mL, 0.109 mol) over 5 min. Upon addition of the final 20 mL a precipitate started to form. The mixture was heated to reflux and then left to cool to room temperature and allowed to stand for 2 days. The resulting crystals (21.7 g) were filtered off and dried. Three recrystallizations from EtOH upgraded this material to 8.83 g (24.8%) of (3<i>S</i>)-3-(4-aminophenyl)piperidinium (2<i>R</i>,3<i>R</i>)-3-carboxy-2,3-dihydroxypropanoate (<b>61</b>) with >82% ee. Enantiomeric excess was determined by SFC on semiprep system: column, Chiralpak AD-H (1 cm × 25 cm); flow, 10 mL/min; modifier, gradient from (MeOH + 0.2% DEA) 20% (1 min) to 20% (5.7 min) to 60% to 60% (2 min); <i>T</i><sub>col</sub> = 35 °C; <i>P</i><sub>col</sub> = 100 bar; retention time for desired enantiomer, 4.6 min; retention time for minor enantiomer, 5.2 min.</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl (3<i>S</i>)-3-(4-Aminophenyl)piperidine-1-carboxylate (<b>62</b>)</h4><div class="NLM_p last">A solution of Boc<sub>2</sub>O (4.62 g, 21.2 mmol) in DCM (20 mL) was added dropwise (10 min) to a stirred suspension of (3<i>S</i>)-3-(4-aminophenyl)piperidinium (2<i>R</i>,3<i>R</i>)-3-carboxy-2,3-dihydroxypropanoate (<b>61</b>) (6.3 g, 19.3 mmol) in DCM (80 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 40 min. Then a solution of 7 N NH<sub>3</sub> in MeOH (8 mL) was added and the mixture was stirred for 30 min at 0 °C. After dilution with DCM (250 mL) the organic phase was washed with saturated aqueous NaHCO<sub>3</sub> (2 × 250 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave <i>tert</i>-butyl (3<i>S</i>)-3-(4-aminophenyl)piperidine-1-carboxylate (<b>62</b>) (4.9 g, 92%) as a white foam which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.02 (2H, d, <i>J =</i> 8.0 Hz), 6.65 (2H, d, <i>J =</i> 8.0 Hz), 4.23−4.06 (2H, m), 3.65−3.48 (1H, m), 2.74−2.50 (3H, m), 2.00−1.92 (1H, m), 1.78−1.59 (1H, m), 1.64−1.52 (3H, m), 1.46 (9H, s). MS (ES) C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub> requires 276, found 277 (M + H<sup>+</sup>).</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Methyl 2-{4-[(3<i>S</i>)-1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl]phenyl}-2H-indazole-7-carboxylate (<b>7k</b>)</h4><div class="NLM_p">A mixture of methyl 3-formyl-2-nitrobenzoate (<b>5</b>) (3.5 g, 16.9 mmol) and <i>tert</i>-butyl (3<i>S</i>)-3-(4-aminophenyl)piperidine-1-carboxylate (<b>62</b>) (4.9 g, 17.7 mmol) in EtOH (85 mL) was stirred at reflux under N<sub>2</sub> atmosphere overnight until TLC revealed completion of the reaction (petroleum ether/EtOAc = 4:1). Evaporation of the solvent gave <i>tert</i>-butyl (3<i>S</i>)-3-[4-({(1<i>E</i>)-[3-(methoxycarbonyl)-2-nitrophenyl]methylene}amino)phenyl]piperidine-1-carboxylate (<b>6k</b>) as an oil which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.54 (1H, s), 8.36 (1H, dd, <i>J =</i> 7.8, 1.3 Hz), 8.14 (1H, dd, <i>J =</i> 7.8, 1.3 Hz), 7.89 (1H, t, <i>J =</i> 7.8 Hz), 7.33 (2H, d, <i>J =</i> 8.4 Hz), 7.23 (2H, d, <i>J =</i> 8.4 Hz), 4.00−3.90 (2H, m), 3.87 (3H, s), 2.91−2.59 (3H, m), 1.88 (1H, m), 1.73−1.40 (3H, m), 1.39 (9H, s).</div><div class="NLM_p last">NaN<sub>3</sub> (1.1 g, 17.7 mmol) was added to a solution of crude <i>tert</i>-butyl (3<i>S</i>)-3-[4-({(1<i>E</i>)-[3-(methoxycarbonyl)-2-nitrophenyl]methylene}amino)phenyl]piperidine-1-carboxylate (<b>6k</b>) (16.9 mmol) in dry DMF (68 mL). The reaction mixture was heated at 90 °C for 3 days under N<sub>2</sub> atmosphere. The solvent was removed under reduced pressure and the residue purified by flash column chromatography on silica gel with 20−30% EtOAc/petroleum ether to yield methyl 2-{4-[(3<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>7k</b>) (3.4 g, 46% over two steps) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.51 (1H, s), 8.13 (1H, d, <i>J =</i> 7.1 Hz), 7.95 (1H, d, <i>J =</i> 8.3 Hz), 7.91 (2H, d, <i>J =</i> 8.4 Hz), 7.39 (2H, d, <i>J =</i> 8.4 Hz), 7.18 (1H, app t, <i>J =</i> 7.2 Hz), 4.30−4.10 (2H, m), 4.00 (3H, s), 2.85−2.70 (3H, m), 2.11−2.03 (1H, m), 1.83−1.75 (1H, m), 1.73−1.53 (2H, m), 1.48 (9H, s). MS (ES) C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> requires 435, found 436 (M + H)<sup>+</sup>.</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl (3<i>S</i>)-3-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidine-1-carboxylate (<b>63</b>)</h4><div class="NLM_p last">A solution of methyl 2-{4-[(3<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxylate (<b>7k</b>) (3.4 g, 7.8 mmol) in 7 N NH<sub>3</sub> in MeOH (195 mL, 1.37 mol) was heated to 60 °C in a sealed tube for 2 days. The solvents were reduced under reduced pressure and the residue purified by flash column chromatography on silica gel 30−80% EtOAc/petroleum ether to yield <i>tert</i>-butyl (3<i>S</i>)-3-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidine-1-carboxylate (<b>63</b>) (2.36 g, 72%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3,</sub> 300 K) δ 9.04 (1H, br s), 8.51 (1H, s), 8.31 (1H, d, <i>J =</i> 6.8 Hz), 7.91 (1H, d, <i>J =</i> 8.3 Hz), 7.84 (2H, d, <i>J =</i> 8.2 Hz), 7.42 (2H, d, <i>J =</i> 8.2 Hz), 7.31−7.22 (1H, m), 5.95 (1H, br s), 4.40−4.05 (2H, m), 2.90−2.70 (3H, m), 2.15−2.00 (1H, m), 1.85−1.75 (1H, m), 1.75−1.50 (2H, m), 1.48 (9H, s). MS (ES) C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> requires 420, found 421 (M + H)<sup>+</sup>.</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3<i>S</i>)-3-{4-[7-(Aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidinium Chloride (<b>56</b>)</h4><div class="NLM_p last">HCl (4 N in 1,4-dioxane, 13.7 mL, 55 mmol) was added to a stirred solution of <i>tert</i>-butyl (3<i>S</i>)-3-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidine-1-carboxylate (<b>63</b>) (2.3 g, 5.5 mmol) in EtOAc (27.5 mL) at room temperature. The reaction mixture was stirred at room temperature for 3 h. Solvent was evaporated under reduced pressure and the crude product purified by trituration with Et<sub>2</sub>O to yield (3<i>S</i>)-3-{4-[7-(aminocarbonyl)-2<i>H</i>-indazol-2-yl]phenyl}piperidinium chloride (1.92 g, 98%) as a yellow solid (91% ee).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63"><a href="/doi/suppl/10.1021/jm901188v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures for the biological assays including protocols for the PARP isoforms and proliferation assays in additional cell lines; general experimental details for the chemistry procedures including synthetic procedures for compounds <b>9</b>−<b>15</b>, <b>17</b>, <b>38</b>−<b>42</b>, <b>44</b>−<b>47</b>, <b>52</b>, and <b>54</b>; purity analysis results of the final compounds; and Mosher’s amide analysis of the stereochemistry of <b>56</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901188v/suppl_file/jm901188v_si_001.pdf">jm901188v_si_001.pdf (154.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901188v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Jones</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c1b1a9a8ada8b19eabaeafa4b281aca4b3a2aaefa2aeac"><span class="__cf_email__" data-cfemail="1b6b737277726b447174757e685b767e69787035787476">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Altamura</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia Boueres</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Ferrigno</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimiliano Fonsi</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Giomini</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Lamartina</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Monteagudo</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesus M. Ontoria</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Vittoria Orsale</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Cecilia Palumbi</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Pesci</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Roscilli</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Scarpelli</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carsten Schultz-Fademrecht</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlo Toniatti</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">IRBM/Merck Research Labs Rome, Via Pontina km 30,600, 00040 Pomezia, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Anna Alfieri, Maria Verdirame, and Fabio Bonelli for analytical support, and Fabrizio Fiore and Massimo Aquilina for routine PK studies.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hottiger, M. O.</span><span> </span><span class="NLM_article-title">The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3046</span><span class="NLM_x">–</span> <span class="NLM_lpage">3082</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.2741%2F2909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17981777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=3046-3082&author=P.+O.+Hassaauthor=M.+O.+Hottiger&title=The+diverse+biological+roles+of+mammalian+PARPS%2C+a+small+but+powerful+family+of+poly-ADP-ribose+polymerases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADP-ribose polymerases</span></div><div class="casAuthors">Hassa, Paul O.; Hottiger, Michael O.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3046-3082</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Poly-ADP-ribose metab. plays a mayor role in a wide range of biol. processes, such as maintenance of genomic stability, transcriptional regulation, energy metab., and cell death.  Poly-ADP-ribose polymerases (PARPs) are an ancient family of enzymes, as evidenced by the poly-ADP-ribosylating activities reported in dinoflagellates and archaebacteria and by the identification of Parp-like genes in eubacterial and archaeabacterial genomes.  Six genes encoding "bona fide" PARP enzymes have been identified in mammalians: PARP1, PARP2, PARP3, PARP4/vPARP, PARP5/Tankyrases-1, and PARP6/Tankyrases-2.  The best studied of these enzymes, PARP1, plays a primary role in the process of poly-ADP-ribosylation.  PARP1-mediated poly-ADP-ribosylation has been implicated in the pathogenesis of cancer, inflammatory, and neurodegenerative disorders.  Here, the authors summarize novel findings and concepts for PARP enzymes and their poly-ADP-ribosylation activity in the regulation of physiol. and pathophysiol. processes.  A special focus is placed on the proposed mol. mechanisms involved in these processes, such as signaling, regulation of telomere dynamics, remodeling of chromatin structure, and transcriptional regulation.  A potential functional cross-talk between PARP family members and other NAD-consuming enzymes is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoNyzgIk1gtrVg90H21EOLACvtfcHk0ljWIszkM2pwzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cntrk%253D&md5=1e62c4597ec219b0797a29c1458b98b4</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2741%2F2909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2909%26sid%3Dliteratum%253Aachs%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26atitle%3DThe%2520diverse%2520biological%2520roles%2520of%2520mammalian%2520PARPS%252C%2520a%2520small%2520but%2520powerful%2520family%2520of%2520poly-ADP-ribose%2520polymerases%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D3046%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amé, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spenlehauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">The PARP superfamily</span> <span class="citation_source-journal">BioEssays</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=882-893&author=J.-C.+Am%C3%A9author=C.+Spenlehauerauthor=G.+de+Murcia&title=The+PARP+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAm%25C3%25A9%26aufirst%3DJ.-C.%26aulast%3DSpenlehauer%26aufirst%3DC.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DThe%2520PARP%2520superfamily%26jtitle%3DBioEssays%26date%3D2004%26volume%3D26%26spage%3D882%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kleine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poreba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniewicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hottiger, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüscher, B.</span><span> </span><span class="NLM_article-title">Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.molcel.2008.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18851833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=57-69&author=H.+Kleineauthor=E.+Porebaauthor=K.+Lesniewiczauthor=P.+O.+Hassaauthor=M.+O.+Hottigerauthor=D.+W.+Litchfieldauthor=B.+H.+Shiltonauthor=B.+L%C3%BCscher&title=Substrate-assisted+catalysis+by+PARP10+limits+its+activity+to+mono-ADP-ribosylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation</span></div><div class="casAuthors">Kleine, Henning; Poreba, Elzbieta; Lesniewicz, Krzysztof; Hassa, Paul O.; Hottiger, Michael O.; Litchfield, David W.; Shilton, Brian H.; Luescher, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ADP-ribosylation controls many processes, including transcription, DNA repair, and bacterial toxicity.  ADP-ribosyltransferases and poly-ADP-ribose polymerases (PARPs) catalyze mono- and poly-ADP-ribosylation, resp., and depend on a highly conserved glutamate residue in the active center for catalysis.  However, there is an apparent absence of this glutamate for the recently described PARP6-PARP16, raising questions about how these enzymes function.  We find that PARP10, in contrast to PARP1, lacks the catalytic glutamate and has transferase rather than polymerase activity.  Despite this fundamental difference, PARP10 also modifies acidic residues.  Consequently, we propose an alternative catalytic mechanism for PARP10 compared to PARP1 in which the acidic target residue of the substrate functionally substitutes for the catalytic glutamate by using substrate-assisted catalysis to transfer ADP-ribose.  This mechanism explains why the novel PARPs are unable to function as polymerases.  This discovery will help to illuminate the different biol. functions of mono- vs. poly-ADP-ribosylation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopRTvaqa_wIrVg90H21EOLACvtfcHk0liWFYBpfIXbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLzO&md5=a7d3d0b015773d18f92a434f6a8e0232</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DKleine%26aufirst%3DH.%26aulast%3DPoreba%26aufirst%3DE.%26aulast%3DLesniewicz%26aufirst%3DK.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DShilton%26aufirst%3DB.%2BH.%26aulast%3DL%25C3%25BCscher%26aufirst%3DB.%26atitle%3DSubstrate-assisted%2520catalysis%2520by%2520PARP10%2520limits%2520its%2520activity%2520to%2520mono-ADP-ribosylation%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D32%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrd1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15864271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&author=P.+Jagtapauthor=C.+Szab%C3%B3&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span></div><div class="casAuthors">Jagtap, Prakash; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-440</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are involved in the regulation of many cellular functions.  Three consequences of the activation of PARP1, which is the main isoform of the PARP family, are particularly important for drug development: first, its role in DNA repair; second, its capacity to deplete cellular energetic pools, which culminates in cell dysfunction and necrosis; and third, its capacity to promote the transcription of pro-inflammatory genes.  Consequently, pharmacol. inhibitors of PARP have the potential to enhance the cytotoxicity of certain DNA-damaging anticancer drugs, reduce parenchymal cell necrosis (for example, in stroke or myocardial infarction) and downregulate multiple simultaneous pathways of inflammation and tissue injury (for example, in circulatory shock, colitis or diabetic complications).  The first ultrapotent novel PARP inhibitors have now entered human clin. trials.  This article presents an overview of the principal pathophysiol. pathways and mechanisms that are governed by PARP, followed by the main structures and therapeutic actions of various classes of novel PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDsrfd_xv8g7Vg90H21EOLACvtfcHk0liWFYBpfIXbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D&md5=1dfd177b8064b017efb5dd7779655d55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1718%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amé, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose): novel functions for an old molecule</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrm1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=16829982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=517-528&author=V.+Schreiberauthor=F.+Dantzerauthor=J.-C.+Am%C3%A9author=G.+de+Murcia&title=Poly%28ADP-ribose%29%3A+novel+functions+for+an+old+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose): novel functions for an old molecule</span></div><div class="casAuthors">Schreiber, Valerie; Dantzer, Francoise; Ame, Jean-Christophe; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The addn. to proteins of the neg. charged polymer of ADP-ribose, which is synthesized by poly(ADP-ribose) polymerase (PARPs) from NAD, is a unique post-translational modification.  It regulates not only cell survival and cell-death programs, but also an increasing no. of other biol. functions with which novel members of the PARP family have been assocd.  These functions include transcriptional regulation, telomere cohesion and mitotic spindle formation during cell division, intracellular trafficking, and energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLsI4_BKfjdrVg90H21EOLACvtfcHk0liWFYBpfIXbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D&md5=676e83755491500f3bf2137f348dfa1b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrm1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1963%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DAm%25C3%25A9%26aufirst%3DJ.-C.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPoly%2528ADP-ribose%2529%253A%2520novel%2520functions%2520for%2520an%2520old%2520molecule%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D517%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Huber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1103-1108&author=A.+Huberauthor=P.+Baiauthor=J.+M.+de+Murciaauthor=G.+de+Murcia&title=PARP-1%2C+PARP-2+and+ATM+in+the+DNA+damage+response%3A+functional+synergy+in+mouse+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DA.%26aulast%3DBai%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPARP-1%252C%2520PARP-2%2520and%2520ATM%2520in%2520the%2520DNA%2520damage%2520response%253A%2520functional%2520synergy%2520in%2520mouse%2520development%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D1103%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Durkacz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omidiji, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shall, S.</span><span> </span><span class="NLM_article-title">(ADP-ribose)<sub><i>n</i></sub> participates in DNA excision repair</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2F283593a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=6243744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaL3cXktVagtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1980&pages=593-596&author=B.+W.+Durkaczauthor=O.+Omidijiauthor=D.+A.+Grayauthor=S.+Shall&title=%28ADP-ribose%29n+participates+in+DNA+excision+repair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">(ADP-ribose)n participates in DNA excision repair</span></div><div class="casAuthors">Durkacz, Barbara W.; Omidiji, Olusesan; Gray, Douglas A.; Shall, Sydney</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">5747</span>),
    <span class="NLM_cas:pages">593-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The drop in cellular NAD content and the rejoining of DNA strand breaks, i.e. elevation of poly(ADP-ribose) polymerase (I) activity, after treatment of L1210 leukemia lymphoblast cells with alkylating agent, 10.5-210.6 μM Me2SO4, were inhibited by inhibitors of I, e.g. 3-aminobenzamide (Ki 4.4 μM at 26°).  The inhibitors all potentiated the cytotoxicity of Me2SO4; 2 mM aminobenzamide increased the cytotoxicity 4-fold.  In addn., the rejoining of strand breaks was prevented by nutritionally depleting cells of NAD (10-20% of normal).  Poly(ADP-ribose) may thus be involved in DNA excision repair, and possible mechanisms are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSidm4P44EPbVg90H21EOLACvtfcHk0lgClR6K6b-oVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVagtLc%253D&md5=93bfba1a7a3d3a2ea3705741d9f63734</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F283593a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F283593a0%26sid%3Dliteratum%253Aachs%26aulast%3DDurkacz%26aufirst%3DB.%2BW.%26aulast%3DOmidiji%26aufirst%3DO.%26aulast%3DGray%26aufirst%3DD.%2BA.%26aulast%3DShall%26aufirst%3DS.%26atitle%3D%2528ADP-ribose%2529n%2520participates%2520in%2520DNA%2520excision%2520repair%26jtitle%3DNature%2520%2528London%2529%26date%3D1980%26volume%3D283%26spage%3D593%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutrillaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walztinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">7303</span><span class="NLM_x">–</span> <span class="NLM_lpage">7307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1073%2Fpnas.94.14.7303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=9207086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=7303-7307&author=J.+M.+de+Murciaauthor=C.+Niedergangauthor=C.+Truccoauthor=M.+Ricoulauthor=B.+Dutrillauxauthor=M.+Markauthor=F.+J.+Oliverauthor=M.+Massonauthor=A.+Dierichauthor=M.+LeMeurauthor=C.+Walztingerauthor=P.+Chambonauthor=G.+de+Murcia&title=Requirement+of+poly%28ADP-ribose%29+polymerase+in+recovery+from+DNA+damage+in+mice+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Niedergang, Claude; Trucco, Carlotta; Ricoul, Michele; Dutrillaux, Bernard; Mark, Manuel; Oliver, F. Javier; Masson, Murielle; Dierich, Andree; LeMeur, Marianne; Walztinger, Caroline; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7303-7307</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase [PARP; NAD+ ADP-ribosyltransferase; NAD+:poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyltransferase, EC 2.4.2.30] is a zinc-finger DNA-binding protein that detects specifically DNA strand breaks generated by genotoxic agents.  To det. its biol. function, the authors have inactivated both alleles by gene targeting in mice.  Treatment of PARP-/- mice either by the alkylating agent N-methyl-N-nitrosourea (MNU) or by γ-irradn. revealed an extreme sensitivity and a high genomic instability to both agents.  Following whole body γ-irradn. (8 Gy) mutant mice died rapidly from acute radiation toxicity to the small intestine.  Mice-derived PARP-/- cells displayed a high sensitivity to MNU exposure: a G2/M arrest in mouse embryonic fibroblasts and a rapid apoptotic response and a p53 accumulation were obsd. in splenocytes.  Altogether these results demonstrate that PARP is a survival factor playing an essential and pos. role during DNA damage recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwmTBk-nHc7Vg90H21EOLACvtfcHk0lgClR6K6b-oVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D&md5=a652d7d877fa0c29ff1aeb9769fbd86f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.14.7303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.14.7303%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DTrucco%26aufirst%3DC.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DDutrillaux%26aufirst%3DB.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DWalztinger%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DRequirement%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520recovery%2520from%2520DNA%2520damage%2520in%2520mice%2520and%2520in%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D7303%26epage%3D7307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghammer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haidacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E. F.</span><span> </span><span class="NLM_article-title">Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=509-520&author=Z.-Q.+Wangauthor=B.+Auerauthor=L.+Stinglauthor=H.+Berghammerauthor=D.+Haidacherauthor=M.+Schweigerauthor=E.+F.+Wagner&title=Mice+lacking+ADPRT+and+poly%28ADP-ribosyl%29ation+develop+normally+but+are+susceptible+to+skin+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.-Q.%26aulast%3DAuer%26aufirst%3DB.%26aulast%3DStingl%26aufirst%3DL.%26aulast%3DBerghammer%26aufirst%3DH.%26aulast%3DHaidacher%26aufirst%3DD.%26aulast%3DSchweiger%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26atitle%3DMice%2520lacking%2520ADPRT%2520and%2520poly%2528ADP-ribosyl%2529ation%2520develop%2520normally%2520but%2520are%2520susceptible%2520to%2520skin%2520disease%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D509%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tentori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, G.</span><span> </span><span class="NLM_article-title">Chemopotentiation by PARP inhibitors in cancer therapy</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=25-33&author=L.+Tentoriauthor=G.+Graziani&title=Chemopotentiation+by+PARP+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopotentiation by PARP inhibitors in cancer therapy</span></div><div class="casAuthors">Tentori, Lucio; Graziani, Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARP) constitute a family of enzymes involved in the regulation of many cellular processes such as DNA repair, gene transcription, cell cycle progression, cell death, chromatin functions and genomic stability.  Among the 18 members identified so far, PARP-1 and PARP-2 are the only proteins stimulated by DNA strand breaks and implicated in the repair of DNA injury.  Therefore, these mols. have been exploited as potential targets for the development of pharmacol. strategies to increase the antitumor efficacy of chemotherapeutic agents, which induce DNA damage.  PARP inhibitors have been shown to restore sensitivity of resistant tumors to methylating agents or topoisomerase I inhibitors, drugs presently used for the treatment of primary and secondary brain tumors or malignancies refractory to std. chemotherapy.  Interestingly, PARP inhibitors may also provide protection from the untoward effects exerted by certain anticancer drugs, which cause oxidative stress and consequent PARP overactivation.  The aim of this article is to provide a brief overview of the recent literature on preclin. studies with the specific and potent inhibitors newly synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImZCOb5elR7Vg90H21EOLACvtfcHk0lgClR6K6b-oVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wltr8%253D&md5=2a2f1893efeefc3f1d140979beae6f4d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DTentori%26aufirst%3DL.%26aulast%3DGraziani%26aufirst%3DG.%26atitle%3DChemopotentiation%2520by%2520PARP%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D25%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniesta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, K.</span><span> </span><span class="NLM_article-title">Development of PARP inhibitors in oncology</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F13543780802525324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=19053880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=31-43&author=J.+Rodonauthor=M.+D.+Iniestaauthor=K.+Papadopoulos&title=Development+of+PARP+inhibitors+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Development of PARP inhibitors in oncology</span></div><div class="casAuthors">Rodon, Jordi; Iniesta, Maria D.; Papadopoulos, Kyriakos</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Poly (ADP-ribose) polymerase (PARP) plays a key role in DNA repair mechanisms by detecting and initiating repair after DNA strand breaks.  Inhibition of PARP in DNA repair-defective tumors (like those with BRCA1 or BRCA2 mutations) can lead to gross genomic instability and cell death.  Likewise, combining PARP inhibition with cytotoxic agents such as chemotherapy or radiation therapy is synergistic in many preclin. models.  Several drugs designed to inhibit PARP are currently in clin. development, many following a development path different from that of typical anticancer agents.  In this review we will focus on the early clin. data from PARP inhibitors that are entering clin. trials, the potential tumors they might target, their combination with other drugs and the different biomarkers that are being explored.  Concepts such as 'BRCAness', synthetic lethality, Phase 0 trials and pharmacodynamic markers will be discussed in the context of the development of PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNslMhf0aSo7Vg90H21EOLACvtfcHk0lhOubfoShwiPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvJ&md5=e031c4e938fd49b8cbf674dbc3ca8410</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F13543780802525324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780802525324%26sid%3Dliteratum%253Aachs%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DIniesta%26aufirst%3DM.%2BD.%26aulast%3DPapadopoulos%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520PARP%2520inhibitors%2520in%2520oncology%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D31%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ratnam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1078-0432.CCR-06-2260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17332279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1383-1388&author=K.+Ratnamauthor=J.+A.+Low&title=Current+development+of+clinical+inhibitors+of+poly%28ADP-ribose%29+polymerase+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology</span></div><div class="casAuthors">Ratnam, Kapila; Low, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme that signals the presence of DNA damage by catalyzing the addn. of ADP-ribose units to DNA, histones, and various DNA repair enzymes and by facilitating DNA repair.  PARP has been gaining increasing interest as a therapeutic target for many diseases and esp. for cancer.  Inhibition of PARP potentiates the activity of DNA-damaging agents, such as alkylators, platinums, topoisomerase inhibitors, and radiation in in vitro and in vivo models.  In addn., tumors with DNA repair defects, such as those arising from patients with BRCA mutations, may be more sensitive to PARP inhibition.  At least five different companies have now initiated oncol. clin. trials with PARP inhibitors, ranging in stage from phase 0 to phase 2.  This review summarizes the preclin. and clin. data currently available for these agents and some of the challenges facing the clin. development of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Muf0l4FhVLVg90H21EOLACvtfcHk0lhOubfoShwiPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjtr8%253D&md5=9676a8bf09a0ee2bbb19e3e26b060ba7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2260%26sid%3Dliteratum%253Aachs%26aulast%3DRatnam%26aufirst%3DK.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DCurrent%2520development%2520of%2520clinical%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520oncology%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1383%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, U.</span><span> </span><span class="NLM_article-title">New inhibitors of poly(ADP-ribose) polymerase (PARP)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1531</span><span class="NLM_x">–</span> <span class="NLM_lpage">1551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F13543776.14.11.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslemu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1531-1551&author=S.+Peukertauthor=U.+Schwahn&title=New+inhibitors+of+poly%28ADP-ribose%29+polymerase+%28PARP%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">New inhibitors of poly(ADP-ribose) polymerase (PARP)</span></div><div class="casAuthors">Peukert, Stefan; Schwahn, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1531-1551</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1), the most prominent member of the PARP family, is a DNA-binding protein that is activated by nicks in DNA occurring during inflammation, ischemia, neurodegeneration or cancer therapy.  Activated PARP-1 consumes NAD+ that is cleaved into nicotinamide and ADP-ribose and polymerizes the latter onto nuclear acceptor proteins.  This highly energy consuming process is pivotal for the maintenance of genomic stability although over-activation can culminate in cell dysfunction and necrosis.  Therefore, PARP-1 is regarded as a promising target for the development of drugs useful in various forms of inflammation, ischemia-reperfusion injury and as an adjunct in cancer therapy.  This review summarizes the structural classes of known PARP-1 inhibitors, with a focus on new inhibitors published for this target, between 2002 and July 2004.  The chem. and biol. data disclosed in these patent applications are discussed in light of new structural knowledge of the catalytic domain of the PARP family and recent work with potent inhibitors demonstrating the effects of PARP inhibition in various animal disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbTHYakSgCR7Vg90H21EOLACvtfcHk0lhOubfoShwiPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslemu7k%253D&md5=56e768ccf3d5520f34e17b6886ba4405</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.11.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.11.1531%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DSchwahn%26aufirst%3DU.%26atitle%3DNew%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D1531%26epage%3D1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alarcon de la Lastra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Fidalgo, S.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.2174%2F138161207780414241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17430191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=933-962&author=C.+Alarcon+de+la+Lastraauthor=I.+Villegasauthor=S.+Sanchez-Fidalgo&title=Poly%28ADP-ribose%29+polymerase+inhibitors%3A+new+pharmacological+functions+and+potential+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications</span></div><div class="casAuthors">Alarcon de la Lastra, C.; Villegas, I.; Sanchez-Fidalgo, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">933-962</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase (PARP) comprise of a family of enzymes which catalyzes poly(ADP-ribosyl)ation of DNA-binding proteins.  To date, seven isoforms have been identified: PARP-1, PARP-2, PARP-3, PARP-4 (Vault-PARP), PARP-5 (Tankyrases), PARP-7 and PARP-10 with structural domains and different functions.  PARP-1, the best characterized member, works as a DNA damage nick-sensor protein that uses beta-NAD+ to form polymers of ADP-ribose and has been implicated in DNA repair, maintenance of genomic integrity and mammalian longevity.  The generation of free radicals, reactive oxygen species, and peroxynitrite causes overactivation of PARP resulting in the depletion of NAD+ and ATP and consequently in necrotic cell death and organ dysfunction.  PARP has also been involved in the up-regulation of numerous pro-inflammatory genes through the activation of several transcription nuclear factors.  Thus, PARP plays an important role in the pathogenesis of several diseases, such as, stroke, myocardial infarction, circulatory shock, diabetes, neurodegenerative disorders, including Parkinson and Alzheimer diseases, allergy, colitis and other inflammatory disorders.  Pharmacol. modulation of PARP activity may constitute a suitable target to enhance the cytotoxicity of certain DNA-damaging anticancer drugs.  Also, PARP inhibition may be a viable strategy to control viral infections.  This review is intended to provide an appreciation of new pharmacol. perspectives of these remarkable drugs, summarize novel underlying mechanisms and discuss their potential clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2YUML7xYpQbVg90H21EOLACvtfcHk0lhOubfoShwiPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVWmurk%253D&md5=e9d12443a8fd98524ff305311a613e23</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.2174%2F138161207780414241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780414241%26sid%3Dliteratum%253Aachs%26aulast%3DAlarcon%2Bde%2Bla%2BLastra%26aufirst%3DC.%26aulast%3DVillegas%26aufirst%3DI.%26aulast%3DSanchez-Fidalgo%26aufirst%3DS.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520inhibitors%253A%2520new%2520pharmacological%2520functions%2520and%2520potential%2520clinical%2520implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D933%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.coph.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18032109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=96-103&author=F.+Moroni&title=Poly%28ADP-ribose%29polymerase+1+%28PARP-1%29+and+postischemic+brain+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage</span></div><div class="casAuthors">Moroni, Flavio</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose)polymerases (PARPs) are enzymes that are able to catalyze the transfer of ADP-ribose units from NAD to substrate proteins and are particularly abundant in cell nuclei where they play key roles in the maintenance of genomic integrity, control of cell cycle and gene expression.  Brain ischemia overactivates PARPs and PARP-deficient mice or animal treated with PARP inhibitors have a drastically reduced brain damage in various stroke models.  PARP 'overactivation' occurs not only in neurons but also in astrocytes, microglial cells, endothelia, and infiltrating leukocytes.  The ensuing cell death occurs through various mol. mechanisms: (a) excessive ATP use for NAD synthesis and inhibition of mitochondrial function with subsequent energy failure (particularly important in neurons); (b) apoptosis-inducing factor (AIF) translocation from the mitochondria to the nucleus (present in neurons, endothelial, and other cells); (c) excessive expression of inflammatory mediators (well demonstrated in glial cells) or (d) reduced expression of prosurvival factors.  Thus PARPs seem to play key roles in postischemic brain damage and are now considered interesting targets for therapies aimed at reducing stroke pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFXTGZaYQ57Vg90H21EOLACvtfcHk0lgiH_uF_HiMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7k%253D&md5=ebdc57710dfc2345b536fb967d1e7d8d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DPoly%2528ADP-ribose%2529polymerase%25201%2520%2528PARP-1%2529%2520and%2520postischemic%2520brain%2520damage%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D96%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Cardioprotective effects of poly(ADP-ribose) polymerase inhibition</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=34-43&author=C.+Szab%C3%B3&title=Cardioprotective+effects+of+poly%28ADP-ribose%29+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cardioprotective effects of poly(ADP-ribose) polymerase inhibition</span></div><div class="casAuthors">Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Free radical and oxidant prodn. in cardiac myocytes during ischemia/reperfusion, cardiomyopathy, cardiotoxic drug exposure and aging leads to DNA strand-breakage which activates the nuclear enzyme poly(ADP-ribose) polymerase (PARP) and initiates an energy consuming, inefficient cellular metabolic cycle with transfer of the ADP-ribosyl moiety of NAD+ to protein acceptors.  These processes lead to the functional impairment of the myocytes and promote myocyte death.  During the last decade a growing no. of exptl. studies demonstrated the beneficial effects of PARP inhibition in cell cultures through rodent models and more recently in pre-clin. large animal models of regional and global ischemia/reperfusion injury and various forms of heart failure.  The current article provides an overview of the exptl. evidence implicating PARP as a pathophysiol. modulator of cardiac myocyte injury in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclFgydgnqurVg90H21EOLACvtfcHk0lgiH_uF_HiMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wltrw%253D&md5=9ee8be5ba582b6b80bc4ad268b62766f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DCardioprotective%2520effects%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span> </span><span class="NLM_article-title">Shock, inflammation and PARP</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=72-82&author=S.+Cuzzocrea&title=Shock%2C+inflammation+and+PARP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Shock, inflammation and PARP</span></div><div class="casAuthors">Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The activation of poly(ADP-ribose) polymerase (PARP) is well considered to play an important role in various patho-physiol. conditions like inflammation and shock.  A vast amt. of circumstantial evidence implicates oxygen-derived free radicals (esp., superoxide and hydroxyl radical) and high-energy oxidants (such as peroxynitrite) as mediators of inflammation and shock.  ROS (e.g., superoxide, peroxynitrite, hydroxyl radical and hydrogen peroxide) are all potential reactants capable of initiating DNA single strand breakage, with subsequent activation of the nuclear enzyme poly(ADP-ribose) synthetase (PARS), leading to eventual severe energy depletion of the cells, and necrotic-type cell death.  During the last years, numerous exptl. studies have clearly demonstrated the beneficial effects of PARP inhibition in cell cultures through rodent models and more recently in pre-clin. large animal models of acute and chronic inflammation.  The aim of this review is to describe recent exptl. evidence implicating PARP as a pathophysiol. modulator of acute and chronic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Exd627XiZbVg90H21EOLACvtfcHk0lgiH_uF_HiMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wlt78%253D&md5=91556b95fcafc778639c4caf747c4675</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DShock%252C%2520inflammation%2520and%2520PARP%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D72%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=235-260&author=P.+Pacherauthor=C.+Szab%C3%B3&title=Role+of+poly%28ADP-ribose%29+polymerase+1+%28PARP-1%29+in+cardiovascular+diseases%3A+the+therapeutic+potential+of+PARP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DRole%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%25201%2520%2528PARP-1%2529%2520in%2520cardiovascular%2520diseases%253A%2520the%2520therapeutic%2520potential%2520of%2520PARP%2520inhibitors%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2007%26volume%3D25%26spage%3D235%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kauppinen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R. A.</span><span> </span><span class="NLM_article-title">The role of poly(ADP-ribose) polymerase-1 in CNS disease</span> <span class="citation_source-journal">Neuroscience (Amsterdam)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVyjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2007&pages=1267-1272&author=T.+M.+Kauppinenauthor=R.+A.+Swanson&title=The+role+of+poly%28ADP-ribose%29+polymerase-1+in+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of poly(ADP-ribose) polymerase-1 in CNS disease</span></div><div class="casAuthors">Kauppinen, T. M.; Swanson, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme that contributes to both neuronal death and survival under stress conditions.  PARP-1 is the most abundant of several PARP family members, accounting for more than 85% of nuclear PARP activity, and is present in all nucleated cells of multicellular animals.  When activated by DNA damage, PARP-1 consumes NAD (NAD+) to form branched polymers of ADP-ribose on target proteins.  This process can have at least three important consequences in the CNS, depending on the cell type and the extent of DNA damage: (1) Poly(ADP-ribose) formation on histones and on enzymes involved in DNA repair can prevent sister chromatid exchange and facilitate base-excision repair; (2) poly(ADP-ribose) formation can influence the action of transcription factors, notably nuclear factor κB, and thereby promote inflammation; and (3) extensive PARP-1 activation can promote neuronal death through mechanisms involving NAD+ depletion and release of apoptosis inducing factor from the mitochondria.  PARP-1 activation is thereby a key mediator of neuronal death during excitotoxicity, ischemia, and oxidative stress, and PARP-1 gene deletion or pharmacol. inhibition can markedly improve neuronal survival in these settings.  PARP-1 activation has also been identified in Alzheimer's disease and in exptl. allergic encephalitis, but the role of PARP-1 in these disorders remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTPVvqjcGkLVg90H21EOLACvtfcHk0lgiH_uF_HiMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVyjtL0%253D&md5=d14e8206bd45407517e3e1f5f4c9fcc2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKauppinen%26aufirst%3DT.%2BM.%26aulast%3DSwanson%26aufirst%3DR.%2BA.%26atitle%3DThe%2520role%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520in%2520CNS%2520disease%26jtitle%3DNeuroscience%2520%2528Amsterdam%2529%26date%3D2007%26volume%3D145%26spage%3D1267%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnature03443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15829966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=913-917&author=H.+E.+Bryantauthor=N.+Schultzauthor=H.+D.+Thomasauthor=K.+M.+Parkerauthor=D.+Flowerauthor=E.+Lopezauthor=S.+Kyleauthor=M.+Meuthauthor=N.+J.+Curtinauthor=T.+Helleday&title=Specific+killing+of+BRCA2-deficient+tumours+with+inhibitors+of+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase</span></div><div class="casAuthors">Bryant, Helen E.; Schultz, Niklas; Thomas, Huw D.; Parker, Kayan M.; Flower, Dan; Lopez, Elena; Kyle, Suzanne; Meuth, Mark; Curtin, Nicola J.; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">913-917</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage.  Nevertheless, PARP1-/- mice are viable, fertile and do not develop early onset tumors.  Here, the authors show that PARP inhibitors trigger γ-H2AX and RAD51 foci formation.  The authors propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair.  Furthermore, the authors show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired.  Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells.  The authors exploit this requirement in order to kill BRCA2-deficient tumors by PARP inhibition alone.  Treatment with PARP inhibitors is likely to be highly tumor specific, because only the tumors (which are BRCA2-/-) in BRCA2+/- patients are defective in homologous recombination.  The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumor, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJ6B7d7dB77Vg90H21EOLACvtfcHk0lgXItVTVgNoag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D&md5=44631eba667cf75ef99c31d011d6db44</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature03443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03443%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BM.%26aulast%3DFlower%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMeuth%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DSpecific%2520killing%2520of%2520BRCA2-deficient%2520tumours%2520with%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DNature%2520%2528London%2529%26date%3D2005%26volume%3D434%26spage%3D913%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Farmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarosa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnature03445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15829967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=917-921&author=H.+Farmerauthor=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+J.+Tuttauthor=D.+A.+Johnsonauthor=T.+B.+Richardsonauthor=M.+Santarosaauthor=K.+J.+Dillonauthor=I.+Hicksonauthor=C.+Knightsauthor=N.+M.+B.+Martinauthor=S.+P.+Jacksonauthor=G.+C.+M.+Smithauthor=A.+Ashworth&title=Targeting+the+DNA+repair+defect+in+BRCA+mutant+cells+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span></div><div class="casAuthors">Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian; Knights, Charlotte; Martin, Niall M. B.; Jackson, Stephen P.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">917-921</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers.  Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks.  The authors show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis.  This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination.  These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVTKE4mFwfrVg90H21EOLACvtfcHk0lgXItVTVgNoag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D&md5=03b5ba0adc21a5627fe17ae535f45078</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03445%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DH.%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BB.%26aulast%3DSantarosa%26aufirst%3DM.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520DNA%2520repair%2520defect%2520in%2520BRCA%2520mutant%2520cells%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNature%2520%2528London%2529%26date%3D2005%26volume%3D434%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluzek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialkowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzienicka, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8109</span><span class="NLM_x">–</span> <span class="NLM_lpage">8115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8109-8115&author=N.+McCabeauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=K.+Kluzekauthor=A.+Bialkowskaauthor=S.+Swiftauthor=S.+Giavaraauthor=M.+J.+O%27Connorauthor=A.+N.+Tuttauthor=M.+Z.+Zdzienickaauthor=G.+C.+M.+Smithauthor=A.+Ashworth&title=Deficiency+in+the+repair+of+DNA+damage+by+homologous+recombination+and+sensitivity+to+poly%28ADP-ribose%29+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DKluzek%26aufirst%3DK.%26aulast%3DBialkowska%26aufirst%3DA.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DGiavara%26aufirst%3DS.%26aulast%3DO%2527Connor%26aufirst%3DM.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DZdzienicka%26aufirst%3DM.%2BZ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DDeficiency%2520in%2520the%2520repair%2520of%2520DNA%2520damage%2520by%2520homologous%2520recombination%2520and%2520sensitivity%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8109%26epage%3D8115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkitaraman, A. R.</span><span> </span><span class="NLM_article-title">Cancer susceptibility and the functions of BRCA1 and BRCA2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2002&pages=171-182&author=A.+R.+Venkitaraman&title=Cancer+susceptibility+and+the+functions+of+BRCA1+and+BRCA2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26atitle%3DCancer%2520susceptibility%2520and%2520the%2520functions%2520of%2520BRCA1%2520and%2520BRCA2%26jtitle%3DCell%26date%3D2002%26volume%3D108%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Narod, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulkes, W. D.</span><span> </span><span class="NLM_article-title">BRCA1 and BRCA2: 1994 and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrc1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15343273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=665-676&author=S.+A.+Narodauthor=W.+D.+Foulkes&title=BRCA1+and+BRCA2%3A+1994+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA1 and BRCA2: 1994 and beyond</span></div><div class="casAuthors">Narod, Steven A.; Foulkes, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-676</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of the first gene assocd. with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs.  Much has been learned during the past decade about the genetic epidemiol. of breast cancer, the ethnic distribution and clin. consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility.  The ability to translate this knowledge into novel treatments, however, remains elusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1a5S77C977bVg90H21EOLACvtfcHk0lgDT-awxSRBXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCmsbk%253D&md5=200600041061619ba39dfbd8dfc91850</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnrc1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1431%26sid%3Dliteratum%253Aachs%26aulast%3DNarod%26aufirst%3DS.%2BA.%26aulast%3DFoulkes%26aufirst%3DW.%2BD.%26atitle%3DBRCA1%2520and%2520BRCA2%253A%25201994%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copsey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I. T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6581</span><span class="NLM_x">–</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.-L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+W.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+M.+Smithauthor=N.+M.+B.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%2BW.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-1-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6581%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rottenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaspers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersbergen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, A. O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, S. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, P. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zevenhoven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span> </span><span class="NLM_article-title">High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17079</span><span class="NLM_x">–</span> <span class="NLM_lpage">17084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1073%2Fpnas.0806092105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18971340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKlsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17079-17084&author=S.+Rottenbergauthor=J.+E.+Jaspersauthor=A.+Kersbergenauthor=E.+van+der+Burgauthor=A.+O.+H.+Nygrenauthor=S.+A.+L.+Zanderauthor=P.+W.+B.+Derksenauthor=M.+de+Bruinauthor=J.+Zevenhovenauthor=A.+Lauauthor=R.+Boulterauthor=A.+Cranstonauthor=M.+J.+O%27Connorauthor=N.+M.+B.+Martinauthor=P.+Borstauthor=J.+Jonkers&title=High+sensitivity+of+BRCA1-deficient+mammary+tumors+to+the+PARP+inhibitor+AZD2281+alone+and+in+combination+with+platinum+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs</span></div><div class="casAuthors">Rottenberg, Sven; Jaspers, Janneke E.; Kersbergen, Ariena; van der Burg, Eline; Nygren, Anders O. H.; Zander, Serge A. L.; Derksen, Patrick W. B.; de Bruin, Michiel; Zevenhoven, John; Lau, Alan; Boulter, Robert; Cranston, Aaron; O'Connor, Mark J.; Martin, Niall M. B.; Borst, Piet; Jonkers, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17079-17084</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Whereas target-specific drugs are available for treating ERBB2-overexpressing and hormone receptor-pos. breast cancers, no tailored therapy exists for hormone receptor- and ERBB2-neg. ("triple-neg.") mammary carcinomas.  Triple-neg. tumors account for 15% of all breast cancers and frequently harbor defects in DNA double-strand break repair through homologous recombination (HR), such as BRCA1 dysfunction.  The DNA-repair defects characteristic of BRCA1-deficient cells confer sensitivity to poly(ADP-ribose) polymerase 1 (PARP1) inhibition, which could be relevant to treatment of triple-neg. tumors.  To evaluate PARP1 inhibition in a realistic in vivo setting, we tested the PARP inhibitor AZD2281 in a genetically engineered mouse model (GEMM) for BRCA1-assocd. breast cancer.  Treatment of tumor-bearing mice with AZD2281 inhibited tumor growth without signs of toxicity, resulting in strongly increased survival.  Long-term treatment with AZD2281 in this model did result in the development of drug resistance, caused by up-regulation of Abcb1a/b genes encoding P-glycoprotein efflux pumps.  This resistance to AZD2281 could be reversed by coadministration of the P-glycoprotein inhibitor tariquidar.  Combination of AZD2281 with cisplatin or carboplatin increased the recurrence-free and overall survival, suggesting that AZD2281 potentiates the effect of these DNA-damaging agents.  Our results demonstrate in vivo efficacy of AZD2281 against BRCA1-deficient breast cancer and illustrate how GEMMs of cancer can be used for preclin. evaluation of novel therapeutics and for testing ways to overcome or circumvent therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr95zB9OKZ4ObVg90H21EOLACvtfcHk0ljCoUpiP4GLAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKlsr7F&md5=788a7d8b5341b731d007753d5a234dec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806092105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806092105%26sid%3Dliteratum%253Aachs%26aulast%3DRottenberg%26aufirst%3DS.%26aulast%3DJaspers%26aufirst%3DJ.%2BE.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DE.%26aulast%3DNygren%26aufirst%3DA.%2BO.%2BH.%26aulast%3DZander%26aufirst%3DS.%2BA.%2BL.%26aulast%3DDerksen%26aufirst%3DP.%2BW.%2BB.%26aulast%3Dde%2BBruin%26aufirst%3DM.%26aulast%3DZevenhoven%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DO%2527Connor%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DJonkers%26aufirst%3DJ.%26atitle%3DHigh%2520sensitivity%2520of%2520BRCA1-deficient%2520mammary%2520tumors%2520to%2520the%2520PARP%2520inhibitor%2520AZD2281%2520alone%2520and%2520in%2520combination%2520with%2520platinum%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17079%26epage%3D17084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergui-Roelvink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span> </span><span class="NLM_article-title">Inhibition of poly(ADP-ribose)polymerase in tumors from BRCA mutation carriers</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1056%2FNEJMoa0900212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=19553641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=123-134&author=P.+C.+Fongauthor=D.+S.+Bossauthor=T.+A.+Yapauthor=A.+Tuttauthor=P.+Wuauthor=M.+Mergui-Roelvinkauthor=P.+Mortimerauthor=H.+Swaislandauthor=A.+Lauauthor=M.+J.+O%E2%80%99Connorauthor=A.+Ashworthauthor=J.+Carmichaelauthor=S.+B.+Kayeauthor=J.+H.+M.+Schellensauthor=J.+S.+de+Bono&title=Inhibition+of+poly%28ADP-ribose%29polymerase+in+tumors+from+BRCA+mutation+carriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers</span></div><div class="casAuthors">Fong, Peter C.; Boss, David S.; Yap, Timothy A.; Tutt, Andrew; Wu, Peijun; Mergui-Roelvink, Marja; Mortimer, Peter; Swaisland, Helen; Lau, Alan; O'Connor, Mark J.; Ashworth, Alan; Carmichael, James; Kaye, Stan B.; Schellens, Jan H. M.; de Bono, Johann S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The inhibition of poly(ADP-ribose) polymerase (PARP) is a potential synthetic lethal therapeutic strategy for the treatment of cancers with specific DNA-repair defects, including those arising in carriers of a BRCA1 or BRCA2 mutation.  We conducted a clin. evaluation in humans of olaparib (AZD2281), a novel, potent, orally active PARP inhibitor.  This was a phase 1 trial that included the anal. of pharmacokinetic and pharmacodynamic characteristics of olaparib.  Selection was aimed at having a study population enriched in carriers of a BRCA1 or BRCA2 mutation.  We enrolled and treated 60 patients; 22 were carriers of a BRCA1 or BRCA2 mutation and 1 had a strong family history of BRCA-assocd. cancer but declined to undergo mutational testing.  The olaparib dose and schedule were increased from 10 mg daily for 2 of every 3 wk to 600 mg twice daily continuously.  Reversible dose-limiting toxicity was seen in one of eight patients receiving 400 mg twice daily (grade 3 mood alteration and fatigue) and two of five patients receiving 600 mg twice daily (grade 4 thrombocytopenia and grade 3 somnolence).  This led us to enroll another cohort, consisting only of carriers of a BRCA1 or BRCA2 mutation, to receive olaparib at a dose of 200 mg twice daily.  Other adverse effects included mild gastrointestinal symptoms.  There was no obvious increase in adverse effects seen in the mutation carriers.  Pharmacokinetic data indicated rapid absorption and elimination; pharmacodynamic studies confirmed PARP inhibition in surrogate samples (of peripheral-blood mononuclear cells and plucked eyebrow-hair follicles) and tumor tissue.  Objective antitumor activity was reported only in mutation carriers, all of whom had ovarian, breast, or prostate cancer and had received multiple treatment regimens.  Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer assocd. with the BRCA1 or BRCA2 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCT49Hz0HbW7Vg90H21EOLACvtfcHk0ljCoUpiP4GLAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVKrtrw%253D&md5=aec7dcffe3d3cf614362a4f38bbb369a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0900212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0900212%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DP.%2BC.%26aulast%3DBoss%26aufirst%3DD.%2BS.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DMergui-Roelvink%26aufirst%3DM.%26aulast%3DMortimer%26aufirst%3DP.%26aulast%3DSwaisland%26aufirst%3DH.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%2BM.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26atitle%3DInhibition%2520of%2520poly%2528ADP-ribose%2529polymerase%2520in%2520tumors%2520from%2520BRCA%2520mutation%2520carriers%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontcheva-Diaz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span> </span><span class="NLM_article-title">Discovery of the poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(<i>R</i>)-2-methylpyrrolidin-2-yl]-1<i>H</i>-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801171j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=514-523&author=T.+D.+Penningauthor=G.-D.+Zhuauthor=V.+B.+Gandhiauthor=J.+Gongauthor=X.+Liuauthor=Y.+Shiauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=C.+K.+Donawhoauthor=D.+J.+Frostauthor=V.+Bontcheva-Diazauthor=J.+J.+Bouskaauthor=D.+J.+Osterlingauthor=A.+M.+Olsonauthor=K.+C.+Marshauthor=Y.+Luoauthor=V.+L.+Giranda&title=Discovery+of+the+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+2-%5B%28R%29-2-methylpyrrolidin-2-yl%5D-1H-benzimidazole-4-carboxamide+%28ABT-888%29+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer</span></div><div class="casAuthors">Penning, Thomas D.; Zhu, Gui-Dong; Gandhi, Viraj B.; Gong, Jianchun; Liu, Xuesong; Shi, Yan; Klinghofer, Vered; Johnson, Eric F.; Donawho, Cherrie K.; Frost, David J.; Bontcheva-Diaz, Velitchka; Bouska, Jennifer J.; Osterling, Donald J.; Olson, Amanda M.; Marsh, Kennan C.; Luo, Yan; Giranda, Vincent L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">514-523</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclic amine-contg. benzimidazole carboxamide PARP inhibitors with a methyl-substituted quaternary center at the point of attachment to the benzimidazole ring system has been developed.  These compds. exhibit excellent PARP enzyme potency as well as single-digit nanomolar cellular potency.  These efforts led to the identification of (I)·2HCl (2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, ABT-888), currently in human phase I clin. trials.  Compd. I·2HCl displayed excellent potency against both the PARP-1 and PARP-2 enzymes with a Ki of 5 nM and in a C41 whole cell assay with an EC50 of 2 nM.  In addn., I·2HCl is aq. sol., orally bioavailable across multiple species, and demonstrated good in vivo efficacy in a B16F10 s.c. murine melanoma model in combination with temozolomide (TMZ) and in an MX-1 breast cancer xenograft model in combination with either carboplatin or cyclophosphamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBVnNi7EZcbVg90H21EOLACvtfcHk0lhn1pcjsFfPeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7bL&md5=283eddd2e8220740c48865e4e8269a95</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm801171j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801171j%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DZhu%26aufirst%3DG.-D.%26aulast%3DGandhi%26aufirst%3DV.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DDiscovery%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%25202-%255B%2528R%2529-2-methylpyrrolidin-2-yl%255D-1H-benzimidazole-4-carboxamide%2520%2528ABT-888%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D514%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontcheva-Diaz, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWeese, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillehay, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holley-Shanks, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hristov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idler, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasko, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulbroek, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurutani, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span> </span><span class="NLM_article-title">ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1078-0432.CCR-06-3039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17473206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslOhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2728-2737&author=C.+K.+Donawhoauthor=Y.+Luoauthor=Y.+Luoauthor=T.+D.+Penningauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=V.+D.+Bontcheva-Diazauthor=B.+F.+Coxauthor=T.+L.+DeWeeseauthor=L.+E.+Dillehayauthor=D.+C.+Fergusonauthor=N.+S.+Ghoreishi-Haackauthor=D.+R.+Grimmauthor=R.+Guanauthor=E.+K.+Hanauthor=R.+R.+Holley-Shanksauthor=B.+Hristovauthor=K.+B.+Idlerauthor=K.+Jarvisauthor=E.+F.+Johnsonauthor=L.+R.+Kleinbergauthor=V.+Klinghoferauthor=L.+M.+Laskoauthor=X.+Liuauthor=K.+C.+Marshauthor=T.+P.+McGonigalauthor=J.+A.+Meulbroekauthor=A.+M.+Olsonauthor=J.+P.+Palmaauthor=L.+E.+Rodriguezauthor=Y.+Shiauthor=J.+A.+Stavropoulosauthor=A.+C.+Tsurutaniauthor=G.-D.+Zhuauthor=S.+H.+Rosenbergauthor=V.+L.+Girandaauthor=D.+J.+Frost&title=ABT-888%2C+an+orally+active+poly%28ADP-ribose%29+polymerase+inhibitor+that+potentiates+DNA-damaging+agents+in+preclinical+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models</span></div><div class="casAuthors">Donawho, Cherrie K.; Luo, Yan; Luo, Yanping; Penning, Thomas D.; Bauch, Joy L.; Bouska, Jennifer J.; Bontcheva-Diaz, Velitchka D.; Cox, Bryan F.; DeWeese, Theodore L.; Dillehay, Larry E.; Ferguson, Debra C.; Ghoreishi-Haack, Nayereh S.; Grimm, David R.; Guan, Ran; Han, Edward K.; Holley-Shanks, Rhonda R.; Hristov, Boris; Idler, Kenneth B.; Jarvis, Ken; Johnson, Eric F.; Kleinberg, Lawrence R.; Klinghofer, Vered; Lasko, Loren M.; Liu, Xuesong; Marsh, Kennan C.; McGonigal, Thomas P.; Meulbroek, Jonathan A.; Olson, Amanda M.; Palma, Joann P.; Rodriguez, Luis E.; Shi, Yan; Stavropoulos, Jason A.; Tsurutani, Alan C.; Zhu, Gui-Dong; Rosenberg, Saul H.; Giranda, Vincent L.; Frost, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2728-2737</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose is to evaluate the preclin. pharmacokinetics and antitumor efficacy of a novel orally bioavailable poly(ADP-ribose) polymerase (PARP) inhibitor, ABT-888.  In vitro potency was detd. in a PARP-1 and PARP-2 enzyme assay.  In vivo efficacy was evaluated in syngeneic and xenograft models in combination with temozolomide, platinums, cyclophosphamide, and ionizing radiation.  ABT-888 is a potent inhibitor of both PARP-1 and PARP-2 with Kis of 5.2 and 2.9 nmol/L, resp.  The compd. has good oral bioavailability and crosses the blood-brain barrier.  ABT-888 strongly potentiated temozolomide in the B16F10 s.c. murine melanoma model.  PARP inhibition dramatically increased the efficacy of temozolomide at ABT-888 doses as low as 3.1 mg/kg/d and a maximal efficacy achieved at 25 mg/kg/d.  In the 9L orthotopic rat glioma model, temozolomide alone exhibited minimal efficacy, whereas ABT-888, when combined with temozolomide, significantly slowed tumor progression.  In the MX-1 breast xenograft model (BRCA1 deletion and BRCA2 mutation), ABT-888 potentiated cisplatin, carboplatin, and cyclophosphamide, causing regression of established tumors, whereas with comparable doses of cytotoxic agents alone, only modest tumor inhibition was exhibited.  Finally, ABT-888 potentiated radiation (2 Gy/d × 10) in an HCT-116 colon carcinoma model.  In each model, ABT-888 did not display single-agent activity.  ABT-888 is a potent inhibitor of PARP, has good oral bioavailability, can cross the blood-brain barrier, and potentiates temozolomide, platinums, cyclophosphamide, and radiation in syngeneic and xenograft tumor models.  This broad spectrum of chemopotentiation and radiopotentiation makes this compd. an attractive candidate for clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xiIRsPurHLVg90H21EOLACvtfcHk0lhn1pcjsFfPeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslOhurg%253D&md5=4769ee3eec82465993eb9e1443095894</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3039%26sid%3Dliteratum%253Aachs%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%2BD.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DDeWeese%26aufirst%3DT.%2BL.%26aulast%3DDillehay%26aufirst%3DL.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DGrimm%26aufirst%3DD.%2BR.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DHolley-Shanks%26aufirst%3DR.%2BR.%26aulast%3DHristov%26aufirst%3DB.%26aulast%3DIdler%26aufirst%3DK.%2BB.%26aulast%3DJarvis%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DKleinberg%26aufirst%3DL.%2BR.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DLasko%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMcGonigal%26aufirst%3DT.%2BP.%26aulast%3DMeulbroek%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DPalma%26aufirst%3DJ.%2BP.%26aulast%3DRodriguez%26aufirst%3DL.%2BE.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DTsurutani%26aufirst%3DA.%2BC.%26aulast%3DZhu%26aufirst%3DG.-D.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26atitle%3DABT-888%252C%2520an%2520orally%2520active%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520that%2520potentiates%2520DNA-damaging%2520agents%2520in%2520preclinical%2520tumor%2520models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2728%26epage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalitzky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1535-7163.MCT-06-0552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17363489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=945-956&author=H.+D.+Thomasauthor=C.+R.+Calabreseauthor=M.+A.+Bateyauthor=S.+Cananauthor=Z.+Hostomskyauthor=S.+Kyleauthor=K.+A.+Maegleyauthor=D.+R.+Newellauthor=D.+Skalitzkyauthor=L.-Z.+Wangauthor=S.+E.+Webberauthor=N.+J.+Curtin&title=Preclinical+selection+of+a+novel+poly%28ADP-ribose%29+polymerase+inhibitor+for+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span></div><div class="casAuthors">Thomas, Huw D.; Calabrese, Christopher R.; Batey, Michael A.; Canan, Stacie; Hostomsky, Zdenek; Kyle, Suzanne; Maegley, Karen A.; Newell, David R.; Skalitzky, Donald; Wang, Lan-Zhen; Webber, Stephen E.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">945-956</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP)-1 (EC 2.4.2.30) is a nuclear enzyme that promotes the base excision repair of DNA breaks.  Inhibition of PARP-1 enhances the efficacy of DNA alkylating agents, topoisomerase I poisons, and ionizing radiation.  Our aim was to identify a PARP inhibitor for clin. trial from a panel of 42 potent PARP inhibitors (Ki, 1.4-15.1 nmol/L) based on the quinazolinone, benzimidazole, tricyclic benzimidazole, tricyclic indole, and tricyclic indole-1-one core structures.  We evaluated chemosensitization of temozolomide and topotecan using LoVo and SW620 human colorectal cells; in vitro radiosensitization was measured using LoVo cells, and the enhancement of antitumor activity of temozolomide was evaluated in mice bearing SW620 xenografts.  Excellent chemopotentiation and radiopotentiation were obsd. in vitro, with 17 of the compds. causing a greater temozolomide and topotecan sensitization than the benchmark inhibitor AG14361 and 10 compds. were more potent radiosensitizers than AG14361.  In tumor-bearing mice, none of the compds. were toxic when given alone, and the antitumor activity of the PARP inhibitor-temozolomide combinations was unrelated to toxicity.  Compds. that were more potent chemosensitizers in vivo than AG14361 were also more potent in vitro, validating in vitro assays as a prescreen.  These studies have identified a compd., AG14447, as a PARP inhibitor with outstanding in vivo chemosensitization potency at tolerable doses, which is at least 10 times more potent than the initial lead, AG14361.  The phosphate salt of AG14447 (AG014699), which has improved aq. soly., has been selected for clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-3D2oL2giLVg90H21EOLACvtfcHk0lhUb4PfhCHYOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D&md5=b451bf2c1fc836cc5a800c2799e5d211</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0552%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCanan%26aufirst%3DS.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.-Z.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520selection%2520of%2520a%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520for%2520clinical%2520trial%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D945%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdecanas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milas, L.</span><span> </span><span class="NLM_article-title">INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1-5&author=K.+A.+Masonauthor=D.+Valdecanasauthor=N.+R.+Hunterauthor=L.+Milas&title=INO-1001%2C+a+novel+inhibitor+of+poly%28ADP-ribose%29+polymerase%2C+enhances+tumor+response+to+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BA.%26aulast%3DValdecanas%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DN.%2BR.%26aulast%3DMilas%26aufirst%3DL.%26atitle%3DINO-1001%252C%2520a%2520novel%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%252C%2520enhances%2520tumor%2520response%2520to%2520doxorubicin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_contrib-group">Kopetz, S.; Mita, M. M.; Mok, I.; Sankhala, K. K.; Moseley, J.; Sherman, B. M.; Bradley, C. R.; Tolcher, A. W.</span><span> </span><span class="NLM_article-title">First in Human Phase I Study of BSI-201, a Small Molecule Inhibitor of Poly ADP-ribose Polymerase (PARP) in Subjects with Advanced Solid Tumors</span>. Presented at the 44th Annual Meeting of the ASCO, Chicago, IL, May 31−June 3<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 3577.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Kopetz&author=M.+M.+Mita&author=I.+Mok&author=K.+K.+Sankhala&author=J.+Moseley&author=B.+M.+Sherman&author=C.+R.+Bradley&author=A.+W.+Tolcher&title=First+in+Human+Phase+I+Study+of+BSI-201%2C+a+Small+Molecule+Inhibitor+of+Poly+ADP-ribose+Polymerase+%28PARP%29+in+Subjects+with+Advanced+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKopetz%26aufirst%3DS.%26atitle%3DFirst%2520in%2520Human%2520Phase%2520I%2520Study%2520of%2520BSI-201%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Poly%2520ADP-ribose%2520Polymerase%2520%2528PARP%2529%2520in%2520Subjects%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">May 20 Suppl.</span>),  <span class="NLM_fpage">3577</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=J.+Clin.+Oncol.+2008%2C+26+%28May+20+Suppl.%29%2C+3577."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26issue%3DMay%252020%2520Suppl%26spage%3D3577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kuvshinov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulevskaya, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozhkov, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevelev, S. A.</span><span> </span><span class="NLM_article-title">Synthesis of 2-substituted 4,6-dinitro-2<i>H</i>-indazoles from 2,4,6-trinitrotoluene</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1474</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1055%2Fs-2000-7120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1474-1478&author=A.+M.+Kuvshinovauthor=V.+I.+Gulevskayaauthor=V.+V.+Rozhkovauthor=S.+A.+Shevelev&title=Synthesis+of+2-substituted+4%2C6-dinitro-2H-indazoles+from+2%2C4%2C6-trinitrotoluene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-7120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-7120%26sid%3Dliteratum%253Aachs%26aulast%3DKuvshinov%26aufirst%3DA.%2BM.%26aulast%3DGulevskaya%26aufirst%3DV.%2BI.%26aulast%3DRozhkov%26aufirst%3DV.%2BV.%26aulast%3DShevelev%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520of%25202-substituted%25204%252C6-dinitro-2H-indazoles%2520from%25202%252C4%252C6-trinitrotoluene%26jtitle%3DSynthesis%26date%3D2000%26volume%3D10%26spage%3D1474%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Anderson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolella, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">1,3-Dipolar addition of pyridine <i>N</i>-imine to acetylenes and the use of carbon-13 NMR in several structural assignments</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1981&pages=1149-1152&author=P.+L.+Andersonauthor=J.+P.+Hasakauthor=A.+D.+Kahleauthor=N.+A.+Paolellaauthor=M.+J.+Shapiro&title=1%2C3-Dipolar+addition+of+pyridine+N-imine+to+acetylenes+and+the+use+of+carbon-13+NMR+in+several+structural+assignments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%2BL.%26aulast%3DHasak%26aufirst%3DJ.%2BP.%26aulast%3DKahle%26aufirst%3DA.%2BD.%26aulast%3DPaolella%26aufirst%3DN.%2BA.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3D1%252C3-Dipolar%2520addition%2520of%2520pyridine%2520N-imine%2520to%2520acetylenes%2520and%2520the%2520use%2520of%2520carbon-13%2520NMR%2520in%2520several%2520structural%2520assignments%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1981%26volume%3D18%26spage%3D1149%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hajos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schantl, J. G.</span><span> </span><span class="NLM_article-title">A new synthesis of the <i>s</i>-triazolo[1,5-<i>a</i>]pyridine ring system</span> <span class="citation_source-journal">Monatsh. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1007%2FBF00824299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1995&pages=1213-1215&author=G.+Hajosauthor=G.+Timariauthor=A.+Messmerauthor=A.+Zagyvaauthor=I.+Miskolcziauthor=J.+G.+Schantl&title=A+new+synthesis+of+the+s-triazolo%5B1%2C5-a%5Dpyridine+ring+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A new synthesis of the s-triazolo[1,5-a]pyridine ring system</span></div><div class="casAuthors">Hajos, G.; Timari, G.; Messmer, A.; Zagyva, A.; Miskolczi, I.; Schantl, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Monatshefte fuer Chemie</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-15</span>CODEN:
                <span class="NLM_cas:coden">MOCMB7</span>;
        ISSN:<span class="NLM_cas:issn">0026-9247</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A novel and efficient synthesis of s-triazolo[1,5-a]pyridines was elaborated by reacting 1,2-diaminopyridinium salts with aldehydes.  The cyclization of benzaldehyde with 1,2-diaminopyridinium tosylate gave [1,2,4]triazolo[1,5-a]pyridine (68% yield).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_lQItvq1NCbVg90H21EOLACvtfcHk0lhUb4PfhCHYOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurnL&md5=af462673150bb0adceda6cc7613d9e95</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF00824299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00824299%26sid%3Dliteratum%253Aachs%26aulast%3DHajos%26aufirst%3DG.%26aulast%3DTimari%26aufirst%3DG.%26aulast%3DMessmer%26aufirst%3DA.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DSchantl%26aufirst%3DJ.%2BG.%26atitle%3DA%2520new%2520synthesis%2520of%2520the%2520s-triazolo%255B1%252C5-a%255Dpyridine%2520ring%2520system%26jtitle%3DMonatsh.%2520Chem.%26date%3D1995%26volume%3D126%26spage%3D1213%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ritter, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalish, J.</span><span> </span><span class="NLM_article-title">α,α-Dimethyl-β-phenethylamine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1964&pages=44&author=J.+J.+Ritterauthor=J.+Kalish&title=%CE%B1%2C%CE%B1-Dimethyl-%CE%B2-phenethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DJ.%2BJ.%26aulast%3DKalish%26aufirst%3DJ.%26atitle%3D%25CE%25B1%252C%25CE%25B1-Dimethyl-%25CE%25B2-phenethylamine%26jtitle%3DOrg.%2520Synth.%26date%3D1964%26volume%3D44%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennissier de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">7481</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=7481-7485&author=A.+Rufauthor=J.+Mennissier+de+Murciaauthor=G.+de+Murciaauthor=G.+E.+Schulz&title=Structure+of+the+catalytic+fragment+of+poly%28AD-ribose%29+polymerase+from+chicken"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DMennissier%2Bde%2BMurcia%26aufirst%3DJ.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520fragment%2520of%2520poly%2528AD-ribose%2529%2520polymerase%2520from%2520chicken%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D1996%26volume%3D93%26spage%3D7481%26epage%3D7485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Inhibitor and NAD<sup>+</sup> binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3893</span><span class="NLM_x">–</span> <span class="NLM_lpage">3900</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi972383s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=3893-3900&author=A.+Rufauthor=G.+de+Murciaauthor=G.+E.+Schulz&title=Inhibitor+and+NAD%2B+binding+to+poly%28ADP-ribose%29+polymerase+as+derived+from+crystal+structures+and+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fbi972383s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi972383s%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DA.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DInhibitor%2520and%2520NAD%252B%2520binding%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520as%2520derived%2520from%2520crystal%2520structures%2520and%2520homology%2520modeling%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D3893%26epage%3D3900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">[<sup>3</sup>H]<b>43</b> was prepared by reduction of {4-[7-(aminocarbonyl)-3-bromo-2<i>H</i>-indazol-2-yl]-2-chlorophenyl}-<i>N</i>-methylmethanaminium trifluoroacetate. The precursor itself was prepared from <b>35</b> first by reaction with 2-chloro-4-fluorobenzaldehyde and then bromination at the 3-position with Br<sub>2</sub> in DCM/AcOH for 48 h, followed by reductive amination.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Martignoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groothuis, G. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span> </span><span class="NLM_article-title">Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F17425255.2.6.875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17125407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=875-894&author=M.+Martignoniauthor=G.+M.+M.+Groothuisauthor=R.+de+Kanter&title=Species+differences+between+mouse%2C+rat%2C+dog%2C+monkey+and+human+CYP-mediated+drug+metabolism%2C+inhibition+and+induction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</span></div><div class="casAuthors">Martignoni, Marcella; Groothuis, Geny M. M.; de Kanter, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">875-894</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Animal models are commonly used in the preclin. development of new drugs to predict the metabolic behavior of new compds. in humans.  It is, however, important to realize that humans differ from animals with regards to isoform compn., expression and catalytic activities of drug-metabolizing enzymes.  In this review the authors describe similarities and differences in this respect among the different species, including man.  This may be helpful for drug researchers to choose the most relevant animal species in which the metab. of a compd. can be studied for extrapolating the results to humans.  The authors focus on CYPs, which are the main enzymes involved in numerous oxidative reactions and often play a crit. role in the metab. and pharmacokinetics of xenobiotics.  In addn., induction and inhibition of CYPs are compared among species.  The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well.  In contrast, the species-specific isoforms of CYP1A, -2C, -2D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metab. data from animal models to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd9SDz-wmCcLVg90H21EOLACvtfcHk0ljK5N9H7yIXtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eks7nJ&md5=504f34a2aa5e796083f822c6a54acc8a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.6.875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.6.875%26sid%3Dliteratum%253Aachs%26aulast%3DMartignoni%26aufirst%3DM.%26aulast%3DGroothuis%26aufirst%3DG.%2BM.%2BM.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26atitle%3DSpecies%2520differences%2520between%2520mouse%252C%2520rat%252C%2520dog%252C%2520monkey%2520and%2520human%2520CYP-mediated%2520drug%2520metabolism%252C%2520inhibition%2520and%2520induction%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D875%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Harrigan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarrigle, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutter, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, J. R.</span><span> </span><span class="NLM_article-title">Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(<i>a</i>)pyrene</span> <span class="citation_source-journal">Toxicol. in Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=426-438&author=J.+A.+Harriganauthor=B.+P.+McGarrigleauthor=T.+R.+Sutterauthor=J.+R.+Olson&title=Tissue+specific+induction+of+cytochrome+P450+%28CYP%29+1A1+and+1B1+in+rat+liver+and+lung+following+in+vitro+%28tissue+slice%29+and+in+vivo+exposure+to+benzo%28a%29pyrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrigan%26aufirst%3DJ.%2BA.%26aulast%3DMcGarrigle%26aufirst%3DB.%2BP.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DOlson%26aufirst%3DJ.%2BR.%26atitle%3DTissue%2520specific%2520induction%2520of%2520cytochrome%2520P450%2520%2528CYP%2529%25201A1%2520and%25201B1%2520in%2520rat%2520liver%2520and%2520lung%2520following%2520in%2520vitro%2520%2528tissue%2520slice%2529%2520and%2520in%2520vivo%2520exposure%2520to%2520benzo%2528a%2529pyrene%26jtitle%3DToxicol.%2520in%2520Vitro%26date%3D2006%26volume%3D20%26spage%3D426%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. Y. H.</span><span> </span><span class="NLM_article-title">CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1009-1016&author=Q.+Maauthor=A.+Y.+H.+Lu&title=CYP1A+induction+and+human+risk+assessment%3A+an+evolving+tale+of+in+vitro+and+in+vivo+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DCYP1A%2520induction%2520and%2520human%2520risk%2520assessment%253A%2520an%2520evolving%2520tale%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1009%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Amat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantó, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escolano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, J.</span><span> </span><span class="NLM_article-title">Dynamic kinetic resolution of racemic γ-aryl-δ-oxoesters. Enantioselective synthesis of 3-arylpiperidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5343</span><span class="NLM_x">–</span> <span class="NLM_lpage">5351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025894f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=5343-5351&author=M.+Amatauthor=M.+Cant%C3%B3author=N.+Llorauthor=C.+Escolanoauthor=E.+Molinsauthor=E.+Espinosaauthor=J.+Bosch&title=Dynamic+kinetic+resolution+of+racemic+%CE%B3-aryl-%CE%B4-oxoesters.+Enantioselective+synthesis+of+3-arylpiperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo025894f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025894f%26sid%3Dliteratum%253Aachs%26aulast%3DAmat%26aufirst%3DM.%26aulast%3DCant%25C3%25B3%26aufirst%3DM.%26aulast%3DLlor%26aufirst%3DN.%26aulast%3DEscolano%26aufirst%3DC.%26aulast%3DMolins%26aufirst%3DE.%26aulast%3DEspinosa%26aufirst%3DE.%26aulast%3DBosch%26aufirst%3DJ.%26atitle%3DDynamic%2520kinetic%2520resolution%2520of%2520racemic%2520%25CE%25B3-aryl-%25CE%25B4-oxoesters.%2520Enantioselective%2520synthesis%2520of%25203-arylpiperidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D5343%26epage%3D5351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: an issue of potency</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.4161%2Fcbt.4.9.2141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=16251802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=934-936&author=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+Tuttauthor=N.+M.+Martinauthor=G.+C.+Smithauthor=A.+Ashworth&title=BRCA2-deficient+CAPAN-1+cells+are+extremely+sensitive+to+the+inhibition+of+poly+%28ADP-ribose%29+polymerase%3A+an+issue+of+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: an issue of potency</span></div><div class="casAuthors">McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Martin, Niall M. B.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">934-936</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">We have previously demonstrated that deficiency of either the BRCA1 or BRCA2 breast cancer susceptibility proteins confers substantial cellular sensitivity to the inhibition of Poly(ADP-Ribose) polymerase (PARP).  PARP is a key enzyme in the repair of single strand DNA damage via the Base Excision Repair pathway.  We suggested that PARP inhibition produces persistent single-strand DNA breaks or gaps which degenerate into stalled replication forks and double-strand breaks, which may be repaired by homologous recombination, a process partially dependent on BRCA1 and BRCA2.  It has recently been suggested that our results might be limited to certain BRCA2 mutations as the CAPAN-1 cell line, which carries a naturally occurring 6174delT mutation in one BRCA2 allele accompanied by loss of the wild-type allele, is apparently insensitive to two PARP inhibitors 3-aminobenzamide (IC50 33 μM) and NU1025 (IC50 400 nM).  Here we show that CAPAN-1 cells are in fact very sensitive to the potent PARP inhibitors KU0058684 (IC50 3.2 nM) and KU0058948 (IC50 3.4 nM).  In contrast, our results reveal much less sensitivity to a chem. related but much less active compd. KU0051529 (IC50 730 nM) and to NU1025.  These results confirm that treatment with potent PARP inhibitors remains an exciting potential therapy for cancers involving BRCA1 or BRCA2 deficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6va3_ljT7XbVg90H21EOLACvtfcHk0liEE3cqVHyEVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVOhsr4%253D&md5=9a15d48249c7fdf0feb573947883bb29</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.9.2141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.9.2141%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DBRCA2-deficient%2520CAPAN-1%2520cells%2520are%2520extremely%2520sensitive%2520to%2520the%2520inhibition%2520of%2520poly%2520%2528ADP-ribose%2529%2520polymerase%253A%2520an%2520issue%2520of%2520potency%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D934%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span> MK4827 in Patients with Advanced Solid Tumors and BRCA Mutant Ovarian Cancer. <a href="http://clinicaltrial.gov/ct2/show/NCT00749502" class="extLink">http://clinicaltrial.gov/ct2/show/NCT00749502</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK4827+in+Patients+with+Advanced+Solid+Tumors+and+BRCA+Mutant+Ovarian+Cancer.+http%3A%2F%2Fclinicaltrial.gov%2Fct2%2Fshow%2FNCT00749502."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':[],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 190 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nayyef Aljaar, Mousa Al-Noaimi, Jürgen Conrad, <span class="NLM_string-name hlFld-ContribAuthor">Uwe Beifuss</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Formation of 2-Substituted 2H-Indazoles by a Pd-Catalyzed Reaction between 2-Halobenzyl Halides and Arylhydrazines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (2)
                                     , 1408-1418. <a href="https://doi.org/10.1021/acs.joc.0c01923" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01923%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BFormation%252Bof%252B2-Substituted%252B2H-Indazoles%252Bby%252Ba%252BPd-Catalyzed%252BReaction%252Bbetween%252B2-Halobenzyl%252BHalides%252Band%252BArylhydrazines%26aulast%3DAljaar%26aufirst%3DNayyef%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D09082020%26date%3D11122020%26volume%3D86%26issue%3D2%26spage%3D1408%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hexiang Wang, Bo Ren, Ye Liu, Beibei Jiang, Yin Guo, Min Wei, Lusong Luo, Xianzhao Kuang, Ming Qiu, Lei Lv, Hong Xu, Ruipeng Qi, Huibin Yan, Dexu Xu, Zhiwei Wang, Chang-Xin Huo, Yutong Zhu, Yuan Zhao, Yiyuan Wu, Zhen Qin, Dan Su, Tristin Tang, Fan Wang, Xuebing Sun, Yingcai Feng, Hao Peng, Xing Wang, Yajuan Gao, Yong Liu, Wenfeng Gong, Fenglong Yu, Xuesong Liu, Lai Wang, <span class="NLM_string-name hlFld-ContribAuthor">Changyou Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15541-15563. <a href="https://doi.org/10.1021/acs.jmedchem.0c01346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPamiparib%252B%252528BGB-290%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BPoly%252B%252528ADP-ribose%252529%252BPolymerase%252B%252528PARP%252529%252BInhibitor%252Bin%252BClinical%252BDevelopment%26aulast%3DWang%26aufirst%3DHexiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01082020%26date%3D02122020%26volume%3D63%26issue%3D24%26spage%3D15541%26epage%3D15563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Raghunath Reddy Anugu, Sailu Munnuri, <span class="NLM_string-name hlFld-ContribAuthor">John R. Falck</span>. </span><span class="cited-content_cbyCitation_article-title">Picolinate-Directed Arene meta-C–H Amination via FeCl3 Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (11)
                                     , 5266-5271. <a href="https://doi.org/10.1021/jacs.9b13753" title="DOI URL">https://doi.org/10.1021/jacs.9b13753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b13753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b13753%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPicolinate-Directed%252BArene%252Bmeta-C%2525E2%252580%252593H%252BAmination%252Bvia%252BFeCl3%252BCatalysis%26aulast%3DAnugu%26aufirst%3DRaghunath%2BReddy%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D04032020%26date%3D22022020%26volume%3D142%26issue%3D11%26spage%3D5266%26epage%3D5271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junwei Wang, Hui Li, Guangchao He, Zhaoxing Chu, Kewen Peng, Yiran Ge, Qihua Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Yungen Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 122-139. <a href="https://doi.org/10.1021/acs.jmedchem.9b00622" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00622%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BDual%252BPoly%252528ADP-ribose%252529polymerase%252Band%252BPhosphoinositide%252B3-Kinase%252BInhibitors%252Bas%252Ba%252BPromising%252BStrategy%252Bfor%252BCancer%252BTherapy%26aulast%3DWang%26aufirst%3DJunwei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11042019%26date%3D27122019%26date%3D17122019%26volume%3D63%26issue%3D1%26spage%3D122%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diego Alemán-Ponce de León, Anahí C. Sánchez-Chávez, <span class="NLM_string-name hlFld-ContribAuthor">Luis A. Polindara-García</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Mediated γ-C(sp3)–H Bond Activation in Ammonia–Ugi 4-CR Adducts by Using Picolinamide as Directing Group. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (20)
                                     , 12809-12834. <a href="https://doi.org/10.1021/acs.joc.9b01436" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01436%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPd-Mediated%252B%2525CE%2525B3-C%252528sp3%252529%2525E2%252580%252593H%252BBond%252BActivation%252Bin%252BAmmonia%2525E2%252580%252593Ugi%252B4-CR%252BAdducts%252Bby%252BUsing%252BPicolinamide%252Bas%252BDirecting%252BGroup%26aulast%3DAlem%25C3%25A1n-Ponce%2Bde%2BLe%25C3%25B3n%26aufirst%3DDiego%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31052019%26date%3D21082019%26date%3D06082019%26volume%3D84%26issue%3D20%26spage%3D12809%26epage%3D12834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew
C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to the New Drugs Approved During 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7340-7382. <a href="https://doi.org/10.1021/acs.jmedchem.9b00196" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00196%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252Bthe%252BNew%252BDrugs%252BApproved%252BDuring%252B2017%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30012019%26date%3D15042019%26date%3D02042019%26volume%3D62%26issue%3D16%26spage%3D7340%26epage%3D7382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie S. Zhu, Makhluf J. Haddadin, <span class="NLM_string-name hlFld-ContribAuthor">Mark J. Kurth</span>. </span><span class="cited-content_cbyCitation_article-title">Davis–Beirut Reaction: Diverse Chemistries of Highly Reactive Nitroso Intermediates in Heterocycle Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2019,</strong> <em>52 </em>
                                    (8)
                                     , 2256-2265. <a href="https://doi.org/10.1021/acs.accounts.9b00220" title="DOI URL">https://doi.org/10.1021/acs.accounts.9b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.9b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.9b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDavis%2525E2%252580%252593Beirut%252BReaction%25253A%252BDiverse%252BChemistries%252Bof%252BHighly%252BReactive%252BNitroso%252BIntermediates%252Bin%252BHeterocycle%252BSynthesis%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29042019%26date%3D22072019%26volume%3D52%26issue%3D8%26spage%3D2256%26epage%3D2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Uday Kiran Velagapudi, Marie-France Langelier, Cristina Delgado-Martin, Morgan E. Diolaiti, Sietske Bakker, Alan Ashworth, Bhargav A. Patel, Xuwei Shao, John M. Pascal, <span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5330-5357. <a href="https://doi.org/10.1021/acs.jmedchem.8b01709" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01709%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase%252BInhibitors%25253A%252BImpact%252Bof%252BAdenosine%252BPocket-Binding%252BMotif%252BAppendage%252Bto%252Bthe%252B3-Oxo-2%25252C3-dihydrobenzofuran-7-carboxamide%252Bon%252BPotency%252Band%252BSelectivity%26aulast%3DVelagapudi%26aufirst%3DUday%2BKiran%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D01112018%26date%3D24052019%26date%3D01052019%26volume%3D62%26issue%3D11%26spage%3D5330%26epage%3D5357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie S. Zhu, Clarabella J. Li, Ka Yi Tsui, Niklas Kraemer, Jung-Ho Son, Makhluf J. Haddadin, Dean J. Tantillo, <span class="NLM_string-name hlFld-ContribAuthor">Mark J. Kurth</span>. </span><span class="cited-content_cbyCitation_article-title">Accessing Multiple Classes of 2H-Indazoles: Mechanistic Implications for the Cadogan and Davis–Beirut Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (15)
                                     , 6247-6253. <a href="https://doi.org/10.1021/jacs.8b13481" title="DOI URL">https://doi.org/10.1021/jacs.8b13481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b13481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b13481%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAccessing%252BMultiple%252BClasses%252Bof%252B2H-Indazoles%25253A%252BMechanistic%252BImplications%252Bfor%252Bthe%252BCadogan%252Band%252BDavis%2525E2%252580%252593Beirut%252BReactions%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18122018%26date%3D04042019%26date%3D26032019%26volume%3D141%26issue%3D15%26spage%3D6247%26epage%3D6253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Zhang, Sailan Chang, Shanliang Dong, Lihua Qiu, <span class="NLM_string-name hlFld-ContribAuthor">Xinfang Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-Promoted Bicyclization of Diaryl Alkynes: Synthesis of 2H-Indazoles with in Situ Generated Diazonium Salt as Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9125-9136. <a href="https://doi.org/10.1021/acs.joc.8b01199" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01199%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcid-Promoted%252BBicyclization%252Bof%252BDiaryl%252BAlkynes%25253A%252BSynthesis%252Bof%252B2H-Indazoles%252Bwith%252Bin%252BSitu%252BGenerated%252BDiazonium%252BSalt%252Bas%252BNitrogen%252BSource%26aulast%3DZhang%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10052018%26date%3D21062018%26date%3D08062018%26volume%3D83%26issue%3D16%26spage%3D9125%26epage%3D9136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tz-Yi Wu, Sandip Dhole, Manikandan Selvaraju, <span class="NLM_string-name hlFld-ContribAuthor">Chung-Ming Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Pyranone-Fused Indazoles via Reductive Cyclization and Alkyne Insertion. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (3)
                                     , 156-163. <a href="https://doi.org/10.1021/acscombsci.7b00170" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00170%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DRegioselective%252BSynthesis%252Bof%252BPyranone-Fused%252BIndazoles%252Bvia%252BReductive%252BCyclization%252Band%252BAlkyne%252BInsertion%26aulast%3DWu%26aufirst%3DTz-Yi%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D12112017%26date%3D26012018%26date%3D13022018%26date%3D30012018%26volume%3D20%26issue%3D3%26spage%3D156%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanli  Zhen</span> and <span class="hlFld-ContribAuthor ">Yonghao  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Proteomic Analysis of the Downstream Signaling Network of PARP1. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (4)
                                     , 429-440. <a href="https://doi.org/10.1021/acs.biochem.7b01022" title="DOI URL">https://doi.org/10.1021/acs.biochem.7b01022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.7b01022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.7b01022%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DProteomic%252BAnalysis%252Bof%252Bthe%252BDownstream%252BSignaling%252BNetwork%252Bof%252BPARP1%26aulast%3DZhen%26aufirst%3DYuanli%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D09102017%26date%3D10012018%26date%3D19012018%26date%3D30012018%26date%3D12012018%26volume%3D57%26issue%3D4%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob M.  Ganley</span> and <span class="hlFld-ContribAuthor ">Charles S.  Yeung</span>  . </span><span class="cited-content_cbyCitation_article-title">Unprotected Indazoles Are Resilient to Ring-Opening Isomerization: A Case Study on Catalytic C–S Couplings in the Presence of Strong Base. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13557-13562. <a href="https://doi.org/10.1021/acs.joc.7b02712" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02712%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DUnprotected%252BIndazoles%252BAre%252BResilient%252Bto%252BRing-Opening%252BIsomerization%25253A%252BA%252BCase%252BStudy%252Bon%252BCatalytic%252BC%2525E2%252580%252593S%252BCouplings%252Bin%252Bthe%252BPresence%252Bof%252BStrong%252BBase%26aulast%3DGanley%26aufirst%3DJacob%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25102017%26date%3D05122017%26date%3D15122017%26date%3D27112017%26volume%3D82%26issue%3D24%26spage%3D13557%26epage%3D13562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David L.  Hughes</span>  . </span><span class="cited-content_cbyCitation_article-title">Patent Review of Manufacturing Routes to Recently Approved PARP Inhibitors: Olaparib, Rucaparib, and Niraparib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 1227-1244. <a href="https://doi.org/10.1021/acs.oprd.7b00235" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00235%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPatent%252BReview%252Bof%252BManufacturing%252BRoutes%252Bto%252BRecently%252BApproved%252BPARP%252BInhibitors%25253A%252BOlaparib%25252C%252BRucaparib%25252C%252Band%252BNiraparib%26aulast%3DHughes%26aufirst%3DDavid%2BL.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07072017%26date%3D21082017%26date%3D15092017%26date%3D09082017%26volume%3D21%26issue%3D9%26spage%3D1227%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Long</span>, <span class="hlFld-ContribAuthor ">Yudong  Yang</span>, and <span class="hlFld-ContribAuthor ">Jingsong  You</span>  . </span><span class="cited-content_cbyCitation_article-title">Rh(III)-Catalyzed [4 + 1]-Annulation of Azoxy Compounds with Alkynes: A Regioselective Approach to 2H-Indazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (11)
                                     , 2781-2784. <a href="https://doi.org/10.1021/acs.orglett.7b00982" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b00982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b00982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b00982%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRh%252528III%252529-Catalyzed%252B%25255B4%252B%25252B%252B1%25255D-Annulation%252Bof%252BAzoxy%252BCompounds%252Bwith%252BAlkynes%25253A%252BA%252BRegioselective%252BApproach%252Bto%252B2H-Indazoles%26aulast%3DLong%26aufirst%3DZhen%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01042017%26date%3D17052017%26date%3D02062017%26volume%3D19%26issue%3D11%26spage%3D2781%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiarong  Shi</span>, <span class="hlFld-ContribAuthor ">Hai  Xu</span>, <span class="hlFld-ContribAuthor ">Dachuan  Qiu</span>, <span class="hlFld-ContribAuthor ">Jia  He</span>, and <span class="hlFld-ContribAuthor ">Yang  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Aryne Formation via Grob Fragmentation from the [2+2] Cycloadducts of 3-Triflyloxyarynes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (2)
                                     , 623-626. <a href="https://doi.org/10.1021/jacs.6b12161" title="DOI URL">https://doi.org/10.1021/jacs.6b12161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b12161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b12161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSelective%252BAryne%252BFormation%252Bvia%252BGrob%252BFragmentation%252Bfrom%252Bthe%252B%25255B2%25252B2%25255D%252BCycloadducts%252Bof%252B3-Triflyloxyarynes%26aulast%3DShi%26aufirst%3DJiarong%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D25112016%26date%3D10012017%26date%3D18012017%26date%3D30122016%26volume%3D139%26issue%3D2%26spage%3D623%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Safnas F.  AbdulSalam</span>, <span class="hlFld-ContribAuthor ">Fathima Shazna  Thowfeik</span>, and <span class="hlFld-ContribAuthor ">Edward J.  Merino</span>  . </span><span class="cited-content_cbyCitation_article-title">Excessive Reactive Oxygen Species and Exotic DNA Lesions as an Exploitable Liability. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (38)
                                     , 5341-5352. <a href="https://doi.org/10.1021/acs.biochem.6b00703" title="DOI URL">https://doi.org/10.1021/acs.biochem.6b00703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.6b00703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.6b00703%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DExcessive%252BReactive%252BOxygen%252BSpecies%252Band%252BExotic%252BDNA%252BLesions%252Bas%252Ban%252BExploitable%252BLiability%26aulast%3DAbdulSalam%26aufirst%3DSafnas%2BF.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11072016%26date%3D18082016%26date%3D13092016%26date%3D27092016%26date%3D01092016%26volume%3D55%26issue%3D38%26spage%3D5341%26epage%3D5352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Daniel  Chu</span>, <span class="hlFld-ContribAuthor ">Ying  Feng</span>, <span class="hlFld-ContribAuthor ">Yuqiao  Shen</span>, <span class="hlFld-ContribAuthor ">Mika  Aoyagi-Scharber</span>, and <span class="hlFld-ContribAuthor ">Leonard E.  Post</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 335-357. <a href="https://doi.org/10.1021/acs.jmedchem.5b01498" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01498%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252B%2525288S%25252C9R%252529-5-Fluoro-8-%2525284-fluorophenyl%252529-9-%2525281-methyl-1H-1%25252C2%25252C4-triazol-5-yl%252529-2%25252C7%25252C8%25252C9-tetrahydro-3H-pyrido%25255B4%25252C3%25252C2-de%25255Dphthalazin-3-one%252B%252528BMN%252B673%25252C%252BTalazoparib%252529%25252C%252Ba%252BNovel%25252C%252BHighly%252BPotent%25252C%252Band%252BOrally%252BEfficacious%252BPoly%252528ADP-ribose%252529%252BPolymerase-1%25252F2%252BInhibitor%25252C%252Bas%252Ban%252BAnticancer%252BAgent%26aulast%3DWang%26aufirst%3DBing%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D27092015%26date%3D23122015%26date%3D14012016%26date%3D10122015%26volume%3D59%26issue%3D1%26spage%3D335%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluca  Papeo</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Daniela  Borghi</span>, <span class="hlFld-ContribAuthor ">Alina A.  Busel</span>, <span class="hlFld-ContribAuthor ">Francesco  Caprera</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cirla</span>, <span class="hlFld-ContribAuthor ">Emiliana  Corti</span>, <span class="hlFld-ContribAuthor ">Matteo  D’Anello</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Barbara  Forte</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Alexander  Khvat</span>, <span class="hlFld-ContribAuthor ">Mikhail Y.  Krasavin</span>, <span class="hlFld-ContribAuthor ">Rosita  Lupi</span>, <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>, <span class="hlFld-ContribAuthor ">Rita  Perego</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Daniele  Pezzetta</span>, <span class="hlFld-ContribAuthor ">Sonia  Rainoldi</span>, <span class="hlFld-ContribAuthor ">Federico  Riccardi-Sirtori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scolaro</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, and <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6875-6898. <a href="https://doi.org/10.1021/acs.jmedchem.5b00680" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00680%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%25255B1-%2525284%25252C4-Difluorocyclohexyl%252529piperidin-4-yl%25255D-6-fluoro-3-oxo-2%25252C3-dihydro-1H-isoindole-4-carboxamide%252B%252528NMS-P118%252529%25253A%252BA%252BPotent%25252C%252BOrally%252BAvailable%25252C%252Band%252BHighly%252BSelective%252BPARP-1%252BInhibitor%252Bfor%252BCancer%252BTherapy%26aulast%3DPapeo%26aufirst%3DGianluca%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04052015%26date%3D26082015%26date%3D10092015%26date%3D29072015%26volume%3D58%26issue%3D17%26spage%3D6875%26epage%3D6898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Jones</span>, <span class="hlFld-ContribAuthor ">Keith  Wilcoxen</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, and <span class="hlFld-ContribAuthor ">Carlo  Toniatti</span>  . </span><span class="cited-content_cbyCitation_article-title">Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3302-3314. <a href="https://doi.org/10.1021/jm5018237" title="DOI URL">https://doi.org/10.1021/jm5018237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018237%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNiraparib%25253A%252BA%252BPoly%252528ADP-ribose%252529%252BPolymerase%252B%252528PARP%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BTumors%252Bwith%252BDefective%252BHomologous%252BRecombination%26aulast%3DJones%26aufirst%3DPhilip%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D25112014%26date%3D11032015%26date%3D23042015%26volume%3D58%26issue%3D8%26spage%3D3302%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelli M.  Farber</span>, <span class="hlFld-ContribAuthor ">Makhluf J.  Haddadin</span>, and <span class="hlFld-ContribAuthor ">Mark J.  Kurth</span>  . </span><span class="cited-content_cbyCitation_article-title">Davis–Beirut Reaction: Route to Thiazolo-, Thiazino-, and Thiazepino-2H-indazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (15)
                                     , 6939-6945. <a href="https://doi.org/10.1021/jo501014e" title="DOI URL">https://doi.org/10.1021/jo501014e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501014e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501014e%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDavis%2525E2%252580%252593Beirut%252BReaction%25253A%252BRoute%252Bto%252BThiazolo-%25252C%252BThiazino-%25252C%252Band%252BThiazepino-2H-indazoles%26aulast%3DFarber%26aufirst%3DKelli%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D09052014%26date%3D23072014%26date%3D01082014%26date%3D14072014%26volume%3D79%26issue%3D15%26spage%3D6939%26epage%3D6945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Aaditya  Bhatt</span>, <span class="hlFld-ContribAuthor ">Jamin D.  Steffen</span>, <span class="hlFld-ContribAuthor ">Adel  Chergui</span>, <span class="hlFld-ContribAuthor ">Junko  Murai</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">John M.  Pascal</span>, <span class="hlFld-ContribAuthor ">Louis D.  Trombetta</span>, <span class="hlFld-ContribAuthor ">Frank R.  Fronczek</span>, and <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5579-5601. <a href="https://doi.org/10.1021/jm5002502" title="DOI URL">https://doi.org/10.1021/jm5002502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5002502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5002502%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BNovel%252B2%25252C3-Dihydrobenzofuran-7-carboxamide%252Band%252B2%25252C3-Dihydrobenzofuran-3%2525282H%252529-one-7-carboxamide%252BDerivatives%252Bas%252BPoly%252528ADP-ribose%252529polymerase-1%252BInhibitors%26aulast%3DPatel%26aufirst%3DMaulik%2BR.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D31122013%26date%3D25062014%26date%3D10072014%26date%3D12062014%26volume%3D57%26issue%3D13%26spage%3D5579%26epage%3D5601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan E.  Genung</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, and <span class="hlFld-ContribAuthor ">Gary E.  Aspnes</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation–Cadogan Reductive Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (11)
                                     , 3114-3117. <a href="https://doi.org/10.1021/ol5012423" title="DOI URL">https://doi.org/10.1021/ol5012423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol5012423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol5012423%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegioselective%252BSynthesis%252Bof%252B2H-Indazoles%252BUsing%252Ba%252BMild%25252C%252BOne-Pot%252BCondensation%2525E2%252580%252593Cadogan%252BReductive%252BCyclization%26aulast%3DGenung%26aufirst%3DNathan%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30042014%26date%3D21052014%26date%3D06062014%26volume%3D16%26issue%3D11%26spage%3D3114%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheol K.  Chung</span>, <span class="hlFld-ContribAuthor ">Paul G.  Bulger</span>, <span class="hlFld-ContribAuthor ">Birgit  Kosjek</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Belyk</span>, <span class="hlFld-ContribAuthor ">Nelo  Rivera</span>, <span class="hlFld-ContribAuthor ">Mark E.  Scott</span>, <span class="hlFld-ContribAuthor ">Guy R.  Humphrey</span>, <span class="hlFld-ContribAuthor ">John  Limanto</span>, <span class="hlFld-ContribAuthor ">Donald C.  Bachert</span>, and <span class="hlFld-ContribAuthor ">Khateeta M.  Emerson</span>  . </span><span class="cited-content_cbyCitation_article-title">Process Development of C–N Cross-Coupling and Enantioselective Biocatalytic Reactions for the Asymmetric Synthesis of Niraparib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (1)
                                     , 215-227. <a href="https://doi.org/10.1021/op400233z" title="DOI URL">https://doi.org/10.1021/op400233z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400233z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400233z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252BC%2525E2%252580%252593N%252BCross-Coupling%252Band%252BEnantioselective%252BBiocatalytic%252BReactions%252Bfor%252Bthe%252BAsymmetric%252BSynthesis%252Bof%252BNiraparib%26aulast%3DChung%26aufirst%3DCheol%2BK.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D26082013%26date%3D25102013%26date%3D17012014%26volume%3D18%26issue%3D1%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Ye</span>, <span class="hlFld-ContribAuthor ">Chuan-Huizi  Chen</span>, <span class="hlFld-ContribAuthor ">TianTian  Chen</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Jin-Xue  He</span>, <span class="hlFld-ContribAuthor ">Xia-Juan  Huan</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Song</span>, <span class="hlFld-ContribAuthor ">Qiufeng  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Yechun  Xu</span>, <span class="hlFld-ContribAuthor ">Ze-Hong  Miao</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 2885-2903. <a href="https://doi.org/10.1021/jm301825t" title="DOI URL">https://doi.org/10.1021/jm301825t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301825t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301825t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BSeries%252Bof%252BBenzo%25255Bde%25255D%25255B1%25252C7%25255Dnaphthyridin-7%2525288H%252529-ones%252BBearing%252Ba%252BFunctionalized%252BLonger%252BChain%252BAppendage%252Bas%252BNovel%252BPARP1%252BInhibitors%26aulast%3DYe%26aufirst%3DNa%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D11122012%26date%3D21032013%26date%3D11042013%26date%3D08032013%26volume%3D56%26issue%3D7%26spage%3D2885%26epage%3D2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Charrier</span>, <span class="hlFld-ContribAuthor ">Zhibo  Liu</span>, and <span class="hlFld-ContribAuthor ">Samir Z.  Zard</span>  . </span><span class="cited-content_cbyCitation_article-title">Desulfonylative Radical Ring Closure onto Aromatics. A Modular Route to Benzazepin-2-ones and 5-Arylpiperidin-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (8)
                                     , 2018-2021. <a href="https://doi.org/10.1021/ol3005276" title="DOI URL">https://doi.org/10.1021/ol3005276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol3005276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol3005276%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDesulfonylative%252BRadical%252BRing%252BClosure%252Bonto%252BAromatics.%252BA%252BModular%252BRoute%252Bto%252BBenzazepin-2-ones%252Band%252B5-Arylpiperidin-2-ones%26aulast%3DCharrier%26aufirst%3DNicolas%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D01032012%26date%3D30032012%26date%3D20042012%26volume%3D14%26issue%3D8%26spage%3D2018%26epage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debra J.  Wallace</span>, <span class="hlFld-ContribAuthor ">Carl A.  Baxter</span>, <span class="hlFld-ContribAuthor ">Karel J. M.  Brands</span>, <span class="hlFld-ContribAuthor ">Nadine  Bremeyer</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Brewer</span>, <span class="hlFld-ContribAuthor ">Richard  Desmond</span>, <span class="hlFld-ContribAuthor ">Khateeta M.  Emerson</span>, <span class="hlFld-ContribAuthor ">Jennifer  Foley</span>, <span class="hlFld-ContribAuthor ">Paul  Fernandez</span>, <span class="hlFld-ContribAuthor ">Weifeng  Hu</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Keen</span>, <span class="hlFld-ContribAuthor ">Peter  Mullens</span>, <span class="hlFld-ContribAuthor ">Daniel  Muzzio</span>, <span class="hlFld-ContribAuthor ">Peter  Sajonz</span>, <span class="hlFld-ContribAuthor ">Lushi  Tan</span>, <span class="hlFld-ContribAuthor ">Robert D.  Wilson</span>, <span class="hlFld-ContribAuthor ">George  Zhou</span>, and <span class="hlFld-ContribAuthor ">Guoyue  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Fit-for-Purpose Large-Scale Synthesis of an Oral PARP Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2011,</strong> <em>15 </em>
                                    (4)
                                     , 831-840. <a href="https://doi.org/10.1021/op2000783" title="DOI URL">https://doi.org/10.1021/op2000783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op2000783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop2000783%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BFit-for-Purpose%252BLarge-Scale%252BSynthesis%252Bof%252Ban%252BOral%252BPARP%252BInhibitor%26aulast%3DWallace%26aufirst%3DDebra%2BJ.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D29032011%26date%3D09062011%26date%3D15072011%26date%3D17052011%26volume%3D15%26issue%3D4%26spage%3D831%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter T.  Sunderland</span>, <span class="hlFld-ContribAuthor ">Esther C. Y.  Woon</span>, <span class="hlFld-ContribAuthor ">Archana  Dhami</span>, <span class="hlFld-ContribAuthor ">Aoife B.  Bergin</span>, <span class="hlFld-ContribAuthor ">Mary F.  Mahon</span>, <span class="hlFld-ContribAuthor ">Pauline J.  Wood</span>, <span class="hlFld-ContribAuthor ">Louise A.  Jones</span>, <span class="hlFld-ContribAuthor ">Sophie R.  Tully</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Thompson</span>, <span class="hlFld-ContribAuthor ">Hashim  Javaid</span>, <span class="hlFld-ContribAuthor ">Niall M. B.  Martin</span>, and <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>  . </span><span class="cited-content_cbyCitation_article-title">5-Benzamidoisoquinolin-1-ones and 5-(ω-Carboxyalkyl)isoquinolin-1-ones as Isoform-Selective Inhibitors of Poly(ADP-ribose) Polymerase 2 (PARP-2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (7)
                                     , 2049-2059. <a href="https://doi.org/10.1021/jm1010918" title="DOI URL">https://doi.org/10.1021/jm1010918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1010918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1010918%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Benzamidoisoquinolin-1-ones%252Band%252B5-%252528%2525CF%252589-Carboxyalkyl%252529isoquinolin-1-ones%252Bas%252BIsoform-Selective%252BInhibitors%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase%252B2%252B%252528PARP-2%252529%26aulast%3DSunderland%26aufirst%3DPeter%2BT.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D23082010%26date%3D18032011%26date%3D14042011%26volume%3D54%26issue%3D7%26spage%3D2049%26epage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana V.  Ferraris</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (12)
                                     , 4561-4584. <a href="https://doi.org/10.1021/jm100012m" title="DOI URL">https://doi.org/10.1021/jm100012m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100012m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100012m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvolution%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase-1%252B%252528PARP-1%252529%252BInhibitors.%252BFrom%252BConcept%252Bto%252BClinic%26aulast%3DFerraris%26aufirst%3DDana%2BV.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D06012010%26date%3D05042010%26date%3D24062010%26volume%3D53%26issue%3D12%26spage%3D4561%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas D.  Penning</span>, <span class="hlFld-ContribAuthor ">Gui-Dong  Zhu</span>, <span class="hlFld-ContribAuthor ">Jianchun  Gong</span>, <span class="hlFld-ContribAuthor ">Sheela  Thomas</span>, <span class="hlFld-ContribAuthor ">Viraj B.  Gandhi</span>, <span class="hlFld-ContribAuthor ">Xuesong  Liu</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Vered  Klinghofer</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Elizabeth H.  Fry</span>, <span class="hlFld-ContribAuthor ">Cherrie K.  Donawho</span>, <span class="hlFld-ContribAuthor ">David J.  Frost</span>, <span class="hlFld-ContribAuthor ">Fritz G.  Buchanan</span>, <span class="hlFld-ContribAuthor ">Gail T.  Bukofzer</span>, <span class="hlFld-ContribAuthor ">Luis E.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Velitchka  Bontcheva-Diaz</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Bouska</span>, <span class="hlFld-ContribAuthor ">Donald J.  Osterling</span>, <span class="hlFld-ContribAuthor ">Amanda M.  Olson</span>, <span class="hlFld-ContribAuthor ">Kennan C.  Marsh</span>, <span class="hlFld-ContribAuthor ">Yan  Luo</span> and <span class="hlFld-ContribAuthor ">Vincent L.  Giranda</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (S)-2-(2-Fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a Highly Potent and Efficacious Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (8)
                                     , 3142-3153. <a href="https://doi.org/10.1021/jm901775y" title="DOI URL">https://doi.org/10.1021/jm901775y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901775y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901775y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPhenyl-Substituted%252BBenzimidazole%252BCarboxamide%252BPoly%252528ADP-Ribose%252529%252BPolymerase%252BInhibitors%25253A%252BIdentification%252Bof%252B%252528S%252529-2-%2525282-Fluoro-4-%252528pyrrolidin-2-yl%252529phenyl%252529-1H-benzimidazole-4-carboxamide%252B%252528A-966492%252529%25252C%252Ba%252BHighly%252BPotent%252Band%252BEfficacious%252BInhibitor%26aulast%3DPenning%26aufirst%3DThomas%2BD.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D30112009%26date%3D25032010%26date%3D22042010%26volume%3D53%26issue%3D8%26spage%3D3142%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Shen</span>, <span class="hlFld-ContribAuthor ">Yiran  Ge</span>, <span class="hlFld-ContribAuthor ">Junwei  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel molecules as potent PARP-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128169. <a href="https://doi.org/10.1016/j.bmcl.2021.128169" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128169%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bmolecules%252Bas%252Bpotent%252BPARP-1%252Binhibitors%26aulast%3DShen%26aufirst%3DHui%26date%3D2021%26volume%3D47%26spage%3D128169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiawei  Zhang</span>, <span class="hlFld-ContribAuthor ">Kaimin  Kong</span>, <span class="hlFld-ContribAuthor ">Xiangjun  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Kemp-type elimination of 1-arylsulfonyl-3-iodo-1
              H
              -indazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (15)
                                     , 2365-2376. <a href="https://doi.org/10.1080/00397911.2021.1939053" title="DOI URL">https://doi.org/10.1080/00397911.2021.1939053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1939053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1939053%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DKemp-type%252Belimination%252Bof%252B1-arylsulfonyl-3-iodo-1%252BH%252B-indazoles%26aulast%3DZhang%26aufirst%3DJiawei%26date%3D2021%26date%3D2021%26volume%3D51%26issue%3D15%26spage%3D2365%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Yunyu  Xie</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">An update of new small-molecule anticancer drugs approved from 2015 to 2020. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113473. <a href="https://doi.org/10.1016/j.ejmech.2021.113473" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113473%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bupdate%252Bof%252Bnew%252Bsmall-molecule%252Banticancer%252Bdrugs%252Bapproved%252Bfrom%252B2015%252Bto%252B2020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D220%26spage%3D113473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uday Kiran  Velagapudi</span>, <span class="hlFld-ContribAuthor ">Bhargav A.  Patel</span>, <span class="hlFld-ContribAuthor ">Xuwei  Shao</span>, <span class="hlFld-ContribAuthor ">Sanjai Kumar  Pathak</span>, <span class="hlFld-ContribAuthor ">Dana V.  Ferraris</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (7)
                                     , 609-623. <a href="https://doi.org/10.1080/13543776.2021.1886275" title="DOI URL">https://doi.org/10.1080/13543776.2021.1886275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1886275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1886275%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bdevelopment%252Bin%252Bthe%252Bdiscovery%252Bof%252BPARP%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252Ba%252Bpatent%252Bupdate%252B%2525282016-2020%252529%26aulast%3DVelagapudi%26aufirst%3DUday%2BKiran%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D7%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueqian  Zuo</span>, <span class="hlFld-ContribAuthor ">Haibo  Zhao</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2021,</strong> <em>34 </em>
                                    (7)
                                     <a href="https://doi.org/10.1002/jmr.2891" title="DOI URL">https://doi.org/10.1002/jmr.2891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2891%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DSystematic%252Binhibitor%252Bselectivity%252Bbetween%252BPARP1%252Band%252BPARP2%252Benzymes%25253A%252BMolecular%252Bimplications%252Bfor%252Bovarian%252Bcancer%252Bpersonalized%252Btherapy%26aulast%3DZuo%26aufirst%3DXueqian%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuyen T.  Dang</span>, <span class="hlFld-ContribAuthor ">Julio C.  Morales</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of CENP-I Impairs Homologous Recombination and Sensitizes Cells to PARP1 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 3202. <a href="https://doi.org/10.3390/cancers13133202" title="DOI URL">https://doi.org/10.3390/cancers13133202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13133202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13133202%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLoss%252Bof%252BCENP-I%252BImpairs%252BHomologous%252BRecombination%252Band%252BSensitizes%252BCells%252Bto%252BPARP1%252BInhibition%26aulast%3DDang%26aufirst%3DTuyen%2BT.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Paterniti</span>, <span class="hlFld-ContribAuthor ">Sarah Adriana  Scuderi</span>, <span class="hlFld-ContribAuthor ">Giovanna  Casili</span>, <span class="hlFld-ContribAuthor ">Marika  Lanza</span>, <span class="hlFld-ContribAuthor ">Marzia  Mare</span>, <span class="hlFld-ContribAuthor ">Raffella  Giuffrida</span>, <span class="hlFld-ContribAuthor ">Cristina  Colarossi</span>, <span class="hlFld-ContribAuthor ">Marco  Portelli</span>, <span class="hlFld-ContribAuthor ">Salvatore  Cuzzocrea</span>, <span class="hlFld-ContribAuthor ">Emanuela  Esposito</span>. </span><span class="cited-content_cbyCitation_article-title">Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (7)
                                     , 771. <a href="https://doi.org/10.3390/biomedicines9070771" title="DOI URL">https://doi.org/10.3390/biomedicines9070771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9070771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9070771%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DPoly%252B%252528ADP-Ribose%252529%252BPolymerase%252BInhibitor%25252C%252BABT888%25252C%252BImproved%252BCisplatin%252BEffect%252Bin%252BHuman%252BOral%252BCell%252BCarcinoma%26aulast%3DPaterniti%26aufirst%3DIrene%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D7%26spage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingqi  Huang</span>, <span class="hlFld-ContribAuthor ">Jinghui  Ren</span>, <span class="hlFld-ContribAuthor ">Yuhong  Wang</span>, <span class="hlFld-ContribAuthor ">Xixi  Chen</span>, <span class="hlFld-ContribAuthor ">Jia  Yang</span>, <span class="hlFld-ContribAuthor ">Tu  Tang</span>, <span class="hlFld-ContribAuthor ">Zhenyong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Li</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2021,</strong> <em>69 </em>
                                    (7)
                                     , 620-629. <a href="https://doi.org/10.1248/cpb.c20-01018" title="DOI URL">https://doi.org/10.1248/cpb.c20-01018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c20-01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c20-01018%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BActivity%252BEvaluation%252Bof%252BNew%252BPhthalazinone%252BPARP%252BInhibitors%26aulast%3DHuang%26aufirst%3DMingqi%26date%3D2021%26volume%3D69%26issue%3D7%26spage%3D620%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liliana  Raimundo</span>, <span class="hlFld-ContribAuthor ">Juliana  Calheiros</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (14)
                                     , 3438. <a href="https://doi.org/10.3390/cancers13143438" title="DOI URL">https://doi.org/10.3390/cancers13143438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13143438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13143438%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DExploiting%252BDNA%252BDamage%252BRepair%252Bin%252BPrecision%252BCancer%252BTherapy%25253A%252BBRCA1%252Bas%252Ba%252BPrime%252BTherapeutic%252BTarget%26aulast%3DRaimundo%26aufirst%3DLiliana%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D14%26spage%3D3438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yigao  Li</span>, <span class="hlFld-ContribAuthor ">Linlin  Shi</span>, <span class="hlFld-ContribAuthor ">Xinju  Zhu</span>, <span class="hlFld-ContribAuthor ">Xin-Qi  Hao</span>, <span class="hlFld-ContribAuthor ">Mao-Ping  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed C–H acetoxylation of 2-arylindazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>93 </em>, 132277. <a href="https://doi.org/10.1016/j.tet.2021.132277" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132277%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPalladium-catalyzed%252BC%2525E2%252580%252593H%252Bacetoxylation%252Bof%252B2-arylindazoles%26aulast%3DWang%26aufirst%3DXu-Yan%26date%3D2021%26volume%3D93%26spage%3D132277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunhua  Ma</span>, <span class="hlFld-ContribAuthor ">Zhiwen  Feng</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Dandan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Yuqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Bing  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Photocatalytic transition-metal-free direct 3-alkylation of 2-aryl-2
              H
              -indazoles in dimethyl carbonate. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (13)
                                     , 3286-3291. <a href="https://doi.org/10.1039/D1QO00064K" title="DOI URL">https://doi.org/10.1039/D1QO00064K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00064K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00064K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPhotocatalytic%252Btransition-metal-free%252Bdirect%252B3-alkylation%252Bof%252B2-aryl-2%252BH%252B-indazoles%252Bin%252Bdimethyl%252Bcarbonate%26aulast%3DMa%26aufirst%3DChunhua%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D13%26spage%3D3286%26epage%3D3291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maninder  Singh</span>, <span class="hlFld-ContribAuthor ">Jyotika  Rajawat</span>, <span class="hlFld-ContribAuthor ">Jitendra  Kuldeep</span>, <span class="hlFld-ContribAuthor ">Nidhi  Shukla</span>, <span class="hlFld-ContribAuthor ">Durga Prasad  Mishra</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>45 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2021.1913229" title="DOI URL">https://doi.org/10.1080/07391102.2021.1913229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1913229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1913229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIntegrated%252Bsupport%252Bvector%252Bmachine%252Band%252Bpharmacophore%252Bbased%252Bvirtual%252Bscreening%252Bdriven%252Bidentification%252Bof%252Bthiophene%252Bcarboxamide%252Bscaffold%252Bcontaining%252Bcompound%252Bas%252Bpotential%252BPARP1%252Binhibitor%26aulast%3DSingh%26aufirst%3DManinder%26date%3D2021%26date%3D2021%26volume%3D45%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratik  Chheda</span>, <span class="hlFld-ContribAuthor ">Maria  Spies</span>, <span class="hlFld-ContribAuthor ">M. Ashley  Spies</span>. </span><span class="cited-content_cbyCitation_article-title">Small‐molecule Effectors of
              DNA
              Repair Proteins: Applications for Development of Cancer Therapeutics and Research. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-39. <a href="https://doi.org/10.1002/0471266949.bmc287" title="DOI URL">https://doi.org/10.1002/0471266949.bmc287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc287%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%2525E2%252580%252590molecule%252BEffectors%252Bof%252BDNA%252BRepair%252BProteins%25253A%252BApplications%252Bfor%252BDevelopment%252Bof%252BCancer%252BTherapeutics%252Band%252BResearch%26aulast%3DChheda%26aufirst%3DPratik%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D39%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richa  Sharma</span>, <span class="hlFld-ContribAuthor ">Lalit  Yadav</span>, <span class="hlFld-ContribAuthor ">Ravi Kant  Yadav</span>, <span class="hlFld-ContribAuthor ">Sandeep  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative cross-dehydrogenative coupling (CDC)
              via
              C
              (sp2)
              –H bond functionalization:
              tert
              -butyl peroxybenzoate (TBPB)-promoted regioselective direct C-3 acylation/benzoylation of 2
              H
              -indazoles with aldehydes/benzyl alcohols/styrenes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (23)
                                     , 14178-14192. <a href="https://doi.org/10.1039/D1RA02225C" title="DOI URL">https://doi.org/10.1039/D1RA02225C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA02225C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA02225C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOxidative%252Bcross-dehydrogenative%252Bcoupling%252B%252528CDC%252529%252Bvia%252BC%252B%252528sp2%252529%252B%2525E2%252580%252593H%252Bbond%252Bfunctionalization%25253A%252Btert%252B-butyl%252Bperoxybenzoate%252B%252528TBPB%252529-promoted%252Bregioselective%252Bdirect%252BC-3%252Bacylation%25252Fbenzoylation%252Bof%252B2%252BH%252B-indazoles%252Bwith%252Baldehydes%25252Fbenzyl%252Balcohols%25252Fstyrenes%26aulast%3DSharma%26aufirst%3DRicha%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D23%26spage%3D14178%26epage%3D14192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junwei  Wang</span>, <span class="hlFld-ContribAuthor ">Guangchao  He</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Yiran  Ge</span>, <span class="hlFld-ContribAuthor ">Shuping  Wang</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113054. <a href="https://doi.org/10.1016/j.ejmech.2020.113054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BPARP%25252FPI3K%252Bdual%252Binhibitors%252Bwith%252Bhigh%252Befficiency%252Bagainst%252BBRCA-proficient%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DWang%26aufirst%3DJunwei%26date%3D2021%26volume%3D213%26spage%3D113054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew J.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Malte  Peters</span>, <span class="hlFld-ContribAuthor ">Barbara L.  Weber</span>, <span class="hlFld-ContribAuthor ">Charles B.  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency‐Guided First‐in‐Human Studies. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2021,</strong> <em>14 </em>
                                    (2)
                                     , 536-543. <a href="https://doi.org/10.1111/cts.12902" title="DOI URL">https://doi.org/10.1111/cts.12902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12902%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DOptimizing%252Bthe%252BTherapeutic%252BWindow%252Bof%252BTargeted%252BDrugs%252Bin%252BOncology%25253A%252BPotency%2525E2%252580%252590Guided%252BFirst%2525E2%252580%252590in%2525E2%252580%252590Human%252BStudies%26aulast%3DGoldstein%26aufirst%3DMatthew%2BJ.%26date%3D2021%26date%3D2020%26volume%3D14%26issue%3D2%26spage%3D536%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binghe  Xu</span>, <span class="hlFld-ContribAuthor ">Yongmei  Yin</span>, <span class="hlFld-ContribAuthor ">Mei  Dong</span>, <span class="hlFld-ContribAuthor ">Yan  Song</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Xiang  Huang</span>, <span class="hlFld-ContribAuthor ">Tongshan  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  He</span>, <span class="hlFld-ContribAuthor ">Xiyan  Mu</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Song  Mu</span>, <span class="hlFld-ContribAuthor ">Wa  Zhang</span>, <span class="hlFld-ContribAuthor ">Miao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Pamiparib dose escalation in Chinese patients with non‐mucinous high‐grade ovarian cancer or advanced triple‐negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Medicine</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 109-118. <a href="https://doi.org/10.1002/cam4.3575" title="DOI URL">https://doi.org/10.1002/cam4.3575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cam4.3575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcam4.3575%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Medicine%26atitle%3DPamiparib%252Bdose%252Bescalation%252Bin%252BChinese%252Bpatients%252Bwith%252Bnon%2525E2%252580%252590mucinous%252Bhigh%2525E2%252580%252590grade%252Bovarian%252Bcancer%252Bor%252Badvanced%252Btriple%2525E2%252580%252590negative%252Bbreast%252Bcancer%26aulast%3DXu%26aufirst%3DBinghe%26date%3D2021%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D109%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navnath P.  Karche</span>, <span class="hlFld-ContribAuthor ">Mandar  Bhonde</span>, <span class="hlFld-ContribAuthor ">Neelima  Sinha</span>, <span class="hlFld-ContribAuthor ">Gourhari  Jana</span>, <span class="hlFld-ContribAuthor ">Gagan  Kukreja</span>, <span class="hlFld-ContribAuthor ">Sanjay P.  Kurhade</span>, <span class="hlFld-ContribAuthor ">Arun R.  Jagdale</span>, <span class="hlFld-ContribAuthor ">Ajay R.  Tilekar</span>, <span class="hlFld-ContribAuthor ">Anil K.  Hajare</span>, <span class="hlFld-ContribAuthor ">Ganesh R.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Nishant R.  Gupta</span>, <span class="hlFld-ContribAuthor ">Rohan  Limaye</span>, <span class="hlFld-ContribAuthor ">Nilesh  Khedkar</span>, <span class="hlFld-ContribAuthor ">Baban R.  Thube</span>, <span class="hlFld-ContribAuthor ">Javed S.  Shaikh</span>, <span class="hlFld-ContribAuthor ">Nageswara  Rao Irlapati</span>, <span class="hlFld-ContribAuthor ">Samiron  Phukan</span>, <span class="hlFld-ContribAuthor ">Gopal  Gole</span>, <span class="hlFld-ContribAuthor ">Apparao  Bommakanti</span>, <span class="hlFld-ContribAuthor ">Harshal  Khanwalkar</span>, <span class="hlFld-ContribAuthor ">Yogesh  Pawar</span>, <span class="hlFld-ContribAuthor ">Ramesh  Kale</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajesh  Gupta</span>, <span class="hlFld-ContribAuthor ">V.R.  Praveen Kumar</span>, <span class="hlFld-ContribAuthor ">Saif  Wahid</span>, <span class="hlFld-ContribAuthor ">Albi  Francis</span>, <span class="hlFld-ContribAuthor ">Tariq  Bhat</span>, <span class="hlFld-ContribAuthor ">Nivrutti  Kamble</span>, <span class="hlFld-ContribAuthor ">Vinod  Patil</span>, <span class="hlFld-ContribAuthor ">Prashant B.  Nigade</span>, <span class="hlFld-ContribAuthor ">Dipak  Modi</span>, <span class="hlFld-ContribAuthor ">Shashikant  Pawar</span>, <span class="hlFld-ContribAuthor ">Sneha  Naidu</span>, <span class="hlFld-ContribAuthor ">Harish  Volam</span>, <span class="hlFld-ContribAuthor ">Vamsi  Pagdala</span>, <span class="hlFld-ContribAuthor ">Sadanand  Mallurwar</span>, <span class="hlFld-ContribAuthor ">Hemant  Goyal</span>, <span class="hlFld-ContribAuthor ">Pushpak  Bora</span>, <span class="hlFld-ContribAuthor ">Prajakta  Ahirrao</span>, <span class="hlFld-ContribAuthor ">Minakshi  Singh</span>, <span class="hlFld-ContribAuthor ">Prabhakaran  Kamalakannan</span>, <span class="hlFld-ContribAuthor ">Kumar Ram  Naik</span>, <span class="hlFld-ContribAuthor ">Pradipta  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajendra G.  Powar</span>, <span class="hlFld-ContribAuthor ">Rajesh B.  Shankar</span>, <span class="hlFld-ContribAuthor ">Peter R.  Bernstein</span>, <span class="hlFld-ContribAuthor ">Jayasagar  Gundu</span>, <span class="hlFld-ContribAuthor ">Kumar  Nemmani</span>, <span class="hlFld-ContribAuthor ">Lakshmi  Narasimham</span>, <span class="hlFld-ContribAuthor ">Kochumalayil Shaji  George</span>, <span class="hlFld-ContribAuthor ">Sharad  Sharma</span>, <span class="hlFld-ContribAuthor ">Dhananjay  Bakhle</span>, <span class="hlFld-ContribAuthor ">Rajender Kumar  Kamboj</span>, <span class="hlFld-ContribAuthor ">Venkata P.  Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115819. <a href="https://doi.org/10.1016/j.bmc.2020.115819" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115819%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bisoquinolinone%252Band%252Bnaphthyridinone-based%252Binhibitors%252Bof%252Bpoly%252528ADP-ribose%252529%252Bpolymerase-1%252B%252528PARP1%252529%252Bas%252Banticancer%252Bagents%25253A%252BStructure%252Bactivity%252Brelationship%252Band%252Bpreclinical%252Bcharacterization%26aulast%3DKarche%26aufirst%3DNavnath%2BP.%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel R.  Twarog</span>, <span class="hlFld-ContribAuthor ">Michele  Connelly</span>, <span class="hlFld-ContribAuthor ">Anang A.  Shelat</span>. </span><span class="cited-content_cbyCitation_article-title">A critical evaluation of methods to interpret drug combinations. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-61923-1" title="DOI URL">https://doi.org/10.1038/s41598-020-61923-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-61923-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-61923-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bcritical%252Bevaluation%252Bof%252Bmethods%252Bto%252Binterpret%252Bdrug%252Bcombinations%26aulast%3DTwarog%26aufirst%3DNathaniel%2BR.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verena  Weigert</span>, <span class="hlFld-ContribAuthor ">Tina  Jost</span>, <span class="hlFld-ContribAuthor ">Markus  Hecht</span>, <span class="hlFld-ContribAuthor ">Ilka  Knippertz</span>, <span class="hlFld-ContribAuthor ">Lucie  Heinzerling</span>, <span class="hlFld-ContribAuthor ">Rainer  Fietkau</span>, <span class="hlFld-ContribAuthor ">Luitpold V.  Distel</span>. </span><span class="cited-content_cbyCitation_article-title">PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-020-07190-9" title="DOI URL">https://doi.org/10.1186/s12885-020-07190-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-020-07190-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-020-07190-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DPARP%252Binhibitors%252Bcombined%252Bwith%252Bionizing%252Bradiation%252Binduce%252Bdifferent%252Beffects%252Bin%252Bmelanoma%252Bcells%252Band%252Bhealthy%252Bfibroblasts%26aulast%3DWeigert%26aufirst%3DVerena%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-Bo  Tan</span>, <span class="hlFld-ContribAuthor ">Ya-Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Fenghuang  Zhan</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-66137-z" title="DOI URL">https://doi.org/10.1038/s41598-020-66137-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-66137-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-66137-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCatalyst-Free%252BOne-Pot%252BSynthesis%252Bof%252BDensely%252BSubstituted%252BPyrazole-Pyrazines%252Bas%252BAnti-Colorectal%252BCancer%252BAgents%26aulast%3DXu%26aufirst%3DJia%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Qing  Jin</span>, <span class="hlFld-ContribAuthor ">Wen-Xia  Gao</span>, <span class="hlFld-ContribAuthor ">Yun-Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Miao-Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Hua-Yue  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of 2-aryl-2
              H
              -indazoles by base-catalyzed benzyl C–H deprotonation and cyclization. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (93)
                                     , 14617-14620. <a href="https://doi.org/10.1039/D0CC05862A" title="DOI URL">https://doi.org/10.1039/D0CC05862A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC05862A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC05862A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DEfficient%252Bsynthesis%252Bof%252B2-aryl-2%252BH%252B-indazoles%252Bby%252Bbase-catalyzed%252Bbenzyl%252BC%2525E2%252580%252593H%252Bdeprotonation%252Band%252Bcyclization%26aulast%3DJin%26aufirst%3DGuo-Qing%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D93%26spage%3D14617%26epage%3D14620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">BJ  Rimel</span>, <span class="hlFld-ContribAuthor ">Lauren  Dockery</span>, <span class="hlFld-ContribAuthor ">Leslie M  Randall</span>, <span class="hlFld-ContribAuthor ">Kathleen  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (33)
                                     , 2701-2711. <a href="https://doi.org/10.2217/fon-2020-0538" title="DOI URL">https://doi.org/10.2217/fon-2020-0538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0538%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DNiraparib%252Bin%252Bthe%252Btreatment%252Bof%252Bpreviously%252Btreated%252Badvanced%252Bovarian%25252C%252Bfallopian%252Btube%2525C2%2525A0or%252Bprimary%252Bperitoneal%252Bcancer%26aulast%3DRimel%26aufirst%3DBJ%26date%3D2020%26volume%3D16%26issue%3D33%26spage%3D2701%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert  Jang</span>, <span class="hlFld-ContribAuthor ">Oliver  Sartor</span>, <span class="hlFld-ContribAuthor ">Pedro C.  Barata</span>, <span class="hlFld-ContribAuthor ">Channing J.  Paller</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3467. <a href="https://doi.org/10.3390/cancers12113467" title="DOI URL">https://doi.org/10.3390/cancers12113467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113467%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTherapeutic%252BPotential%252Bof%252BPARP%252BInhibitors%252Bin%252Bthe%252BTreatment%252Bof%252BMetastatic%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DJang%26aufirst%3DAlbert%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Gai  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Die  Wang</span>, <span class="hlFld-ContribAuthor ">Linlin  Shi</span>, <span class="hlFld-ContribAuthor ">Xinju  Zhu</span>, <span class="hlFld-ContribAuthor ">Xin-Qi  Hao</span>, <span class="hlFld-ContribAuthor ">Mao-Ping  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(III)-catalyzed C–H acylmethylation of 2H-indazoles with sulfoxonium ylides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Saudi Chemical Society</span><span> <strong>2020,</strong> <em>24 </em>
                                    (11)
                                     , 850-856. <a href="https://doi.org/10.1016/j.jscs.2020.09.001" title="DOI URL">https://doi.org/10.1016/j.jscs.2020.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jscs.2020.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jscs.2020.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Saudi%2520Chemical%2520Society%26atitle%3DRh%252528III%252529-catalyzed%252BC%2525E2%252580%252593H%252Bacylmethylation%252Bof%252B2H-indazoles%252Bwith%252Bsulfoxonium%252Bylides%26aulast%3DWang%26aufirst%3DYa-Gai%26date%3D2020%26volume%3D24%26issue%3D11%26spage%3D850%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Zhao</span>, <span class="hlFld-ContribAuthor ">Liu-Xia  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Long</span>, <span class="hlFld-ContribAuthor ">Zhong-Ye  Ma</span>, <span class="hlFld-ContribAuthor ">Ai-Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yan  Cheng</span>, <span class="hlFld-ContribAuthor ">Dong-Sheng  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy–Current progress and future direction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112570. <a href="https://doi.org/10.1016/j.ejmech.2020.112570" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112570%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bups%252Band%252Bdowns%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase-1%252Binhibitors%252Bin%252Bcancer%252Btherapy%2525E2%252580%252593Current%252Bprogress%252Band%252Bfuture%252Bdirection%26aulast%3DZhao%26aufirst%3DYue%26date%3D2020%26volume%3D203%26spage%3D112570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola J.  Curtin</span>, <span class="hlFld-ContribAuthor ">Csaba  Szabo</span>. </span><span class="cited-content_cbyCitation_article-title">Poly(ADP-ribose) polymerase inhibition: past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2020,</strong> <em>19 </em>
                                    (10)
                                     , 711-736. <a href="https://doi.org/10.1038/s41573-020-0076-6" title="DOI URL">https://doi.org/10.1038/s41573-020-0076-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-020-0076-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-020-0076-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPoly%252528ADP-ribose%252529%252Bpolymerase%252Binhibition%25253A%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DCurtin%26aufirst%3DNicola%2BJ.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D10%26spage%3D711%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuwei  Shao</span>, <span class="hlFld-ContribAuthor ">Steven  Pak</span>, <span class="hlFld-ContribAuthor ">Uday Kiran  Velagapudi</span>, <span class="hlFld-ContribAuthor ">Shruthi  Gobbooru</span>, <span class="hlFld-ContribAuthor ">Sai Shilpa  Kommaraju</span>, <span class="hlFld-ContribAuthor ">Woon-Kai  Low</span>, <span class="hlFld-ContribAuthor ">Gopal  Subramaniam</span>, <span class="hlFld-ContribAuthor ">Sanjai Kumar  Pathak</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide and 3-oxo-3,4-dihydrobenzo[b][1,4]oxazine-8-carboxamide derivatives as PARP1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104075. <a href="https://doi.org/10.1016/j.bioorg.2020.104075" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%25252C3-dihydrobenzo%25255Bb%25255D%25255B1%25252C4%25255Ddioxine-5-carboxamide%252Band%252B3-oxo-3%25252C4-dihydrobenzo%25255Bb%25255D%25255B1%25252C4%25255Doxazine-8-carboxamide%252Bderivatives%252Bas%252BPARP1%252Binhibitors%26aulast%3DShao%26aufirst%3DXuwei%26date%3D2020%26volume%3D102%26spage%3D104075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruth  Plummer</span>, <span class="hlFld-ContribAuthor ">Divyanshu  Dua</span>, <span class="hlFld-ContribAuthor ">Nicola  Cresti</span>, <span class="hlFld-ContribAuthor ">Yvette  Drew</span>, <span class="hlFld-ContribAuthor ">Peter  Stephens</span>, <span class="hlFld-ContribAuthor ">Marie  Foegh</span>, <span class="hlFld-ContribAuthor ">Steen  Knudsen</span>, <span class="hlFld-ContribAuthor ">Pallavi  Sachdev</span>, <span class="hlFld-ContribAuthor ">Bipin M.  Mistry</span>, <span class="hlFld-ContribAuthor ">Vaishali  Dixit</span>, <span class="hlFld-ContribAuthor ">Sharon  McGonigle</span>, <span class="hlFld-ContribAuthor ">Nancy  Hall</span>, <span class="hlFld-ContribAuthor ">Mark  Matijevic</span>, <span class="hlFld-ContribAuthor ">Shannon  McGrath</span>, <span class="hlFld-ContribAuthor ">Debashis  Sarker</span>. </span><span class="cited-content_cbyCitation_article-title">First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>123 </em>
                                    (4)
                                     , 525-533. <a href="https://doi.org/10.1038/s41416-020-0916-5" title="DOI URL">https://doi.org/10.1038/s41416-020-0916-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-0916-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-0916-5%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DFirst-in-human%252Bstudy%252Bof%252Bthe%252BPARP%25252Ftankyrase%252Binhibitor%252BE7449%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumours%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bdrug-response%252Bpredictor%26aulast%3DPlummer%26aufirst%3DRuth%26date%3D2020%26date%3D2020%26volume%3D123%26issue%3D4%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalit  Yadav</span>, <span class="hlFld-ContribAuthor ">Sandeep  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Bu
              4
              NI-catalyzed, oxidative C
              (sp2)
              –C
              (sp3)
              cross dehydrogenative coupling for the regioselective direct C-3 benzylation of 2
              H
              -indazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (30)
                                     , 5927-5936. <a href="https://doi.org/10.1039/D0OB01282C" title="DOI URL">https://doi.org/10.1039/D0OB01282C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01282C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01282C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DBu%252B4%252BNI-catalyzed%25252C%252Boxidative%252BC%252B%252528sp2%252529%252B%2525E2%252580%252593C%252B%252528sp3%252529%252Bcross%252Bdehydrogenative%252Bcoupling%252Bfor%252Bthe%252Bregioselective%252Bdirect%252BC-3%252Bbenzylation%252Bof%252B2%252BH%252B-indazoles%26aulast%3DYadav%26aufirst%3DLalit%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D30%26spage%3D5927%26epage%3D5936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuyen T.  Dang</span>, <span class="hlFld-ContribAuthor ">Julio C.  Morales</span>. </span><span class="cited-content_cbyCitation_article-title">XRN2 Links RNA:DNA Hybrid Resolution to Double Strand Break Repair Pathway Choice. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1821. <a href="https://doi.org/10.3390/cancers12071821" title="DOI URL">https://doi.org/10.3390/cancers12071821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071821%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DXRN2%252BLinks%252BRNA%25253ADNA%252BHybrid%252BResolution%252Bto%252BDouble%252BStrand%252BBreak%252BRepair%252BPathway%252BChoice%26aulast%3DDang%26aufirst%3DTuyen%2BT.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tuyen T.  Dang</span>, <span class="hlFld-ContribAuthor ">Julio C.  Morales</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     , 4245. <a href="https://doi.org/10.3390/ijms21124245" title="DOI URL">https://doi.org/10.3390/ijms21124245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21124245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21124245%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInvolvement%252Bof%252BPOLA2%252Bin%252BDouble%252BStrand%252BBreak%252BRepair%252Band%252BGenotoxic%252BStress%26aulast%3DDang%26aufirst%3DTuyen%2BT.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12%26spage%3D4245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sedef  Karabiyikoglu</span>, <span class="hlFld-ContribAuthor ">Alexandre V.  Brethomé</span>, <span class="hlFld-ContribAuthor ">Thomas  Palacin</span>, <span class="hlFld-ContribAuthor ">Robert S.  Paton</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Fletcher</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiomerically enriched tetrahydropyridine allyl chlorides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (16)
                                     , 4125-4130. <a href="https://doi.org/10.1039/D0SC00377H" title="DOI URL">https://doi.org/10.1039/D0SC00377H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC00377H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC00377H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DEnantiomerically%252Benriched%252Btetrahydropyridine%252Ballyl%252Bchlorides%26aulast%3DKarabiyikoglu%26aufirst%3DSedef%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D16%26spage%3D4125%26epage%3D4130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dea  Slade</span>. </span><span class="cited-content_cbyCitation_article-title">PARP and PARG inhibitors in cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Genes & Development</span><span> <strong>2020,</strong> <em>34 </em>
                                    (5-6)
                                     , 360-394. <a href="https://doi.org/10.1101/gad.334516.119" title="DOI URL">https://doi.org/10.1101/gad.334516.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/gad.334516.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fgad.334516.119%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Development%26atitle%3DPARP%252Band%252BPARG%252Binhibitors%252Bin%252Bcancer%252Btreatment%26aulast%3DSlade%26aufirst%3DDea%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D5-6%26spage%3D360%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Dian  Xiao</span>, <span class="hlFld-ContribAuthor ">Lianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Fei  Xie</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xinbo  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 407. <a href="https://doi.org/10.3390/molecules25020407" title="DOI URL">https://doi.org/10.3390/molecules25020407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25020407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25020407%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252Bthe%252BPhotoactivatable%252BProdrug%252Bof%252Bthe%252BPARP%252BInhibitor%252BTalazoparib%26aulast%3DLi%26aufirst%3DJiaguo%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Ling  Liu</span>, <span class="hlFld-ContribAuthor ">You-Lu  Pan</span>, <span class="hlFld-ContribAuthor ">Gang-Jian  Li</span>, <span class="hlFld-ContribAuthor ">Hai-Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The nickel-catalyzed
              C
              3-acylation of 2
              H
              -indazoles with aldehydes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (38)
                                     , 8749-8755. <a href="https://doi.org/10.1039/C9OB01749F" title="DOI URL">https://doi.org/10.1039/C9OB01749F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01749F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01749F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bnickel-catalyzed%252BC%252B3-acylation%252Bof%252B2%252BH%252B-indazoles%252Bwith%252Baldehydes%26aulast%3DLiu%26aufirst%3DYan-Ling%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D38%26spage%3D8749%26epage%3D8755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed  Eddahmi</span>, <span class="hlFld-ContribAuthor ">Nuno M. M.  Moura</span>, <span class="hlFld-ContribAuthor ">Latifa  Bouissane</span>, <span class="hlFld-ContribAuthor ">Ahmed  Gamouh</span>, <span class="hlFld-ContribAuthor ">Maria A. F.  Faustino</span>, <span class="hlFld-ContribAuthor ">José A. S.  Cavaleiro</span>, <span class="hlFld-ContribAuthor ">Filipe A. A.  Paz</span>, <span class="hlFld-ContribAuthor ">Ricardo F.  Mendes</span>, <span class="hlFld-ContribAuthor ">Carlos  Lodeiro</span>, <span class="hlFld-ContribAuthor ">Sérgio M.  Santos</span>, <span class="hlFld-ContribAuthor ">Maria G. P. M. S.  Neves</span>, <span class="hlFld-ContribAuthor ">El Mostapha  Rakib</span>. </span><span class="cited-content_cbyCitation_article-title">New nitroindazolylacetonitriles: efficient synthetic access
              via
              vicarious nucleophilic substitution and tautomeric switching mediated by anions. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (36)
                                     , 14355-14367. <a href="https://doi.org/10.1039/C9NJ02807B" title="DOI URL">https://doi.org/10.1039/C9NJ02807B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ02807B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ02807B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNew%252Bnitroindazolylacetonitriles%25253A%252Befficient%252Bsynthetic%252Baccess%252Bvia%252Bvicarious%252Bnucleophilic%252Bsubstitution%252Band%252Btautomeric%252Bswitching%252Bmediated%252Bby%252Banions%26aulast%3DEddahmi%26aufirst%3DMohammed%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D36%26spage%3D14355%26epage%3D14367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Schoene</span>, <span class="hlFld-ContribAuthor ">Thais  Gazzi</span>, <span class="hlFld-ContribAuthor ">Peter  Lindemann</span>, <span class="hlFld-ContribAuthor ">Mathias  Christmann</span>, <span class="hlFld-ContribAuthor ">Andrea  Volkamer</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">Probing 2
              H
              ‐Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1514-1527. <a href="https://doi.org/10.1002/cmdc.201900328" title="DOI URL">https://doi.org/10.1002/cmdc.201900328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900328%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DProbing%252B2%252BH%252B%2525E2%252580%252590Indazoles%252Bas%252BTemplates%252Bfor%252BSGK1%25252C%252BTie2%25252C%252Band%252BSRC%252BKinase%252BInhibitors%26aulast%3DSchoene%26aufirst%3DJens%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1514%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Chuan-Huizi  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Ne  Guo</span>, <span class="hlFld-ContribAuthor ">Yu-Nan  Tian</span>, <span class="hlFld-ContribAuthor ">Xia-Juan  Huan</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Song</span>, <span class="hlFld-ContribAuthor ">Jin-Xue  He</span>, <span class="hlFld-ContribAuthor ">Ze-Hong  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2019,</strong> <em>145 </em>
                                    (3)
                                     , 714-727. <a href="https://doi.org/10.1002/ijc.32131" title="DOI URL">https://doi.org/10.1002/ijc.32131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.32131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.32131%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DIncreased%252BPARP1-DNA%252Bbinding%252Bdue%252Bto%252BautoPARylation%252Binhibition%252Bof%252BPARP1%252Bon%252BDNA%252Brather%252Bthan%252BPARP1-DNA%252Btrapping%252Bis%252Bcorrelated%252Bwith%252BPARP1%252Binhibitor%252527s%252Bcytotoxicity%26aulast%3DChen%26aufirst%3DHua-Dong%26date%3D2019%26date%3D2019%26volume%3D145%26issue%3D3%26spage%3D714%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaru  Kondo</span>, <span class="hlFld-ContribAuthor ">Shinobu  Takizawa</span>, <span class="hlFld-ContribAuthor ">Yuzhao  Jiang</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Sasai</span>. </span><span class="cited-content_cbyCitation_article-title">Room‐Temperature, Metal‐Free, and One‐Pot Preparation of 2
              H
              ‐Indazoles through a Mills Reaction and Cyclization Sequence. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (42)
                                     , 9866-9869. <a href="https://doi.org/10.1002/chem.201902242" title="DOI URL">https://doi.org/10.1002/chem.201902242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902242%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRoom%2525E2%252580%252590Temperature%25252C%252BMetal%2525E2%252580%252590Free%25252C%252Band%252BOne%2525E2%252580%252590Pot%252BPreparation%252Bof%252B2%252BH%252B%2525E2%252580%252590Indazoles%252Bthrough%252Ba%252BMills%252BReaction%252Band%252BCyclization%252BSequence%26aulast%3DKondo%26aufirst%3DMasaru%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D42%26spage%3D9866%26epage%3D9869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Toma</span>, <span class="hlFld-ContribAuthor ">Tomasz  Skorski</span>, <span class="hlFld-ContribAuthor ">Tomasz  Sliwinski</span>. </span><span class="cited-content_cbyCitation_article-title">DNA Double Strand Break Repair - Related Synthetic Lethality. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (8)
                                     , 1446-1482. <a href="https://doi.org/10.2174/0929867325666180201114306" title="DOI URL">https://doi.org/10.2174/0929867325666180201114306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180201114306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180201114306%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DDNA%252BDouble%252BStrand%252BBreak%252BRepair%252B-%252BRelated%252BSynthetic%252BLethality%26aulast%3DToma%26aufirst%3DMonika%26date%3D2019%26volume%3D26%26issue%3D8%26spage%3D1446%26epage%3D1482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria J  Sambade</span>, <span class="hlFld-ContribAuthor ">Amanda E D  Van Swearingen</span>, <span class="hlFld-ContribAuthor ">Marni B  McClure</span>, <span class="hlFld-ContribAuthor ">Allison M  Deal</span>, <span class="hlFld-ContribAuthor ">Charlene  Santos</span>, <span class="hlFld-ContribAuthor ">Kaiming  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Keith  Mikule</span>, <span class="hlFld-ContribAuthor ">Carey K  Anders</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology Advances</span><span> <strong>2019,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/noajnl/vdz005" title="DOI URL">https://doi.org/10.1093/noajnl/vdz005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/noajnl/vdz005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnoajnl%2Fvdz005%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%2520Advances%26atitle%3DEfficacy%252Band%252Bpharmacodynamics%252Bof%252Bniraparib%252Bin%252BBRCA-mutant%252Band%252Bwild-type%252Bintracranial%252Btriple-negative%252Bbreast%252Bcancer%252Bmurine%252Bmodels%26aulast%3DSambade%26aufirst%3DMaria%2BJ%26date%3D2019%26date%3D2019%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Min</span>, <span class="hlFld-ContribAuthor ">Weibin  Wu</span>, <span class="hlFld-ContribAuthor ">Mingzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Tang</span>, <span class="hlFld-ContribAuthor ">Dawei  Chen</span>, <span class="hlFld-ContribAuthor ">Huan  Zhao</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1H-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (10)
                                     , 1901. <a href="https://doi.org/10.3390/molecules24101901" title="DOI URL">https://doi.org/10.3390/molecules24101901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24101901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24101901%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252B2-%2525281-%2525283-%2525284-Chloroxyphenyl%252529-3-oxo-%252Bpropyl%252529pyrrolidine-3-yl%252529-1H-benzo%25255Bd%25255Dimidazole-4-carboxamide%25253A%252BA%252BPotent%252BPoly%252528ADP-ribose%252529%252BPolymerase%252B%252528PARP%252529%252BInhibitor%252Bfor%252BTreatment%252Bof%252BCancer%26aulast%3DMin%26aufirst%3DRui%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D10%26spage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Man  Keung</span>, <span class="hlFld-ContribAuthor ">Yanyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Jaydutt  Vadgama</span>. </span><span class="cited-content_cbyCitation_article-title">PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2019,</strong> <em>8 </em>
                                    (4)
                                     , 435. <a href="https://doi.org/10.3390/jcm8040435" title="DOI URL">https://doi.org/10.3390/jcm8040435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm8040435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm8040435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DPARP%252BInhibitors%252Bas%252Ba%252BTherapeutic%252BAgent%252Bfor%252BHomologous%252BRecombination%252BDeficiency%252Bin%252BBreast%252BCancers%26aulast%3DKeung%26aufirst%3DMan%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D4%26spage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Hsien  Hou</span>, <span class="hlFld-ContribAuthor ">Shih-Hsun  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Poly-ADP ribosylation in DNA damage response and cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Mutation Research/Reviews in Mutation Research</span><span> <strong>2019,</strong> <em>780 </em>, 82-91. <a href="https://doi.org/10.1016/j.mrrev.2017.09.004" title="DOI URL">https://doi.org/10.1016/j.mrrev.2017.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mrrev.2017.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mrrev.2017.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DMutation%2520Research%252FReviews%2520in%2520Mutation%2520Research%26atitle%3DPoly-ADP%252Bribosylation%252Bin%252BDNA%252Bdamage%252Bresponse%252Band%252Bcancer%252Btherapy%26aulast%3DHou%26aufirst%3DWei-Hsien%26date%3D2019%26volume%3D780%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weijie  Ding</span>, <span class="hlFld-ContribAuthor ">Shengshi  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Yu</span>, <span class="hlFld-ContribAuthor ">Shun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Unsymmetrical Aromatic Azoxy Compounds by Silver‐Mediated Oxidative Coupling of Aromatic Amines with Nitrosoarenes. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (6)
                                     , 1394-1399. <a href="https://doi.org/10.1002/adsc.201801175" title="DOI URL">https://doi.org/10.1002/adsc.201801175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201801175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201801175%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BUnsymmetrical%252BAromatic%252BAzoxy%252BCompounds%252Bby%252BSilver%2525E2%252580%252590Mediated%252BOxidative%252BCoupling%252Bof%252BAromatic%252BAmines%252Bwith%252BNitrosoarenes%26aulast%3DDing%26aufirst%3DWeijie%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D6%26spage%3D1394%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Shiva Kumar</span>, <span class="hlFld-ContribAuthor ">Praveen Kumar  Naikawadi</span>, <span class="hlFld-ContribAuthor ">Bandari  Rajesham</span>, <span class="hlFld-ContribAuthor ">D.  Rambabu</span>. </span><span class="cited-content_cbyCitation_article-title">Four-component, three-step cascade reaction: an effective synthesis of indazole-fused triazolo[5,1-
              c
              ]quinoxalines. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (11)
                                     , 4333-4337. <a href="https://doi.org/10.1039/C8NJ06299D" title="DOI URL">https://doi.org/10.1039/C8NJ06299D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ06299D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ06299D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DFour-component%25252C%252Bthree-step%252Bcascade%252Breaction%25253A%252Ban%252Beffective%252Bsynthesis%252Bof%252Bindazole-fused%252Btriazolo%25255B5%25252C1-%252Bc%252B%25255Dquinoxalines%26aulast%3DShiva%2BKumar%26aufirst%3DK.%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D11%26spage%3D4333%26epage%3D4337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick G.  Pilié</span>, <span class="hlFld-ContribAuthor ">Chad  Tang</span>, <span class="hlFld-ContribAuthor ">Gordon B.  Mills</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Yap</span>. </span><span class="cited-content_cbyCitation_article-title">State-of-the-art strategies for targeting the DNA damage response in cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Clinical Oncology</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 81-104. <a href="https://doi.org/10.1038/s41571-018-0114-z" title="DOI URL">https://doi.org/10.1038/s41571-018-0114-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41571-018-0114-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41571-018-0114-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Clinical%2520Oncology%26atitle%3DState-of-the-art%252Bstrategies%252Bfor%252Btargeting%252Bthe%252BDNA%252Bdamage%252Bresponse%252Bin%252Bcancer%26aulast%3DPili%25C3%25A9%26aufirst%3DPatrick%2BG.%26date%3D2019%26date%3D2018%26volume%3D16%26issue%3D2%26spage%3D81%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuye  Zhao</span>, <span class="hlFld-ContribAuthor ">Tianlong  Lan</span>, <span class="hlFld-ContribAuthor ">Shang  Su</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (3)
                                     , 369-372. <a href="https://doi.org/10.1039/C8CC07813K" title="DOI URL">https://doi.org/10.1039/C8CC07813K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC07813K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC07813K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DInduction%252Bof%252Bapoptosis%252Bin%252BMDA-MB-231%252Bbreast%252Bcancer%252Bcells%252Bby%252Ba%252BPARP1-targeting%252BPROTAC%252Bsmall%252Bmolecule%26aulast%3DZhao%26aufirst%3DQiuye%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D3%26spage%3D369%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel S.  Macedo</span>, <span class="hlFld-ContribAuthor ">Barbara  Alemar</span>, <span class="hlFld-ContribAuthor ">Patricia  Ashton-Prolla</span>. </span><span class="cited-content_cbyCitation_article-title">Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era. </span><span class="cited-content_cbyCitation_journal-name">Genetics and Molecular Biology</span><span> <strong>2019,</strong> <em>42 </em>
                                    (1 suppl 1)
                                     , 215-231. <a href="https://doi.org/10.1590/1678-4685-gmb-2018-0104" title="DOI URL">https://doi.org/10.1590/1678-4685-gmb-2018-0104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1590/1678-4685-gmb-2018-0104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1590%2F1678-4685-gmb-2018-0104%26sid%3Dliteratum%253Aachs%26jtitle%3DGenetics%2520and%2520Molecular%2520Biology%26atitle%3DReviewing%252Bthe%252Bcharacteristics%252Bof%252BBRCA%252Band%252BPALB2-related%252Bcancers%252Bin%252Bthe%252Bprecision%252Bmedicine%252Bera%26aulast%3DMacedo%26aufirst%3DGabriel%2BS.%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D1%2520suppl%25201%26spage%3D215%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaiming  Sun</span>, <span class="hlFld-ContribAuthor ">Keith  Mikule</span>, <span class="hlFld-ContribAuthor ">Zebin  Wang</span>, <span class="hlFld-ContribAuthor ">Grace  Poon</span>, <span class="hlFld-ContribAuthor ">Aparajitha  Vaidyanathan</span>, <span class="hlFld-ContribAuthor ">Gillian  Smith</span>, <span class="hlFld-ContribAuthor ">Zhi-Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hanke</span>, <span class="hlFld-ContribAuthor ">Sridhar  Ramaswamy</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (98)
                                     , 37080-37096. <a href="https://doi.org/10.18632/oncotarget.26354" title="DOI URL">https://doi.org/10.18632/oncotarget.26354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.26354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.26354%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DA%252Bcomparative%252Bpharmacokinetic%252Bstudy%252Bof%252BPARP%252Binhibitors%252Bdemonstrates%252Bfavorable%252Bproperties%252Bfor%252Bniraparib%252Befficacy%252Bin%252Bpreclinical%252Btumor%252Bmodels%26aulast%3DSun%26aufirst%3DKaiming%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D98%26spage%3D37080%26epage%3D37096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon  Carney</span>, <span class="hlFld-ContribAuthor ">Susanne  Kossatz</span>, <span class="hlFld-ContribAuthor ">Benjamin H.  Lok</span>, <span class="hlFld-ContribAuthor ">Valentina  Schneeberger</span>, <span class="hlFld-ContribAuthor ">Kishore K.  Gangangari</span>, <span class="hlFld-ContribAuthor ">Naga Vara Kishore  Pillarsetty</span>, <span class="hlFld-ContribAuthor ">Wolfgang A.  Weber</span>, <span class="hlFld-ContribAuthor ">Charles M.  Rudin</span>, <span class="hlFld-ContribAuthor ">John T.  Poirier</span>, <span class="hlFld-ContribAuthor ">Thomas  Reiner</span>. </span><span class="cited-content_cbyCitation_article-title">Target engagement imaging of PARP inhibitors in small-cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02096-w" title="DOI URL">https://doi.org/10.1038/s41467-017-02096-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02096-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02096-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTarget%252Bengagement%252Bimaging%252Bof%252BPARP%252Binhibitors%252Bin%252Bsmall-cell%252Blung%252Bcancer%26aulast%3DCarney%26aufirst%3DBrandon%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ádám  Póti</span>, <span class="hlFld-ContribAuthor ">Kinga  Berta</span>, <span class="hlFld-ContribAuthor ">Yonghong  Xiao</span>, <span class="hlFld-ContribAuthor ">Orsolya  Pipek</span>, <span class="hlFld-ContribAuthor ">Gregory T.  Klus</span>, <span class="hlFld-ContribAuthor ">Thomas  Ried</span>, <span class="hlFld-ContribAuthor ">István  Csabai</span>, <span class="hlFld-ContribAuthor ">Keith  Wilcoxen</span>, <span class="hlFld-ContribAuthor ">Keith  Mikule</span>, <span class="hlFld-ContribAuthor ">Zoltan  Szallasi</span>, <span class="hlFld-ContribAuthor ">Dávid  Szüts</span>. </span><span class="cited-content_cbyCitation_article-title">Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2018,</strong> <em>119 </em>
                                    (11)
                                     , 1392-1400. <a href="https://doi.org/10.1038/s41416-018-0312-6" title="DOI URL">https://doi.org/10.1038/s41416-018-0312-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-018-0312-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-018-0312-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DLong-term%252Btreatment%252Bwith%252Bthe%252BPARP%252Binhibitor%252Bniraparib%252Bdoes%252Bnot%252Bincrease%252Bthe%252Bmutation%252Bload%252Bin%252Bcell%252Bline%252Bmodels%252Band%252Btumour%252Bxenografts%26aulast%3DP%25C3%25B3ti%26aufirst%3D%25C3%2581d%25C3%25A1m%26date%3D2018%26date%3D2018%26volume%3D119%26issue%3D11%26spage%3D1392%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Josee-Lyne  Ethier</span>, <span class="hlFld-ContribAuthor ">Stephanie  Lheureux</span>, <span class="hlFld-ContribAuthor ">Amit M  Oza</span>. </span><span class="cited-content_cbyCitation_article-title">The role of niraparib for the treatment of ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (25)
                                     , 2565-2577. <a href="https://doi.org/10.2217/fon-2018-0101" title="DOI URL">https://doi.org/10.2217/fon-2018-0101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2018-0101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2018-0101%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DThe%252Brole%252Bof%252Bniraparib%252Bfor%252Bthe%252Btreatment%252Bof%252Bovarian%252Bcancer%26aulast%3DEthier%26aufirst%3DJosee-Lyne%26date%3D2018%26volume%3D14%26issue%3D25%26spage%3D2565%26epage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen G.  Essel</span>, <span class="hlFld-ContribAuthor ">Kathleen N.  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Niraparib for the treatment of ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2018,</strong> <em>18 </em>
                                    (8)
                                     , 727-733. <a href="https://doi.org/10.1080/14737140.2018.1490180" title="DOI URL">https://doi.org/10.1080/14737140.2018.1490180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2018.1490180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2018.1490180%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DNiraparib%252Bfor%252Bthe%252Btreatment%252Bof%252Bovarian%252Bcancer%26aulast%3DEssel%26aufirst%3DKathleen%2BG.%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D8%26spage%3D727%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-A  Heo</span>, <span class="hlFld-ContribAuthor ">Sean T.  Duggan</span>. </span><span class="cited-content_cbyCitation_article-title">Niraparib: A Review in Ovarian Cancer. </span><span class="cited-content_cbyCitation_journal-name">Targeted Oncology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 533-539. <a href="https://doi.org/10.1007/s11523-018-0582-1" title="DOI URL">https://doi.org/10.1007/s11523-018-0582-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11523-018-0582-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11523-018-0582-1%26sid%3Dliteratum%253Aachs%26jtitle%3DTargeted%2520Oncology%26atitle%3DNiraparib%25253A%252BA%252BReview%252Bin%252BOvarian%252BCancer%26aulast%3DHeo%26aufirst%3DYoung-A%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3D533%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanxin  Lu</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Pang</span>, <span class="hlFld-ContribAuthor ">Karel  Pacak</span>, <span class="hlFld-ContribAuthor ">Chunzhang  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>188 </em>, 168-175. <a href="https://doi.org/10.1016/j.pharmthera.2018.03.006" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DDouble-barreled%252Bgun%25253A%252BCombination%252Bof%252BPARP%252Binhibitor%252Bwith%252Bconventional%252Bchemotherapy%26aulast%3DLu%26aufirst%3DYanxin%26date%3D2018%26volume%3D188%26spage%3D168%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Schoene</span>, <span class="hlFld-ContribAuthor ">Hassen  Bel Abed</span>, <span class="hlFld-ContribAuthor ">Peter  Schmieder</span>, <span class="hlFld-ContribAuthor ">Mathias  Christmann</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">A General One-Pot Synthesis of 2
              H
              -Indazoles Using an Organophosphorus-Silane System. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (36)
                                     , 9090-9100. <a href="https://doi.org/10.1002/chem.201800763" title="DOI URL">https://doi.org/10.1002/chem.201800763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201800763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201800763%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BGeneral%252BOne-Pot%252BSynthesis%252Bof%252B2%252BH%252B-Indazoles%252BUsing%252Ban%252BOrganophosphorus-Silane%252BSystem%26aulast%3DSchoene%26aufirst%3DJens%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D36%26spage%3D9090%26epage%3D9100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa C.  Longoria</span>, <span class="hlFld-ContribAuthor ">Krishnansu S.  Tewari</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic drug evaluation of niraparib for the treatment of ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (5)
                                     , 543-550. <a href="https://doi.org/10.1080/17425255.2018.1461838" title="DOI URL">https://doi.org/10.1080/17425255.2018.1461838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2018.1461838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2018.1461838%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DPharmacokinetic%252Bdrug%252Bevaluation%252Bof%252Bniraparib%252Bfor%252Bthe%252Btreatment%252Bof%252Bovarian%252Bcancer%26aulast%3DLongoria%26aufirst%3DTeresa%2BC.%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D5%26spage%3D543%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jill J. J.  Geenen</span>, <span class="hlFld-ContribAuthor ">Sabine C.  Linn</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>, <span class="hlFld-ContribAuthor ">Jan H. M.  Schellens</span>. </span><span class="cited-content_cbyCitation_article-title">PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2018,</strong> <em>57 </em>
                                    (4)
                                     , 427-437. <a href="https://doi.org/10.1007/s40262-017-0587-4" title="DOI URL">https://doi.org/10.1007/s40262-017-0587-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-017-0587-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-017-0587-4%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPARP%252BInhibitors%252Bin%252Bthe%252BTreatment%252Bof%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DGeenen%26aufirst%3DJill%2BJ.%2BJ.%26date%3D2018%26date%3D2017%26volume%3D57%26issue%3D4%26spage%3D427%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen  Moore</span>, <span class="hlFld-ContribAuthor ">Zhi-Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Shefali  Agarwal</span>, <span class="hlFld-ContribAuthor ">Howard  Burris</span>, <span class="hlFld-ContribAuthor ">Manish R.  Patel</span>, <span class="hlFld-ContribAuthor ">Vikram  Kansra</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2018,</strong> <em>81 </em>
                                    (3)
                                     , 497-503. <a href="https://doi.org/10.1007/s00280-017-3512-5" title="DOI URL">https://doi.org/10.1007/s00280-017-3512-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-017-3512-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-017-3512-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DThe%252Beffect%252Bof%252Bfood%252Bon%252Bthe%252Bpharmacokinetics%252Bof%252Bniraparib%25252C%252Ba%252Bpoly%252528ADP-ribose%252529%252Bpolymerase%252B%252528PARP%252529%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Brecurrent%252Bovarian%252Bcancer%26aulast%3DMoore%26aufirst%3DKathleen%26date%3D2018%26date%3D2018%26volume%3D81%26issue%3D3%26spage%3D497%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  He</span>, <span class="hlFld-ContribAuthor ">Xin-yang  Li</span>, <span class="hlFld-ContribAuthor ">Jing-wei  Liang</span>, <span class="hlFld-ContribAuthor ">Chong  Cao</span>, <span class="hlFld-ContribAuthor ">Shuai  Li</span>, <span class="hlFld-ContribAuthor ">Ting-jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Fan-hao  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer activities evaluation of novel 5 H -dibenzo[ b , e ]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (5)
                                     , 847-852. <a href="https://doi.org/10.1016/j.bmcl.2018.02.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bactivities%252Bevaluation%252Bof%252Bnovel%252B5%252BH%252B-dibenzo%25255B%252Bb%252B%25252C%252Be%252B%25255Dazepine-6%25252C11-dione%252Bderivatives%252Bcontaining%252B1%25252C3%25252C4-oxadiazole%252Bunits%26aulast%3DHe%26aufirst%3DXin%26date%3D2018%26volume%3D28%26issue%3D5%26spage%3D847%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashish P.  Shah</span>, <span class="hlFld-ContribAuthor ">Chhagan N.  Patel</span>, <span class="hlFld-ContribAuthor ">Dipen K.  Sureja</span>, <span class="hlFld-ContribAuthor ">Kirtan P.  Sanghavi</span>. </span><span class="cited-content_cbyCitation_article-title">A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Folia Medica</span><span> <strong>2018,</strong> <em>60 </em>
                                    (1)
                                     , 39-47. <a href="https://doi.org/10.1515/folmed-2017-0067" title="DOI URL">https://doi.org/10.1515/folmed-2017-0067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/folmed-2017-0067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Ffolmed-2017-0067%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Medica%26atitle%3DA%252BReview%252Bon%252BDNA%252BRepair%252BInhibition%252Bby%252BPARP%252BInhibitors%252Bin%252BCancer%252BTherapy%26aulast%3DShah%26aufirst%3DAshish%2BP.%26date%3D2018%26volume%3D60%26issue%3D1%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Ferrara</span>, <span class="hlFld-ContribAuthor ">Francesca  Simionato</span>, <span class="hlFld-ContribAuthor ">Chiara  Ciccarese</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Grego</span>, <span class="hlFld-ContribAuthor ">Sara  Cingarlini</span>, <span class="hlFld-ContribAuthor ">Roberto  Iacovelli</span>, <span class="hlFld-ContribAuthor ">Emilio  Bria</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Tortora</span>, <span class="hlFld-ContribAuthor ">Davide  Melisi</span>. </span><span class="cited-content_cbyCitation_article-title">The development of PARP as a successful target for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2018,</strong> <em>18 </em>
                                    (2)
                                     , 161-175. <a href="https://doi.org/10.1080/14737140.2018.1419870" title="DOI URL">https://doi.org/10.1080/14737140.2018.1419870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2018.1419870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2018.1419870%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DThe%252Bdevelopment%252Bof%252BPARP%252Bas%252Ba%252Bsuccessful%252Btarget%252Bfor%252Bcancer%252Btherapy%26aulast%3DFerrara%26aufirst%3DRoberto%26date%3D2018%26date%3D2017%26volume%3D18%26issue%3D2%26spage%3D161%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilsa T.  Kirby</span>, <span class="hlFld-ContribAuthor ">Michael S.  Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 211-231. <a href="https://doi.org/10.1007/82_2018_137" title="DOI URL">https://doi.org/10.1007/82_2018_137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/82_2018_137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F82_2018_137%26sid%3Dliteratum%253Aachs%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BPARPs%25253A%252BFrom%252BTools%252Bfor%252BInvestigating%252BADP-Ribosylation%252Bto%252BTherapeutics%26aulast%3DKirby%26aufirst%3DIlsa%2BT.%26date%3D2018%26date%3D2018%26spage%3D211%26epage%3D231%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DActivity-Based%252BProtein%252BProfiling%26aulast%3DCravatt%26aufirst%3DBenjamin%2BF.%26date%3D2019%26volume%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shannon N.  Westin</span>, <span class="hlFld-ContribAuthor ">Anil K.  Sood</span>, <span class="hlFld-ContribAuthor ">Robert L.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapy and Molecular Genetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 470-492.e10. <a href="https://doi.org/10.1016/B978-0-323-40067-1.00018-8" title="DOI URL">https://doi.org/10.1016/B978-0-323-40067-1.00018-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-40067-1.00018-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-40067-1.00018-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapy%252Band%252BMolecular%252BGenetics%26aulast%3DWestin%26aufirst%3DShannon%2BN.%26date%3D2018%26spage%3D470%26epage%3D492.e10%26pub%3DElsevier%26atitle%3DClinical%252BGynecologic%252BOncology%26date%3D2018%26volume%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Xu</span>, <span class="hlFld-ContribAuthor ">Haitang  Yang</span>, <span class="hlFld-ContribAuthor ">Ensheng  Xu</span>, <span class="hlFld-ContribAuthor ">Shuangshuang  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Jin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of poly(ADP-ribose) polymerase-1 by enzyme-initiated auto-PARylation-controlled aggregation of hemin-graphene nanocomposites. </span><span class="cited-content_cbyCitation_journal-name">The Analyst</span><span> <strong>2018,</strong> <em>143 </em>
                                    (11)
                                     , 2501-2507. <a href="https://doi.org/10.1039/C8AN00009C" title="DOI URL">https://doi.org/10.1039/C8AN00009C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8AN00009C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8AN00009C%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Analyst%26atitle%3DAnalysis%252Bof%252Bpoly%252528ADP-ribose%252529%252Bpolymerase-1%252Bby%252Benzyme-initiated%252Bauto-PARylation-controlled%252Baggregation%252Bof%252Bhemin-graphene%252Bnanocomposites%26aulast%3DLiu%26aufirst%3DYong%26date%3D2018%26date%3D2018%26volume%3D143%26issue%3D11%26spage%3D2501%26epage%3D2507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Ming  Ji</span>, <span class="hlFld-ContribAuthor ">Haiping  Yao</span>, <span class="hlFld-ContribAuthor ">Ran  Cao</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Bailing  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of quinazoline-2,4(1
              H
              ,3
              H
              )-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (17)
                                     , 3189-3202. <a href="https://doi.org/10.1039/C8OB00286J" title="DOI URL">https://doi.org/10.1039/C8OB00286J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00286J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00286J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bquinazoline-2%25252C4%2525281%252BH%252B%25252C3%252BH%252B%252529-dione%252Bderivatives%252Bas%252Bnovel%252BPARP-1%25252F2%252Binhibitors%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Btheir%252Bantitumor%252Bactivity%26aulast%3DZhou%26aufirst%3DJie%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D17%26spage%3D3189%26epage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">LUMA G.  MAGALHAES</span>, <span class="hlFld-ContribAuthor ">LEONARDO L.G.  FERREIRA</span>, <span class="hlFld-ContribAuthor ">ADRIANO D.  ANDRICOPULO</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances and Perspectives in Cancer Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Anais da Academia Brasileira de Ciências</span><span> <strong>2018,</strong> <em>90 </em>
                                    (1 suppl 2)
                                     , 1233-1250. <a href="https://doi.org/10.1590/0001-3765201820170823" title="DOI URL">https://doi.org/10.1590/0001-3765201820170823</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1590/0001-3765201820170823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1590%2F0001-3765201820170823%26sid%3Dliteratum%253Aachs%26jtitle%3DAnais%2520da%2520Academia%2520Brasileira%2520de%2520Ci%25C3%25AAncias%26atitle%3DRecent%252BAdvances%252Band%252BPerspectives%252Bin%252BCancer%252BDrug%252BDesign%26aulast%3DMAGALHAES%26aufirst%3DLUMA%2BG.%26date%3D2018%26date%3D2018%26volume%3D90%26issue%3D1%2520suppl%25202%26spage%3D1233%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lotte  van Andel</span>, <span class="hlFld-ContribAuthor ">Z.  Zhang</span>, <span class="hlFld-ContribAuthor ">S.  Lu</span>, <span class="hlFld-ContribAuthor ">V.  Kansra</span>, <span class="hlFld-ContribAuthor ">S.  Agarwal</span>, <span class="hlFld-ContribAuthor ">L.  Hughes</span>, <span class="hlFld-ContribAuthor ">M. M.  Tibben</span>, <span class="hlFld-ContribAuthor ">A.  Gebretensae</span>, <span class="hlFld-ContribAuthor ">L.  Lucas</span>, <span class="hlFld-ContribAuthor ">M. J. X.  Hillebrand</span>, <span class="hlFld-ContribAuthor ">H.  Rosing</span>, <span class="hlFld-ContribAuthor ">J. H. M.  Schellens</span>, <span class="hlFld-ContribAuthor ">J. H.  Beijnen</span>. </span><span class="cited-content_cbyCitation_article-title">Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2017,</strong> <em>35 </em>
                                    (6)
                                     , 751-765. <a href="https://doi.org/10.1007/s10637-017-0451-2" title="DOI URL">https://doi.org/10.1007/s10637-017-0451-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-017-0451-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-017-0451-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DHuman%252Bmass%252Bbalance%252Bstudy%252Band%252Bmetabolite%252Bprofiling%252Bof%252B14C-niraparib%25252C%252Ba%252Bnovel%252Bpoly%252528ADP-Ribose%252529%252Bpolymerase%252B%252528PARP%252529-1%252Band%252BPARP-2%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bcancer%26aulast%3Dvan%2BAndel%26aufirst%3DLotte%26date%3D2017%26date%3D2017%26volume%3D35%26issue%3D6%26spage%3D751%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm901188v&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm901188v%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=190&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PARP inhibitors currently undergoing clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HCl, MeOH, Δ; (b) NBS, (BzO)<sub>2</sub>, CCl<sub>4</sub>, Δ; (c) NMMO, MeCN; (d) RNH<sub>2</sub>, EtOH, Δ; (e) NaN<sub>3</sub>, DMF, 90 °C; (f) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (g) H<sub>2</sub>, Pd/C, MeOH; (h) nitrosobenzene, AcOH; (i) Cu(OAc)<sub>2</sub>, O<sub>2</sub>, DMF, 80 °C; (j) NaOH, then HATU, NH<sub>3</sub>, DIPEA, DMF; (k) H<sub>2</sub>N-OMes, DCM; (l) PhCCCO<sub>2</sub>Bn, K<sub>2</sub>CO<sub>3</sub>, THF; (m) H<sub>2</sub>, Pd/C, EtOH, EtOAc; (n) 48% HBr, Δ; (o) H<sub>2</sub>N-OMes, dioxane; (p) PhCHO, Δ; (q) KOH, MeOH.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>p</i>-FC<sub>6</sub>H<sub>4</sub>COR, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave; (b) R′R′′NH, NaBH<sub>3</sub>(CN), ZnCl<sub>2</sub>, MeOH, DCE; (c) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (d) MeMgBr, THF; (e) NaCN, H<sub>2</sub>SO<sub>4</sub>, DCM; (f) BH<sub>3</sub>.THF, THF; (g) MeOCH<sub>2</sub>P<sup>+</sup>Ph<sub>3</sub> Cl<sup>−</sup>, KO<sup><i>t</i></sup>Bu, Et<sub>2</sub>O/THF, −78 °C to room temp, then HCl, Et<sub>2</sub>O; (h) formaldehyde, NaBH<sub>3</sub>(CN), then H<sub>2</sub>, Pd/C, MeOH; (i) ArNH<sub>2</sub>, EtOH, Δ; (j) NaN<sub>3</sub>, DMF, 90 °C; (k) TFA, DCM, H<sub>2</sub>O.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) ArNH<sub>2</sub>, EtOH, Δ; (b) NaN<sub>3</sub>, DMF, 90 °C; (c) NH<sub>3</sub>, MeOH, sealed tube, 60 °C; (d) HCl, dioxane; (e) SFC separation; (f) 3-pyridyl-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, Δ; (g) 50 psi of H<sub>2</sub>, PtO<sub>2</sub>, MeOH; (h) resolution <span class="smallcaps smallerCapital">l</span>-tartaric acid, EtOH; (i) Boc<sub>2</sub>O, DCM; (j) <b>5</b>, EtOH, Δ.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolite profiles were obtained by radiochromatography of urine and bile following dosing of [<sup>3</sup>H]<b>43</b> (300 μCi/kg).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Separation was by RP-HPLC, using a Ace Act RP C18 150 mm × 2.1 mm column (Mac Mod Analytical Inc., Chadds Ford, PA) coupled to a Packard 515TR radiodetector (Perkin-Elmer Life and Analytical Sciences, Boston, MA) equipped with a 500 μL liquid scintillation flow cell.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Stability of <b>43</b> in the presence of rat rCYP isoforms. (b) Metabolic stability of <b>43</b> in liver, lung, kidney, intestine microsomes and heart homogenate in the presence of NADPH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/medium/jm-2009-01188v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of <b>56</b> in MDA-MB-436 (BRCA-1 mutant) xenograft bearing mice when dosed orally at 100 mg/kg q.d. or 50 mg/kg b.i.d. for 33 days. For each group, <i>n</i> = 7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm901188v/production/images/large/jm-2009-01188v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901188v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hottiger, M. O.</span><span> </span><span class="NLM_article-title">The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3046</span><span class="NLM_x">–</span> <span class="NLM_lpage">3082</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.2741%2F2909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17981777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=3046-3082&author=P.+O.+Hassaauthor=M.+O.+Hottiger&title=The+diverse+biological+roles+of+mammalian+PARPS%2C+a+small+but+powerful+family+of+poly-ADP-ribose+polymerases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADP-ribose polymerases</span></div><div class="casAuthors">Hassa, Paul O.; Hottiger, Michael O.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3046-3082</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Poly-ADP-ribose metab. plays a mayor role in a wide range of biol. processes, such as maintenance of genomic stability, transcriptional regulation, energy metab., and cell death.  Poly-ADP-ribose polymerases (PARPs) are an ancient family of enzymes, as evidenced by the poly-ADP-ribosylating activities reported in dinoflagellates and archaebacteria and by the identification of Parp-like genes in eubacterial and archaeabacterial genomes.  Six genes encoding "bona fide" PARP enzymes have been identified in mammalians: PARP1, PARP2, PARP3, PARP4/vPARP, PARP5/Tankyrases-1, and PARP6/Tankyrases-2.  The best studied of these enzymes, PARP1, plays a primary role in the process of poly-ADP-ribosylation.  PARP1-mediated poly-ADP-ribosylation has been implicated in the pathogenesis of cancer, inflammatory, and neurodegenerative disorders.  Here, the authors summarize novel findings and concepts for PARP enzymes and their poly-ADP-ribosylation activity in the regulation of physiol. and pathophysiol. processes.  A special focus is placed on the proposed mol. mechanisms involved in these processes, such as signaling, regulation of telomere dynamics, remodeling of chromatin structure, and transcriptional regulation.  A potential functional cross-talk between PARP family members and other NAD-consuming enzymes is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoNyzgIk1gtrVg90H21EOLACvtfcHk0lj4xbtFoyySLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cntrk%253D&md5=1e62c4597ec219b0797a29c1458b98b4</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2741%2F2909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2909%26sid%3Dliteratum%253Aachs%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26atitle%3DThe%2520diverse%2520biological%2520roles%2520of%2520mammalian%2520PARPS%252C%2520a%2520small%2520but%2520powerful%2520family%2520of%2520poly-ADP-ribose%2520polymerases%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D3046%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amé, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spenlehauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">The PARP superfamily</span> <span class="citation_source-journal">BioEssays</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=882-893&author=J.-C.+Am%C3%A9author=C.+Spenlehauerauthor=G.+de+Murcia&title=The+PARP+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAm%25C3%25A9%26aufirst%3DJ.-C.%26aulast%3DSpenlehauer%26aufirst%3DC.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DThe%2520PARP%2520superfamily%26jtitle%3DBioEssays%26date%3D2004%26volume%3D26%26spage%3D882%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kleine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poreba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniewicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassa, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hottiger, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüscher, B.</span><span> </span><span class="NLM_article-title">Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.molcel.2008.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18851833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=57-69&author=H.+Kleineauthor=E.+Porebaauthor=K.+Lesniewiczauthor=P.+O.+Hassaauthor=M.+O.+Hottigerauthor=D.+W.+Litchfieldauthor=B.+H.+Shiltonauthor=B.+L%C3%BCscher&title=Substrate-assisted+catalysis+by+PARP10+limits+its+activity+to+mono-ADP-ribosylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation</span></div><div class="casAuthors">Kleine, Henning; Poreba, Elzbieta; Lesniewicz, Krzysztof; Hassa, Paul O.; Hottiger, Michael O.; Litchfield, David W.; Shilton, Brian H.; Luescher, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ADP-ribosylation controls many processes, including transcription, DNA repair, and bacterial toxicity.  ADP-ribosyltransferases and poly-ADP-ribose polymerases (PARPs) catalyze mono- and poly-ADP-ribosylation, resp., and depend on a highly conserved glutamate residue in the active center for catalysis.  However, there is an apparent absence of this glutamate for the recently described PARP6-PARP16, raising questions about how these enzymes function.  We find that PARP10, in contrast to PARP1, lacks the catalytic glutamate and has transferase rather than polymerase activity.  Despite this fundamental difference, PARP10 also modifies acidic residues.  Consequently, we propose an alternative catalytic mechanism for PARP10 compared to PARP1 in which the acidic target residue of the substrate functionally substitutes for the catalytic glutamate by using substrate-assisted catalysis to transfer ADP-ribose.  This mechanism explains why the novel PARPs are unable to function as polymerases.  This discovery will help to illuminate the different biol. functions of mono- vs. poly-ADP-ribosylation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopRTvaqa_wIrVg90H21EOLACvtfcHk0liZJdjRvojdmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLzO&md5=a7d3d0b015773d18f92a434f6a8e0232</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DKleine%26aufirst%3DH.%26aulast%3DPoreba%26aufirst%3DE.%26aulast%3DLesniewicz%26aufirst%3DK.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DShilton%26aufirst%3DB.%2BH.%26aulast%3DL%25C3%25BCscher%26aufirst%3DB.%26atitle%3DSubstrate-assisted%2520catalysis%2520by%2520PARP10%2520limits%2520its%2520activity%2520to%2520mono-ADP-ribosylation%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D32%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrd1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15864271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&author=P.+Jagtapauthor=C.+Szab%C3%B3&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span></div><div class="casAuthors">Jagtap, Prakash; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-440</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) are involved in the regulation of many cellular functions.  Three consequences of the activation of PARP1, which is the main isoform of the PARP family, are particularly important for drug development: first, its role in DNA repair; second, its capacity to deplete cellular energetic pools, which culminates in cell dysfunction and necrosis; and third, its capacity to promote the transcription of pro-inflammatory genes.  Consequently, pharmacol. inhibitors of PARP have the potential to enhance the cytotoxicity of certain DNA-damaging anticancer drugs, reduce parenchymal cell necrosis (for example, in stroke or myocardial infarction) and downregulate multiple simultaneous pathways of inflammation and tissue injury (for example, in circulatory shock, colitis or diabetic complications).  The first ultrapotent novel PARP inhibitors have now entered human clin. trials.  This article presents an overview of the principal pathophysiol. pathways and mechanisms that are governed by PARP, followed by the main structures and therapeutic actions of various classes of novel PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDsrfd_xv8g7Vg90H21EOLACvtfcHk0liZJdjRvojdmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL8%253D&md5=1dfd177b8064b017efb5dd7779655d55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1718%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amé, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose): novel functions for an old molecule</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrm1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=16829982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=517-528&author=V.+Schreiberauthor=F.+Dantzerauthor=J.-C.+Am%C3%A9author=G.+de+Murcia&title=Poly%28ADP-ribose%29%3A+novel+functions+for+an+old+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose): novel functions for an old molecule</span></div><div class="casAuthors">Schreiber, Valerie; Dantzer, Francoise; Ame, Jean-Christophe; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The addn. to proteins of the neg. charged polymer of ADP-ribose, which is synthesized by poly(ADP-ribose) polymerase (PARPs) from NAD, is a unique post-translational modification.  It regulates not only cell survival and cell-death programs, but also an increasing no. of other biol. functions with which novel members of the PARP family have been assocd.  These functions include transcriptional regulation, telomere cohesion and mitotic spindle formation during cell division, intracellular trafficking, and energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLsI4_BKfjdrVg90H21EOLACvtfcHk0liZJdjRvojdmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D&md5=676e83755491500f3bf2137f348dfa1b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrm1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1963%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DAm%25C3%25A9%26aufirst%3DJ.-C.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPoly%2528ADP-ribose%2529%253A%2520novel%2520functions%2520for%2520an%2520old%2520molecule%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D517%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Huber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1103-1108&author=A.+Huberauthor=P.+Baiauthor=J.+M.+de+Murciaauthor=G.+de+Murcia&title=PARP-1%2C+PARP-2+and+ATM+in+the+DNA+damage+response%3A+functional+synergy+in+mouse+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DA.%26aulast%3DBai%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPARP-1%252C%2520PARP-2%2520and%2520ATM%2520in%2520the%2520DNA%2520damage%2520response%253A%2520functional%2520synergy%2520in%2520mouse%2520development%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D1103%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Durkacz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omidiji, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shall, S.</span><span> </span><span class="NLM_article-title">(ADP-ribose)<sub><i>n</i></sub> participates in DNA excision repair</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2F283593a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=6243744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaL3cXktVagtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1980&pages=593-596&author=B.+W.+Durkaczauthor=O.+Omidijiauthor=D.+A.+Grayauthor=S.+Shall&title=%28ADP-ribose%29n+participates+in+DNA+excision+repair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">(ADP-ribose)n participates in DNA excision repair</span></div><div class="casAuthors">Durkacz, Barbara W.; Omidiji, Olusesan; Gray, Douglas A.; Shall, Sydney</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">5747</span>),
    <span class="NLM_cas:pages">593-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The drop in cellular NAD content and the rejoining of DNA strand breaks, i.e. elevation of poly(ADP-ribose) polymerase (I) activity, after treatment of L1210 leukemia lymphoblast cells with alkylating agent, 10.5-210.6 μM Me2SO4, were inhibited by inhibitors of I, e.g. 3-aminobenzamide (Ki 4.4 μM at 26°).  The inhibitors all potentiated the cytotoxicity of Me2SO4; 2 mM aminobenzamide increased the cytotoxicity 4-fold.  In addn., the rejoining of strand breaks was prevented by nutritionally depleting cells of NAD (10-20% of normal).  Poly(ADP-ribose) may thus be involved in DNA excision repair, and possible mechanisms are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSidm4P44EPbVg90H21EOLACvtfcHk0lgi58uQFBL9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVagtLc%253D&md5=93bfba1a7a3d3a2ea3705741d9f63734</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F283593a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F283593a0%26sid%3Dliteratum%253Aachs%26aulast%3DDurkacz%26aufirst%3DB.%2BW.%26aulast%3DOmidiji%26aufirst%3DO.%26aulast%3DGray%26aufirst%3DD.%2BA.%26aulast%3DShall%26aufirst%3DS.%26atitle%3D%2528ADP-ribose%2529n%2520participates%2520in%2520DNA%2520excision%2520repair%26jtitle%3DNature%2520%2528London%2529%26date%3D1980%26volume%3D283%26spage%3D593%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">de Murcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedergang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutrillaux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMeur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walztinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">7303</span><span class="NLM_x">–</span> <span class="NLM_lpage">7307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1073%2Fpnas.94.14.7303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=9207086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=7303-7307&author=J.+M.+de+Murciaauthor=C.+Niedergangauthor=C.+Truccoauthor=M.+Ricoulauthor=B.+Dutrillauxauthor=M.+Markauthor=F.+J.+Oliverauthor=M.+Massonauthor=A.+Dierichauthor=M.+LeMeurauthor=C.+Walztingerauthor=P.+Chambonauthor=G.+de+Murcia&title=Requirement+of+poly%28ADP-ribose%29+polymerase+in+recovery+from+DNA+damage+in+mice+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells</span></div><div class="casAuthors">Menissier de Murcia, Josiane; Niedergang, Claude; Trucco, Carlotta; Ricoul, Michele; Dutrillaux, Bernard; Mark, Manuel; Oliver, F. Javier; Masson, Murielle; Dierich, Andree; LeMeur, Marianne; Walztinger, Caroline; Chambon, Pierre; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7303-7307</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase [PARP; NAD+ ADP-ribosyltransferase; NAD+:poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyltransferase, EC 2.4.2.30] is a zinc-finger DNA-binding protein that detects specifically DNA strand breaks generated by genotoxic agents.  To det. its biol. function, the authors have inactivated both alleles by gene targeting in mice.  Treatment of PARP-/- mice either by the alkylating agent N-methyl-N-nitrosourea (MNU) or by γ-irradn. revealed an extreme sensitivity and a high genomic instability to both agents.  Following whole body γ-irradn. (8 Gy) mutant mice died rapidly from acute radiation toxicity to the small intestine.  Mice-derived PARP-/- cells displayed a high sensitivity to MNU exposure: a G2/M arrest in mouse embryonic fibroblasts and a rapid apoptotic response and a p53 accumulation were obsd. in splenocytes.  Altogether these results demonstrate that PARP is a survival factor playing an essential and pos. role during DNA damage recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlwmTBk-nHc7Vg90H21EOLACvtfcHk0lgi58uQFBL9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFOntb4%253D&md5=a652d7d877fa0c29ff1aeb9769fbd86f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.14.7303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.14.7303%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMurcia%26aufirst%3DJ.%2BM.%26aulast%3DNiedergang%26aufirst%3DC.%26aulast%3DTrucco%26aufirst%3DC.%26aulast%3DRicoul%26aufirst%3DM.%26aulast%3DDutrillaux%26aufirst%3DB.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DF.%2BJ.%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DDierich%26aufirst%3DA.%26aulast%3DLeMeur%26aufirst%3DM.%26aulast%3DWalztinger%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DRequirement%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520recovery%2520from%2520DNA%2520damage%2520in%2520mice%2520and%2520in%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D7303%26epage%3D7307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghammer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haidacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E. F.</span><span> </span><span class="NLM_article-title">Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=509-520&author=Z.-Q.+Wangauthor=B.+Auerauthor=L.+Stinglauthor=H.+Berghammerauthor=D.+Haidacherauthor=M.+Schweigerauthor=E.+F.+Wagner&title=Mice+lacking+ADPRT+and+poly%28ADP-ribosyl%29ation+develop+normally+but+are+susceptible+to+skin+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.-Q.%26aulast%3DAuer%26aufirst%3DB.%26aulast%3DStingl%26aufirst%3DL.%26aulast%3DBerghammer%26aufirst%3DH.%26aulast%3DHaidacher%26aufirst%3DD.%26aulast%3DSchweiger%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26atitle%3DMice%2520lacking%2520ADPRT%2520and%2520poly%2528ADP-ribosyl%2529ation%2520develop%2520normally%2520but%2520are%2520susceptible%2520to%2520skin%2520disease%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D509%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tentori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, G.</span><span> </span><span class="NLM_article-title">Chemopotentiation by PARP inhibitors in cancer therapy</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=25-33&author=L.+Tentoriauthor=G.+Graziani&title=Chemopotentiation+by+PARP+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopotentiation by PARP inhibitors in cancer therapy</span></div><div class="casAuthors">Tentori, Lucio; Graziani, Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARP) constitute a family of enzymes involved in the regulation of many cellular processes such as DNA repair, gene transcription, cell cycle progression, cell death, chromatin functions and genomic stability.  Among the 18 members identified so far, PARP-1 and PARP-2 are the only proteins stimulated by DNA strand breaks and implicated in the repair of DNA injury.  Therefore, these mols. have been exploited as potential targets for the development of pharmacol. strategies to increase the antitumor efficacy of chemotherapeutic agents, which induce DNA damage.  PARP inhibitors have been shown to restore sensitivity of resistant tumors to methylating agents or topoisomerase I inhibitors, drugs presently used for the treatment of primary and secondary brain tumors or malignancies refractory to std. chemotherapy.  Interestingly, PARP inhibitors may also provide protection from the untoward effects exerted by certain anticancer drugs, which cause oxidative stress and consequent PARP overactivation.  The aim of this article is to provide a brief overview of the recent literature on preclin. studies with the specific and potent inhibitors newly synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImZCOb5elR7Vg90H21EOLACvtfcHk0lgi58uQFBL9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wltr8%253D&md5=2a2f1893efeefc3f1d140979beae6f4d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DTentori%26aufirst%3DL.%26aulast%3DGraziani%26aufirst%3DG.%26atitle%3DChemopotentiation%2520by%2520PARP%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D25%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iniesta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, K.</span><span> </span><span class="NLM_article-title">Development of PARP inhibitors in oncology</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F13543780802525324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=19053880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=31-43&author=J.+Rodonauthor=M.+D.+Iniestaauthor=K.+Papadopoulos&title=Development+of+PARP+inhibitors+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Development of PARP inhibitors in oncology</span></div><div class="casAuthors">Rodon, Jordi; Iniesta, Maria D.; Papadopoulos, Kyriakos</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Poly (ADP-ribose) polymerase (PARP) plays a key role in DNA repair mechanisms by detecting and initiating repair after DNA strand breaks.  Inhibition of PARP in DNA repair-defective tumors (like those with BRCA1 or BRCA2 mutations) can lead to gross genomic instability and cell death.  Likewise, combining PARP inhibition with cytotoxic agents such as chemotherapy or radiation therapy is synergistic in many preclin. models.  Several drugs designed to inhibit PARP are currently in clin. development, many following a development path different from that of typical anticancer agents.  In this review we will focus on the early clin. data from PARP inhibitors that are entering clin. trials, the potential tumors they might target, their combination with other drugs and the different biomarkers that are being explored.  Concepts such as 'BRCAness', synthetic lethality, Phase 0 trials and pharmacodynamic markers will be discussed in the context of the development of PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNslMhf0aSo7Vg90H21EOLACvtfcHk0lgvh1l4Hdg72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvJ&md5=e031c4e938fd49b8cbf674dbc3ca8410</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F13543780802525324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780802525324%26sid%3Dliteratum%253Aachs%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DIniesta%26aufirst%3DM.%2BD.%26aulast%3DPapadopoulos%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520PARP%2520inhibitors%2520in%2520oncology%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D31%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ratnam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1078-0432.CCR-06-2260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17332279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1383-1388&author=K.+Ratnamauthor=J.+A.+Low&title=Current+development+of+clinical+inhibitors+of+poly%28ADP-ribose%29+polymerase+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology</span></div><div class="casAuthors">Ratnam, Kapila; Low, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme that signals the presence of DNA damage by catalyzing the addn. of ADP-ribose units to DNA, histones, and various DNA repair enzymes and by facilitating DNA repair.  PARP has been gaining increasing interest as a therapeutic target for many diseases and esp. for cancer.  Inhibition of PARP potentiates the activity of DNA-damaging agents, such as alkylators, platinums, topoisomerase inhibitors, and radiation in in vitro and in vivo models.  In addn., tumors with DNA repair defects, such as those arising from patients with BRCA mutations, may be more sensitive to PARP inhibition.  At least five different companies have now initiated oncol. clin. trials with PARP inhibitors, ranging in stage from phase 0 to phase 2.  This review summarizes the preclin. and clin. data currently available for these agents and some of the challenges facing the clin. development of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Muf0l4FhVLVg90H21EOLACvtfcHk0lgvh1l4Hdg72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjtr8%253D&md5=9676a8bf09a0ee2bbb19e3e26b060ba7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2260%26sid%3Dliteratum%253Aachs%26aulast%3DRatnam%26aufirst%3DK.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DCurrent%2520development%2520of%2520clinical%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520in%2520oncology%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1383%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peukert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, U.</span><span> </span><span class="NLM_article-title">New inhibitors of poly(ADP-ribose) polymerase (PARP)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1531</span><span class="NLM_x">–</span> <span class="NLM_lpage">1551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F13543776.14.11.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslemu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1531-1551&author=S.+Peukertauthor=U.+Schwahn&title=New+inhibitors+of+poly%28ADP-ribose%29+polymerase+%28PARP%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">New inhibitors of poly(ADP-ribose) polymerase (PARP)</span></div><div class="casAuthors">Peukert, Stefan; Schwahn, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1531-1551</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1), the most prominent member of the PARP family, is a DNA-binding protein that is activated by nicks in DNA occurring during inflammation, ischemia, neurodegeneration or cancer therapy.  Activated PARP-1 consumes NAD+ that is cleaved into nicotinamide and ADP-ribose and polymerizes the latter onto nuclear acceptor proteins.  This highly energy consuming process is pivotal for the maintenance of genomic stability although over-activation can culminate in cell dysfunction and necrosis.  Therefore, PARP-1 is regarded as a promising target for the development of drugs useful in various forms of inflammation, ischemia-reperfusion injury and as an adjunct in cancer therapy.  This review summarizes the structural classes of known PARP-1 inhibitors, with a focus on new inhibitors published for this target, between 2002 and July 2004.  The chem. and biol. data disclosed in these patent applications are discussed in light of new structural knowledge of the catalytic domain of the PARP family and recent work with potent inhibitors demonstrating the effects of PARP inhibition in various animal disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbTHYakSgCR7Vg90H21EOLACvtfcHk0lgvh1l4Hdg72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslemu7k%253D&md5=56e768ccf3d5520f34e17b6886ba4405</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.11.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.11.1531%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DSchwahn%26aufirst%3DU.%26atitle%3DNew%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D1531%26epage%3D1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alarcon de la Lastra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Fidalgo, S.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.2174%2F138161207780414241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17430191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=933-962&author=C.+Alarcon+de+la+Lastraauthor=I.+Villegasauthor=S.+Sanchez-Fidalgo&title=Poly%28ADP-ribose%29+polymerase+inhibitors%3A+new+pharmacological+functions+and+potential+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications</span></div><div class="casAuthors">Alarcon de la Lastra, C.; Villegas, I.; Sanchez-Fidalgo, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">933-962</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase (PARP) comprise of a family of enzymes which catalyzes poly(ADP-ribosyl)ation of DNA-binding proteins.  To date, seven isoforms have been identified: PARP-1, PARP-2, PARP-3, PARP-4 (Vault-PARP), PARP-5 (Tankyrases), PARP-7 and PARP-10 with structural domains and different functions.  PARP-1, the best characterized member, works as a DNA damage nick-sensor protein that uses beta-NAD+ to form polymers of ADP-ribose and has been implicated in DNA repair, maintenance of genomic integrity and mammalian longevity.  The generation of free radicals, reactive oxygen species, and peroxynitrite causes overactivation of PARP resulting in the depletion of NAD+ and ATP and consequently in necrotic cell death and organ dysfunction.  PARP has also been involved in the up-regulation of numerous pro-inflammatory genes through the activation of several transcription nuclear factors.  Thus, PARP plays an important role in the pathogenesis of several diseases, such as, stroke, myocardial infarction, circulatory shock, diabetes, neurodegenerative disorders, including Parkinson and Alzheimer diseases, allergy, colitis and other inflammatory disorders.  Pharmacol. modulation of PARP activity may constitute a suitable target to enhance the cytotoxicity of certain DNA-damaging anticancer drugs.  Also, PARP inhibition may be a viable strategy to control viral infections.  This review is intended to provide an appreciation of new pharmacol. perspectives of these remarkable drugs, summarize novel underlying mechanisms and discuss their potential clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2YUML7xYpQbVg90H21EOLACvtfcHk0lgvh1l4Hdg72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVWmurk%253D&md5=e9d12443a8fd98524ff305311a613e23</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.2174%2F138161207780414241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780414241%26sid%3Dliteratum%253Aachs%26aulast%3DAlarcon%2Bde%2Bla%2BLastra%26aufirst%3DC.%26aulast%3DVillegas%26aufirst%3DI.%26aulast%3DSanchez-Fidalgo%26aufirst%3DS.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520inhibitors%253A%2520new%2520pharmacological%2520functions%2520and%2520potential%2520clinical%2520implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D933%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.coph.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18032109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=96-103&author=F.+Moroni&title=Poly%28ADP-ribose%29polymerase+1+%28PARP-1%29+and+postischemic+brain+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage</span></div><div class="casAuthors">Moroni, Flavio</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose)polymerases (PARPs) are enzymes that are able to catalyze the transfer of ADP-ribose units from NAD to substrate proteins and are particularly abundant in cell nuclei where they play key roles in the maintenance of genomic integrity, control of cell cycle and gene expression.  Brain ischemia overactivates PARPs and PARP-deficient mice or animal treated with PARP inhibitors have a drastically reduced brain damage in various stroke models.  PARP 'overactivation' occurs not only in neurons but also in astrocytes, microglial cells, endothelia, and infiltrating leukocytes.  The ensuing cell death occurs through various mol. mechanisms: (a) excessive ATP use for NAD synthesis and inhibition of mitochondrial function with subsequent energy failure (particularly important in neurons); (b) apoptosis-inducing factor (AIF) translocation from the mitochondria to the nucleus (present in neurons, endothelial, and other cells); (c) excessive expression of inflammatory mediators (well demonstrated in glial cells) or (d) reduced expression of prosurvival factors.  Thus PARPs seem to play key roles in postischemic brain damage and are now considered interesting targets for therapies aimed at reducing stroke pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFXTGZaYQ57Vg90H21EOLACvtfcHk0lj4vVsNz0Vu3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7k%253D&md5=ebdc57710dfc2345b536fb967d1e7d8d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DPoly%2528ADP-ribose%2529polymerase%25201%2520%2528PARP-1%2529%2520and%2520postischemic%2520brain%2520damage%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D96%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Cardioprotective effects of poly(ADP-ribose) polymerase inhibition</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=34-43&author=C.+Szab%C3%B3&title=Cardioprotective+effects+of+poly%28ADP-ribose%29+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cardioprotective effects of poly(ADP-ribose) polymerase inhibition</span></div><div class="casAuthors">Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Free radical and oxidant prodn. in cardiac myocytes during ischemia/reperfusion, cardiomyopathy, cardiotoxic drug exposure and aging leads to DNA strand-breakage which activates the nuclear enzyme poly(ADP-ribose) polymerase (PARP) and initiates an energy consuming, inefficient cellular metabolic cycle with transfer of the ADP-ribosyl moiety of NAD+ to protein acceptors.  These processes lead to the functional impairment of the myocytes and promote myocyte death.  During the last decade a growing no. of exptl. studies demonstrated the beneficial effects of PARP inhibition in cell cultures through rodent models and more recently in pre-clin. large animal models of regional and global ischemia/reperfusion injury and various forms of heart failure.  The current article provides an overview of the exptl. evidence implicating PARP as a pathophysiol. modulator of cardiac myocyte injury in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclFgydgnqurVg90H21EOLACvtfcHk0lj4vVsNz0Vu3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wltrw%253D&md5=9ee8be5ba582b6b80bc4ad268b62766f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DCardioprotective%2520effects%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span> </span><span class="NLM_article-title">Shock, inflammation and PARP</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1016%2Fj.phrs.2005.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15911335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=72-82&author=S.+Cuzzocrea&title=Shock%2C+inflammation+and+PARP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Shock, inflammation and PARP</span></div><div class="casAuthors">Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The activation of poly(ADP-ribose) polymerase (PARP) is well considered to play an important role in various patho-physiol. conditions like inflammation and shock.  A vast amt. of circumstantial evidence implicates oxygen-derived free radicals (esp., superoxide and hydroxyl radical) and high-energy oxidants (such as peroxynitrite) as mediators of inflammation and shock.  ROS (e.g., superoxide, peroxynitrite, hydroxyl radical and hydrogen peroxide) are all potential reactants capable of initiating DNA single strand breakage, with subsequent activation of the nuclear enzyme poly(ADP-ribose) synthetase (PARS), leading to eventual severe energy depletion of the cells, and necrotic-type cell death.  During the last years, numerous exptl. studies have clearly demonstrated the beneficial effects of PARP inhibition in cell cultures through rodent models and more recently in pre-clin. large animal models of acute and chronic inflammation.  The aim of this review is to describe recent exptl. evidence implicating PARP as a pathophysiol. modulator of acute and chronic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Exd627XiZbVg90H21EOLACvtfcHk0lj4vVsNz0Vu3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wlt78%253D&md5=91556b95fcafc778639c4caf747c4675</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2005.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2005.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DShock%252C%2520inflammation%2520and%2520PARP%26jtitle%3DPharmacol.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D72%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabó, C.</span><span> </span><span class="NLM_article-title">Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=235-260&author=P.+Pacherauthor=C.+Szab%C3%B3&title=Role+of+poly%28ADP-ribose%29+polymerase+1+%28PARP-1%29+in+cardiovascular+diseases%3A+the+therapeutic+potential+of+PARP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DSzab%25C3%25B3%26aufirst%3DC.%26atitle%3DRole%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%25201%2520%2528PARP-1%2529%2520in%2520cardiovascular%2520diseases%253A%2520the%2520therapeutic%2520potential%2520of%2520PARP%2520inhibitors%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2007%26volume%3D25%26spage%3D235%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kauppinen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R. A.</span><span> </span><span class="NLM_article-title">The role of poly(ADP-ribose) polymerase-1 in CNS disease</span> <span class="citation_source-journal">Neuroscience (Amsterdam)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVyjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2007&pages=1267-1272&author=T.+M.+Kauppinenauthor=R.+A.+Swanson&title=The+role+of+poly%28ADP-ribose%29+polymerase-1+in+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of poly(ADP-ribose) polymerase-1 in CNS disease</span></div><div class="casAuthors">Kauppinen, T. M.; Swanson, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1267-1272</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme that contributes to both neuronal death and survival under stress conditions.  PARP-1 is the most abundant of several PARP family members, accounting for more than 85% of nuclear PARP activity, and is present in all nucleated cells of multicellular animals.  When activated by DNA damage, PARP-1 consumes NAD (NAD+) to form branched polymers of ADP-ribose on target proteins.  This process can have at least three important consequences in the CNS, depending on the cell type and the extent of DNA damage: (1) Poly(ADP-ribose) formation on histones and on enzymes involved in DNA repair can prevent sister chromatid exchange and facilitate base-excision repair; (2) poly(ADP-ribose) formation can influence the action of transcription factors, notably nuclear factor κB, and thereby promote inflammation; and (3) extensive PARP-1 activation can promote neuronal death through mechanisms involving NAD+ depletion and release of apoptosis inducing factor from the mitochondria.  PARP-1 activation is thereby a key mediator of neuronal death during excitotoxicity, ischemia, and oxidative stress, and PARP-1 gene deletion or pharmacol. inhibition can markedly improve neuronal survival in these settings.  PARP-1 activation has also been identified in Alzheimer's disease and in exptl. allergic encephalitis, but the role of PARP-1 in these disorders remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTPVvqjcGkLVg90H21EOLACvtfcHk0lj4vVsNz0Vu3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVyjtL0%253D&md5=d14e8206bd45407517e3e1f5f4c9fcc2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKauppinen%26aufirst%3DT.%2BM.%26aulast%3DSwanson%26aufirst%3DR.%2BA.%26atitle%3DThe%2520role%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520in%2520CNS%2520disease%26jtitle%3DNeuroscience%2520%2528Amsterdam%2529%26date%3D2007%26volume%3D145%26spage%3D1267%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bryant, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleday, T.</span><span> </span><span class="NLM_article-title">Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnature03443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15829966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=913-917&author=H.+E.+Bryantauthor=N.+Schultzauthor=H.+D.+Thomasauthor=K.+M.+Parkerauthor=D.+Flowerauthor=E.+Lopezauthor=S.+Kyleauthor=M.+Meuthauthor=N.+J.+Curtinauthor=T.+Helleday&title=Specific+killing+of+BRCA2-deficient+tumours+with+inhibitors+of+poly%28ADP-ribose%29+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase</span></div><div class="casAuthors">Bryant, Helen E.; Schultz, Niklas; Thomas, Huw D.; Parker, Kayan M.; Flower, Dan; Lopez, Elena; Kyle, Suzanne; Meuth, Mark; Curtin, Nicola J.; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">913-917</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage.  Nevertheless, PARP1-/- mice are viable, fertile and do not develop early onset tumors.  Here, the authors show that PARP inhibitors trigger γ-H2AX and RAD51 foci formation.  The authors propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair.  Furthermore, the authors show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired.  Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells.  The authors exploit this requirement in order to kill BRCA2-deficient tumors by PARP inhibition alone.  Treatment with PARP inhibitors is likely to be highly tumor specific, because only the tumors (which are BRCA2-/-) in BRCA2+/- patients are defective in homologous recombination.  The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumor, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJ6B7d7dB77Vg90H21EOLACvtfcHk0lghx2QE51Z7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrY%253D&md5=44631eba667cf75ef99c31d011d6db44</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature03443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03443%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DH.%2BE.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BM.%26aulast%3DFlower%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMeuth%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DSpecific%2520killing%2520of%2520BRCA2-deficient%2520tumours%2520with%2520inhibitors%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DNature%2520%2528London%2529%26date%3D2005%26volume%3D434%26spage%3D913%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Farmer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarosa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnature03445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15829967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=917-921&author=H.+Farmerauthor=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+J.+Tuttauthor=D.+A.+Johnsonauthor=T.+B.+Richardsonauthor=M.+Santarosaauthor=K.+J.+Dillonauthor=I.+Hicksonauthor=C.+Knightsauthor=N.+M.+B.+Martinauthor=S.+P.+Jacksonauthor=G.+C.+M.+Smithauthor=A.+Ashworth&title=Targeting+the+DNA+repair+defect+in+BRCA+mutant+cells+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy</span></div><div class="casAuthors">Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Johnson, Damian A.; Richardson, Tobias B.; Santarosa, Manuela; Dillon, Krystyna J.; Hickson, Ian; Knights, Charlotte; Martin, Niall M. B.; Jackson, Stephen P.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7035</span>),
    <span class="NLM_cas:pages">917-921</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers.  Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks.  The authors show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis.  This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination.  These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVTKE4mFwfrVg90H21EOLACvtfcHk0lghx2QE51Z7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFOmsrc%253D&md5=03b5ba0adc21a5627fe17ae535f45078</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03445%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DH.%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BB.%26aulast%3DSantarosa%26aufirst%3DM.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520DNA%2520repair%2520defect%2520in%2520BRCA%2520mutant%2520cells%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNature%2520%2528London%2529%26date%3D2005%26volume%3D434%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluzek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bialkowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzienicka, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8109</span><span class="NLM_x">–</span> <span class="NLM_lpage">8115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8109-8115&author=N.+McCabeauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=K.+Kluzekauthor=A.+Bialkowskaauthor=S.+Swiftauthor=S.+Giavaraauthor=M.+J.+O%27Connorauthor=A.+N.+Tuttauthor=M.+Z.+Zdzienickaauthor=G.+C.+M.+Smithauthor=A.+Ashworth&title=Deficiency+in+the+repair+of+DNA+damage+by+homologous+recombination+and+sensitivity+to+poly%28ADP-ribose%29+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DKluzek%26aufirst%3DK.%26aulast%3DBialkowska%26aufirst%3DA.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DGiavara%26aufirst%3DS.%26aulast%3DO%2527Connor%26aufirst%3DM.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DZdzienicka%26aufirst%3DM.%2BZ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DDeficiency%2520in%2520the%2520repair%2520of%2520DNA%2520damage%2520by%2520homologous%2520recombination%2520and%2520sensitivity%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8109%26epage%3D8115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkitaraman, A. R.</span><span> </span><span class="NLM_article-title">Cancer susceptibility and the functions of BRCA1 and BRCA2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2002&pages=171-182&author=A.+R.+Venkitaraman&title=Cancer+susceptibility+and+the+functions+of+BRCA1+and+BRCA2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26atitle%3DCancer%2520susceptibility%2520and%2520the%2520functions%2520of%2520BRCA1%2520and%2520BRCA2%26jtitle%3DCell%26date%3D2002%26volume%3D108%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Narod, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulkes, W. D.</span><span> </span><span class="NLM_article-title">BRCA1 and BRCA2: 1994 and beyond</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1038%2Fnrc1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=15343273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFCmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=665-676&author=S.+A.+Narodauthor=W.+D.+Foulkes&title=BRCA1+and+BRCA2%3A+1994+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA1 and BRCA2: 1994 and beyond</span></div><div class="casAuthors">Narod, Steven A.; Foulkes, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-676</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of the first gene assocd. with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs.  Much has been learned during the past decade about the genetic epidemiol. of breast cancer, the ethnic distribution and clin. consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility.  The ability to translate this knowledge into novel treatments, however, remains elusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1a5S77C977bVg90H21EOLACvtfcHk0lhQnFKggYfnVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFCmsbk%253D&md5=200600041061619ba39dfbd8dfc91850</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnrc1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1431%26sid%3Dliteratum%253Aachs%26aulast%3DNarod%26aufirst%3DS.%2BA.%26aulast%3DFoulkes%26aufirst%3DW.%2BD.%26atitle%3DBRCA1%2520and%2520BRCA2%253A%25201994%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copsey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I. T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6581</span><span class="NLM_x">–</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.-L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+W.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+M.+Smithauthor=N.+M.+B.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%2BW.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-1-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6581%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rottenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaspers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersbergen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, A. O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, S. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derksen, P. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zevenhoven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span> </span><span class="NLM_article-title">High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17079</span><span class="NLM_x">–</span> <span class="NLM_lpage">17084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1073%2Fpnas.0806092105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=18971340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKlsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17079-17084&author=S.+Rottenbergauthor=J.+E.+Jaspersauthor=A.+Kersbergenauthor=E.+van+der+Burgauthor=A.+O.+H.+Nygrenauthor=S.+A.+L.+Zanderauthor=P.+W.+B.+Derksenauthor=M.+de+Bruinauthor=J.+Zevenhovenauthor=A.+Lauauthor=R.+Boulterauthor=A.+Cranstonauthor=M.+J.+O%27Connorauthor=N.+M.+B.+Martinauthor=P.+Borstauthor=J.+Jonkers&title=High+sensitivity+of+BRCA1-deficient+mammary+tumors+to+the+PARP+inhibitor+AZD2281+alone+and+in+combination+with+platinum+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs</span></div><div class="casAuthors">Rottenberg, Sven; Jaspers, Janneke E.; Kersbergen, Ariena; van der Burg, Eline; Nygren, Anders O. H.; Zander, Serge A. L.; Derksen, Patrick W. B.; de Bruin, Michiel; Zevenhoven, John; Lau, Alan; Boulter, Robert; Cranston, Aaron; O'Connor, Mark J.; Martin, Niall M. B.; Borst, Piet; Jonkers, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17079-17084</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Whereas target-specific drugs are available for treating ERBB2-overexpressing and hormone receptor-pos. breast cancers, no tailored therapy exists for hormone receptor- and ERBB2-neg. ("triple-neg.") mammary carcinomas.  Triple-neg. tumors account for 15% of all breast cancers and frequently harbor defects in DNA double-strand break repair through homologous recombination (HR), such as BRCA1 dysfunction.  The DNA-repair defects characteristic of BRCA1-deficient cells confer sensitivity to poly(ADP-ribose) polymerase 1 (PARP1) inhibition, which could be relevant to treatment of triple-neg. tumors.  To evaluate PARP1 inhibition in a realistic in vivo setting, we tested the PARP inhibitor AZD2281 in a genetically engineered mouse model (GEMM) for BRCA1-assocd. breast cancer.  Treatment of tumor-bearing mice with AZD2281 inhibited tumor growth without signs of toxicity, resulting in strongly increased survival.  Long-term treatment with AZD2281 in this model did result in the development of drug resistance, caused by up-regulation of Abcb1a/b genes encoding P-glycoprotein efflux pumps.  This resistance to AZD2281 could be reversed by coadministration of the P-glycoprotein inhibitor tariquidar.  Combination of AZD2281 with cisplatin or carboplatin increased the recurrence-free and overall survival, suggesting that AZD2281 potentiates the effect of these DNA-damaging agents.  Our results demonstrate in vivo efficacy of AZD2281 against BRCA1-deficient breast cancer and illustrate how GEMMs of cancer can be used for preclin. evaluation of novel therapeutics and for testing ways to overcome or circumvent therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr95zB9OKZ4ObVg90H21EOLACvtfcHk0lhQnFKggYfnVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKlsr7F&md5=788a7d8b5341b731d007753d5a234dec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806092105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806092105%26sid%3Dliteratum%253Aachs%26aulast%3DRottenberg%26aufirst%3DS.%26aulast%3DJaspers%26aufirst%3DJ.%2BE.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DE.%26aulast%3DNygren%26aufirst%3DA.%2BO.%2BH.%26aulast%3DZander%26aufirst%3DS.%2BA.%2BL.%26aulast%3DDerksen%26aufirst%3DP.%2BW.%2BB.%26aulast%3Dde%2BBruin%26aufirst%3DM.%26aulast%3DZevenhoven%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DO%2527Connor%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DJonkers%26aufirst%3DJ.%26atitle%3DHigh%2520sensitivity%2520of%2520BRCA1-deficient%2520mammary%2520tumors%2520to%2520the%2520PARP%2520inhibitor%2520AZD2281%2520alone%2520and%2520in%2520combination%2520with%2520platinum%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17079%26epage%3D17084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergui-Roelvink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span> </span><span class="NLM_article-title">Inhibition of poly(ADP-ribose)polymerase in tumors from BRCA mutation carriers</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1056%2FNEJMoa0900212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=19553641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=123-134&author=P.+C.+Fongauthor=D.+S.+Bossauthor=T.+A.+Yapauthor=A.+Tuttauthor=P.+Wuauthor=M.+Mergui-Roelvinkauthor=P.+Mortimerauthor=H.+Swaislandauthor=A.+Lauauthor=M.+J.+O%E2%80%99Connorauthor=A.+Ashworthauthor=J.+Carmichaelauthor=S.+B.+Kayeauthor=J.+H.+M.+Schellensauthor=J.+S.+de+Bono&title=Inhibition+of+poly%28ADP-ribose%29polymerase+in+tumors+from+BRCA+mutation+carriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers</span></div><div class="casAuthors">Fong, Peter C.; Boss, David S.; Yap, Timothy A.; Tutt, Andrew; Wu, Peijun; Mergui-Roelvink, Marja; Mortimer, Peter; Swaisland, Helen; Lau, Alan; O'Connor, Mark J.; Ashworth, Alan; Carmichael, James; Kaye, Stan B.; Schellens, Jan H. M.; de Bono, Johann S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The inhibition of poly(ADP-ribose) polymerase (PARP) is a potential synthetic lethal therapeutic strategy for the treatment of cancers with specific DNA-repair defects, including those arising in carriers of a BRCA1 or BRCA2 mutation.  We conducted a clin. evaluation in humans of olaparib (AZD2281), a novel, potent, orally active PARP inhibitor.  This was a phase 1 trial that included the anal. of pharmacokinetic and pharmacodynamic characteristics of olaparib.  Selection was aimed at having a study population enriched in carriers of a BRCA1 or BRCA2 mutation.  We enrolled and treated 60 patients; 22 were carriers of a BRCA1 or BRCA2 mutation and 1 had a strong family history of BRCA-assocd. cancer but declined to undergo mutational testing.  The olaparib dose and schedule were increased from 10 mg daily for 2 of every 3 wk to 600 mg twice daily continuously.  Reversible dose-limiting toxicity was seen in one of eight patients receiving 400 mg twice daily (grade 3 mood alteration and fatigue) and two of five patients receiving 600 mg twice daily (grade 4 thrombocytopenia and grade 3 somnolence).  This led us to enroll another cohort, consisting only of carriers of a BRCA1 or BRCA2 mutation, to receive olaparib at a dose of 200 mg twice daily.  Other adverse effects included mild gastrointestinal symptoms.  There was no obvious increase in adverse effects seen in the mutation carriers.  Pharmacokinetic data indicated rapid absorption and elimination; pharmacodynamic studies confirmed PARP inhibition in surrogate samples (of peripheral-blood mononuclear cells and plucked eyebrow-hair follicles) and tumor tissue.  Objective antitumor activity was reported only in mutation carriers, all of whom had ovarian, breast, or prostate cancer and had received multiple treatment regimens.  Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer assocd. with the BRCA1 or BRCA2 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCT49Hz0HbW7Vg90H21EOLACvtfcHk0lh0bCM_3v1d4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVKrtrw%253D&md5=aec7dcffe3d3cf614362a4f38bbb369a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0900212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0900212%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DP.%2BC.%26aulast%3DBoss%26aufirst%3DD.%2BS.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DMergui-Roelvink%26aufirst%3DM.%26aulast%3DMortimer%26aufirst%3DP.%26aulast%3DSwaisland%26aufirst%3DH.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%2BM.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26atitle%3DInhibition%2520of%2520poly%2528ADP-ribose%2529polymerase%2520in%2520tumors%2520from%2520BRCA%2520mutation%2520carriers%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontcheva-Diaz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span> </span><span class="NLM_article-title">Discovery of the poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(<i>R</i>)-2-methylpyrrolidin-2-yl]-1<i>H</i>-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801171j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=514-523&author=T.+D.+Penningauthor=G.-D.+Zhuauthor=V.+B.+Gandhiauthor=J.+Gongauthor=X.+Liuauthor=Y.+Shiauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=C.+K.+Donawhoauthor=D.+J.+Frostauthor=V.+Bontcheva-Diazauthor=J.+J.+Bouskaauthor=D.+J.+Osterlingauthor=A.+M.+Olsonauthor=K.+C.+Marshauthor=Y.+Luoauthor=V.+L.+Giranda&title=Discovery+of+the+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+2-%5B%28R%29-2-methylpyrrolidin-2-yl%5D-1H-benzimidazole-4-carboxamide+%28ABT-888%29+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer</span></div><div class="casAuthors">Penning, Thomas D.; Zhu, Gui-Dong; Gandhi, Viraj B.; Gong, Jianchun; Liu, Xuesong; Shi, Yan; Klinghofer, Vered; Johnson, Eric F.; Donawho, Cherrie K.; Frost, David J.; Bontcheva-Diaz, Velitchka; Bouska, Jennifer J.; Osterling, Donald J.; Olson, Amanda M.; Marsh, Kennan C.; Luo, Yan; Giranda, Vincent L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">514-523</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclic amine-contg. benzimidazole carboxamide PARP inhibitors with a methyl-substituted quaternary center at the point of attachment to the benzimidazole ring system has been developed.  These compds. exhibit excellent PARP enzyme potency as well as single-digit nanomolar cellular potency.  These efforts led to the identification of (I)·2HCl (2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, ABT-888), currently in human phase I clin. trials.  Compd. I·2HCl displayed excellent potency against both the PARP-1 and PARP-2 enzymes with a Ki of 5 nM and in a C41 whole cell assay with an EC50 of 2 nM.  In addn., I·2HCl is aq. sol., orally bioavailable across multiple species, and demonstrated good in vivo efficacy in a B16F10 s.c. murine melanoma model in combination with temozolomide (TMZ) and in an MX-1 breast cancer xenograft model in combination with either carboplatin or cyclophosphamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBVnNi7EZcbVg90H21EOLACvtfcHk0lh0bCM_3v1d4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7bL&md5=283eddd2e8220740c48865e4e8269a95</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm801171j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801171j%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DZhu%26aufirst%3DG.-D.%26aulast%3DGandhi%26aufirst%3DV.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DDiscovery%2520of%2520the%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%25202-%255B%2528R%2529-2-methylpyrrolidin-2-yl%255D-1H-benzimidazole-4-carboxamide%2520%2528ABT-888%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D514%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontcheva-Diaz, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWeese, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillehay, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holley-Shanks, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hristov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idler, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinghofer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasko, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulbroek, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurutani, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span> </span><span class="NLM_article-title">ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1078-0432.CCR-06-3039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17473206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslOhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2728-2737&author=C.+K.+Donawhoauthor=Y.+Luoauthor=Y.+Luoauthor=T.+D.+Penningauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=V.+D.+Bontcheva-Diazauthor=B.+F.+Coxauthor=T.+L.+DeWeeseauthor=L.+E.+Dillehayauthor=D.+C.+Fergusonauthor=N.+S.+Ghoreishi-Haackauthor=D.+R.+Grimmauthor=R.+Guanauthor=E.+K.+Hanauthor=R.+R.+Holley-Shanksauthor=B.+Hristovauthor=K.+B.+Idlerauthor=K.+Jarvisauthor=E.+F.+Johnsonauthor=L.+R.+Kleinbergauthor=V.+Klinghoferauthor=L.+M.+Laskoauthor=X.+Liuauthor=K.+C.+Marshauthor=T.+P.+McGonigalauthor=J.+A.+Meulbroekauthor=A.+M.+Olsonauthor=J.+P.+Palmaauthor=L.+E.+Rodriguezauthor=Y.+Shiauthor=J.+A.+Stavropoulosauthor=A.+C.+Tsurutaniauthor=G.-D.+Zhuauthor=S.+H.+Rosenbergauthor=V.+L.+Girandaauthor=D.+J.+Frost&title=ABT-888%2C+an+orally+active+poly%28ADP-ribose%29+polymerase+inhibitor+that+potentiates+DNA-damaging+agents+in+preclinical+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models</span></div><div class="casAuthors">Donawho, Cherrie K.; Luo, Yan; Luo, Yanping; Penning, Thomas D.; Bauch, Joy L.; Bouska, Jennifer J.; Bontcheva-Diaz, Velitchka D.; Cox, Bryan F.; DeWeese, Theodore L.; Dillehay, Larry E.; Ferguson, Debra C.; Ghoreishi-Haack, Nayereh S.; Grimm, David R.; Guan, Ran; Han, Edward K.; Holley-Shanks, Rhonda R.; Hristov, Boris; Idler, Kenneth B.; Jarvis, Ken; Johnson, Eric F.; Kleinberg, Lawrence R.; Klinghofer, Vered; Lasko, Loren M.; Liu, Xuesong; Marsh, Kennan C.; McGonigal, Thomas P.; Meulbroek, Jonathan A.; Olson, Amanda M.; Palma, Joann P.; Rodriguez, Luis E.; Shi, Yan; Stavropoulos, Jason A.; Tsurutani, Alan C.; Zhu, Gui-Dong; Rosenberg, Saul H.; Giranda, Vincent L.; Frost, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2728-2737</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose is to evaluate the preclin. pharmacokinetics and antitumor efficacy of a novel orally bioavailable poly(ADP-ribose) polymerase (PARP) inhibitor, ABT-888.  In vitro potency was detd. in a PARP-1 and PARP-2 enzyme assay.  In vivo efficacy was evaluated in syngeneic and xenograft models in combination with temozolomide, platinums, cyclophosphamide, and ionizing radiation.  ABT-888 is a potent inhibitor of both PARP-1 and PARP-2 with Kis of 5.2 and 2.9 nmol/L, resp.  The compd. has good oral bioavailability and crosses the blood-brain barrier.  ABT-888 strongly potentiated temozolomide in the B16F10 s.c. murine melanoma model.  PARP inhibition dramatically increased the efficacy of temozolomide at ABT-888 doses as low as 3.1 mg/kg/d and a maximal efficacy achieved at 25 mg/kg/d.  In the 9L orthotopic rat glioma model, temozolomide alone exhibited minimal efficacy, whereas ABT-888, when combined with temozolomide, significantly slowed tumor progression.  In the MX-1 breast xenograft model (BRCA1 deletion and BRCA2 mutation), ABT-888 potentiated cisplatin, carboplatin, and cyclophosphamide, causing regression of established tumors, whereas with comparable doses of cytotoxic agents alone, only modest tumor inhibition was exhibited.  Finally, ABT-888 potentiated radiation (2 Gy/d × 10) in an HCT-116 colon carcinoma model.  In each model, ABT-888 did not display single-agent activity.  ABT-888 is a potent inhibitor of PARP, has good oral bioavailability, can cross the blood-brain barrier, and potentiates temozolomide, platinums, cyclophosphamide, and radiation in syngeneic and xenograft tumor models.  This broad spectrum of chemopotentiation and radiopotentiation makes this compd. an attractive candidate for clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2xiIRsPurHLVg90H21EOLACvtfcHk0lh0bCM_3v1d4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslOhurg%253D&md5=4769ee3eec82465993eb9e1443095894</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3039%26sid%3Dliteratum%253Aachs%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%2BD.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DDeWeese%26aufirst%3DT.%2BL.%26aulast%3DDillehay%26aufirst%3DL.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DGrimm%26aufirst%3DD.%2BR.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DHolley-Shanks%26aufirst%3DR.%2BR.%26aulast%3DHristov%26aufirst%3DB.%26aulast%3DIdler%26aufirst%3DK.%2BB.%26aulast%3DJarvis%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DKleinberg%26aufirst%3DL.%2BR.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DLasko%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMcGonigal%26aufirst%3DT.%2BP.%26aulast%3DMeulbroek%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DPalma%26aufirst%3DJ.%2BP.%26aulast%3DRodriguez%26aufirst%3DL.%2BE.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DTsurutani%26aufirst%3DA.%2BC.%26aulast%3DZhu%26aufirst%3DG.-D.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26atitle%3DABT-888%252C%2520an%2520orally%2520active%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520that%2520potentiates%2520DNA-damaging%2520agents%2520in%2520preclinical%2520tumor%2520models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2728%26epage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalitzky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1158%2F1535-7163.MCT-06-0552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17363489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=945-956&author=H.+D.+Thomasauthor=C.+R.+Calabreseauthor=M.+A.+Bateyauthor=S.+Cananauthor=Z.+Hostomskyauthor=S.+Kyleauthor=K.+A.+Maegleyauthor=D.+R.+Newellauthor=D.+Skalitzkyauthor=L.-Z.+Wangauthor=S.+E.+Webberauthor=N.+J.+Curtin&title=Preclinical+selection+of+a+novel+poly%28ADP-ribose%29+polymerase+inhibitor+for+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span></div><div class="casAuthors">Thomas, Huw D.; Calabrese, Christopher R.; Batey, Michael A.; Canan, Stacie; Hostomsky, Zdenek; Kyle, Suzanne; Maegley, Karen A.; Newell, David R.; Skalitzky, Donald; Wang, Lan-Zhen; Webber, Stephen E.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">945-956</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP)-1 (EC 2.4.2.30) is a nuclear enzyme that promotes the base excision repair of DNA breaks.  Inhibition of PARP-1 enhances the efficacy of DNA alkylating agents, topoisomerase I poisons, and ionizing radiation.  Our aim was to identify a PARP inhibitor for clin. trial from a panel of 42 potent PARP inhibitors (Ki, 1.4-15.1 nmol/L) based on the quinazolinone, benzimidazole, tricyclic benzimidazole, tricyclic indole, and tricyclic indole-1-one core structures.  We evaluated chemosensitization of temozolomide and topotecan using LoVo and SW620 human colorectal cells; in vitro radiosensitization was measured using LoVo cells, and the enhancement of antitumor activity of temozolomide was evaluated in mice bearing SW620 xenografts.  Excellent chemopotentiation and radiopotentiation were obsd. in vitro, with 17 of the compds. causing a greater temozolomide and topotecan sensitization than the benchmark inhibitor AG14361 and 10 compds. were more potent radiosensitizers than AG14361.  In tumor-bearing mice, none of the compds. were toxic when given alone, and the antitumor activity of the PARP inhibitor-temozolomide combinations was unrelated to toxicity.  Compds. that were more potent chemosensitizers in vivo than AG14361 were also more potent in vitro, validating in vitro assays as a prescreen.  These studies have identified a compd., AG14447, as a PARP inhibitor with outstanding in vivo chemosensitization potency at tolerable doses, which is at least 10 times more potent than the initial lead, AG14361.  The phosphate salt of AG14447 (AG014699), which has improved aq. soly., has been selected for clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-3D2oL2giLVg90H21EOLACvtfcHk0lgmjaFEICQioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D&md5=b451bf2c1fc836cc5a800c2799e5d211</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0552%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCanan%26aufirst%3DS.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.-Z.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520selection%2520of%2520a%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520for%2520clinical%2520trial%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D945%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdecanas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milas, L.</span><span> </span><span class="NLM_article-title">INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1-5&author=K.+A.+Masonauthor=D.+Valdecanasauthor=N.+R.+Hunterauthor=L.+Milas&title=INO-1001%2C+a+novel+inhibitor+of+poly%28ADP-ribose%29+polymerase%2C+enhances+tumor+response+to+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BA.%26aulast%3DValdecanas%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DN.%2BR.%26aulast%3DMilas%26aufirst%3DL.%26atitle%3DINO-1001%252C%2520a%2520novel%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%252C%2520enhances%2520tumor%2520response%2520to%2520doxorubicin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_contrib-group">Kopetz, S.; Mita, M. M.; Mok, I.; Sankhala, K. K.; Moseley, J.; Sherman, B. M.; Bradley, C. R.; Tolcher, A. W.</span><span> </span><span class="NLM_article-title">First in Human Phase I Study of BSI-201, a Small Molecule Inhibitor of Poly ADP-ribose Polymerase (PARP) in Subjects with Advanced Solid Tumors</span>. Presented at the 44th Annual Meeting of the ASCO, Chicago, IL, May 31−June 3<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 3577.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Kopetz&author=M.+M.+Mita&author=I.+Mok&author=K.+K.+Sankhala&author=J.+Moseley&author=B.+M.+Sherman&author=C.+R.+Bradley&author=A.+W.+Tolcher&title=First+in+Human+Phase+I+Study+of+BSI-201%2C+a+Small+Molecule+Inhibitor+of+Poly+ADP-ribose+Polymerase+%28PARP%29+in+Subjects+with+Advanced+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKopetz%26aufirst%3DS.%26atitle%3DFirst%2520in%2520Human%2520Phase%2520I%2520Study%2520of%2520BSI-201%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Poly%2520ADP-ribose%2520Polymerase%2520%2528PARP%2529%2520in%2520Subjects%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">May 20 Suppl.</span>),  <span class="NLM_fpage">3577</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=J.+Clin.+Oncol.+2008%2C+26+%28May+20+Suppl.%29%2C+3577."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26issue%3DMay%252020%2520Suppl%26spage%3D3577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kuvshinov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulevskaya, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozhkov, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevelev, S. A.</span><span> </span><span class="NLM_article-title">Synthesis of 2-substituted 4,6-dinitro-2<i>H</i>-indazoles from 2,4,6-trinitrotoluene</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1474</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1055%2Fs-2000-7120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1474-1478&author=A.+M.+Kuvshinovauthor=V.+I.+Gulevskayaauthor=V.+V.+Rozhkovauthor=S.+A.+Shevelev&title=Synthesis+of+2-substituted+4%2C6-dinitro-2H-indazoles+from+2%2C4%2C6-trinitrotoluene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-7120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-7120%26sid%3Dliteratum%253Aachs%26aulast%3DKuvshinov%26aufirst%3DA.%2BM.%26aulast%3DGulevskaya%26aufirst%3DV.%2BI.%26aulast%3DRozhkov%26aufirst%3DV.%2BV.%26aulast%3DShevelev%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520of%25202-substituted%25204%252C6-dinitro-2H-indazoles%2520from%25202%252C4%252C6-trinitrotoluene%26jtitle%3DSynthesis%26date%3D2000%26volume%3D10%26spage%3D1474%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Anderson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolella, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. J.</span><span> </span><span class="NLM_article-title">1,3-Dipolar addition of pyridine <i>N</i>-imine to acetylenes and the use of carbon-13 NMR in several structural assignments</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1981&pages=1149-1152&author=P.+L.+Andersonauthor=J.+P.+Hasakauthor=A.+D.+Kahleauthor=N.+A.+Paolellaauthor=M.+J.+Shapiro&title=1%2C3-Dipolar+addition+of+pyridine+N-imine+to+acetylenes+and+the+use+of+carbon-13+NMR+in+several+structural+assignments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%2BL.%26aulast%3DHasak%26aufirst%3DJ.%2BP.%26aulast%3DKahle%26aufirst%3DA.%2BD.%26aulast%3DPaolella%26aufirst%3DN.%2BA.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3D1%252C3-Dipolar%2520addition%2520of%2520pyridine%2520N-imine%2520to%2520acetylenes%2520and%2520the%2520use%2520of%2520carbon-13%2520NMR%2520in%2520several%2520structural%2520assignments%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1981%26volume%3D18%26spage%3D1149%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hajos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schantl, J. G.</span><span> </span><span class="NLM_article-title">A new synthesis of the <i>s</i>-triazolo[1,5-<i>a</i>]pyridine ring system</span> <span class="citation_source-journal">Monatsh. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1007%2FBF00824299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1995&pages=1213-1215&author=G.+Hajosauthor=G.+Timariauthor=A.+Messmerauthor=A.+Zagyvaauthor=I.+Miskolcziauthor=J.+G.+Schantl&title=A+new+synthesis+of+the+s-triazolo%5B1%2C5-a%5Dpyridine+ring+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A new synthesis of the s-triazolo[1,5-a]pyridine ring system</span></div><div class="casAuthors">Hajos, G.; Timari, G.; Messmer, A.; Zagyva, A.; Miskolczi, I.; Schantl, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Monatshefte fuer Chemie</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-15</span>CODEN:
                <span class="NLM_cas:coden">MOCMB7</span>;
        ISSN:<span class="NLM_cas:issn">0026-9247</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A novel and efficient synthesis of s-triazolo[1,5-a]pyridines was elaborated by reacting 1,2-diaminopyridinium salts with aldehydes.  The cyclization of benzaldehyde with 1,2-diaminopyridinium tosylate gave [1,2,4]triazolo[1,5-a]pyridine (68% yield).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_lQItvq1NCbVg90H21EOLACvtfcHk0lgmjaFEICQioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurnL&md5=af462673150bb0adceda6cc7613d9e95</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF00824299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00824299%26sid%3Dliteratum%253Aachs%26aulast%3DHajos%26aufirst%3DG.%26aulast%3DTimari%26aufirst%3DG.%26aulast%3DMessmer%26aufirst%3DA.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DSchantl%26aufirst%3DJ.%2BG.%26atitle%3DA%2520new%2520synthesis%2520of%2520the%2520s-triazolo%255B1%252C5-a%255Dpyridine%2520ring%2520system%26jtitle%3DMonatsh.%2520Chem.%26date%3D1995%26volume%3D126%26spage%3D1213%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ritter, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalish, J.</span><span> </span><span class="NLM_article-title">α,α-Dimethyl-β-phenethylamine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1964&pages=44&author=J.+J.+Ritterauthor=J.+Kalish&title=%CE%B1%2C%CE%B1-Dimethyl-%CE%B2-phenethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DJ.%2BJ.%26aulast%3DKalish%26aufirst%3DJ.%26atitle%3D%25CE%25B1%252C%25CE%25B1-Dimethyl-%25CE%25B2-phenethylamine%26jtitle%3DOrg.%2520Synth.%26date%3D1964%26volume%3D44%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennissier de Murcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">7481</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=7481-7485&author=A.+Rufauthor=J.+Mennissier+de+Murciaauthor=G.+de+Murciaauthor=G.+E.+Schulz&title=Structure+of+the+catalytic+fragment+of+poly%28AD-ribose%29+polymerase+from+chicken"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DMennissier%2Bde%2BMurcia%26aufirst%3DJ.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520fragment%2520of%2520poly%2528AD-ribose%2529%2520polymerase%2520from%2520chicken%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D1996%26volume%3D93%26spage%3D7481%26epage%3D7485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, G. E.</span><span> </span><span class="NLM_article-title">Inhibitor and NAD<sup>+</sup> binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3893</span><span class="NLM_x">–</span> <span class="NLM_lpage">3900</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi972383s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=3893-3900&author=A.+Rufauthor=G.+de+Murciaauthor=G.+E.+Schulz&title=Inhibitor+and+NAD%2B+binding+to+poly%28ADP-ribose%29+polymerase+as+derived+from+crystal+structures+and+homology+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fbi972383s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi972383s%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DA.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DInhibitor%2520and%2520NAD%252B%2520binding%2520to%2520poly%2528ADP-ribose%2529%2520polymerase%2520as%2520derived%2520from%2520crystal%2520structures%2520and%2520homology%2520modeling%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D3893%26epage%3D3900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">[<sup>3</sup>H]<b>43</b> was prepared by reduction of {4-[7-(aminocarbonyl)-3-bromo-2<i>H</i>-indazol-2-yl]-2-chlorophenyl}-<i>N</i>-methylmethanaminium trifluoroacetate. The precursor itself was prepared from <b>35</b> first by reaction with 2-chloro-4-fluorobenzaldehyde and then bromination at the 3-position with Br<sub>2</sub> in DCM/AcOH for 48 h, followed by reductive amination.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Martignoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groothuis, G. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span> </span><span class="NLM_article-title">Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.1517%2F17425255.2.6.875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=17125407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=875-894&author=M.+Martignoniauthor=G.+M.+M.+Groothuisauthor=R.+de+Kanter&title=Species+differences+between+mouse%2C+rat%2C+dog%2C+monkey+and+human+CYP-mediated+drug+metabolism%2C+inhibition+and+induction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</span></div><div class="casAuthors">Martignoni, Marcella; Groothuis, Geny M. M.; de Kanter, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">875-894</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Animal models are commonly used in the preclin. development of new drugs to predict the metabolic behavior of new compds. in humans.  It is, however, important to realize that humans differ from animals with regards to isoform compn., expression and catalytic activities of drug-metabolizing enzymes.  In this review the authors describe similarities and differences in this respect among the different species, including man.  This may be helpful for drug researchers to choose the most relevant animal species in which the metab. of a compd. can be studied for extrapolating the results to humans.  The authors focus on CYPs, which are the main enzymes involved in numerous oxidative reactions and often play a crit. role in the metab. and pharmacokinetics of xenobiotics.  In addn., induction and inhibition of CYPs are compared among species.  The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well.  In contrast, the species-specific isoforms of CYP1A, -2C, -2D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metab. data from animal models to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd9SDz-wmCcLVg90H21EOLACvtfcHk0li3TydOZGCeBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eks7nJ&md5=504f34a2aa5e796083f822c6a54acc8a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.6.875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.6.875%26sid%3Dliteratum%253Aachs%26aulast%3DMartignoni%26aufirst%3DM.%26aulast%3DGroothuis%26aufirst%3DG.%2BM.%2BM.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26atitle%3DSpecies%2520differences%2520between%2520mouse%252C%2520rat%252C%2520dog%252C%2520monkey%2520and%2520human%2520CYP-mediated%2520drug%2520metabolism%252C%2520inhibition%2520and%2520induction%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D875%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Harrigan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarrigle, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutter, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, J. R.</span><span> </span><span class="NLM_article-title">Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(<i>a</i>)pyrene</span> <span class="citation_source-journal">Toxicol. in Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=426-438&author=J.+A.+Harriganauthor=B.+P.+McGarrigleauthor=T.+R.+Sutterauthor=J.+R.+Olson&title=Tissue+specific+induction+of+cytochrome+P450+%28CYP%29+1A1+and+1B1+in+rat+liver+and+lung+following+in+vitro+%28tissue+slice%29+and+in+vivo+exposure+to+benzo%28a%29pyrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrigan%26aufirst%3DJ.%2BA.%26aulast%3DMcGarrigle%26aufirst%3DB.%2BP.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DOlson%26aufirst%3DJ.%2BR.%26atitle%3DTissue%2520specific%2520induction%2520of%2520cytochrome%2520P450%2520%2528CYP%2529%25201A1%2520and%25201B1%2520in%2520rat%2520liver%2520and%2520lung%2520following%2520in%2520vitro%2520%2528tissue%2520slice%2529%2520and%2520in%2520vivo%2520exposure%2520to%2520benzo%2528a%2529pyrene%26jtitle%3DToxicol.%2520in%2520Vitro%26date%3D2006%26volume%3D20%26spage%3D426%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. Y. H.</span><span> </span><span class="NLM_article-title">CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1009-1016&author=Q.+Maauthor=A.+Y.+H.+Lu&title=CYP1A+induction+and+human+risk+assessment%3A+an+evolving+tale+of+in+vitro+and+in+vivo+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DCYP1A%2520induction%2520and%2520human%2520risk%2520assessment%253A%2520an%2520evolving%2520tale%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1009%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Amat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantó, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escolano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, J.</span><span> </span><span class="NLM_article-title">Dynamic kinetic resolution of racemic γ-aryl-δ-oxoesters. Enantioselective synthesis of 3-arylpiperidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5343</span><span class="NLM_x">–</span> <span class="NLM_lpage">5351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025894f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=5343-5351&author=M.+Amatauthor=M.+Cant%C3%B3author=N.+Llorauthor=C.+Escolanoauthor=E.+Molinsauthor=E.+Espinosaauthor=J.+Bosch&title=Dynamic+kinetic+resolution+of+racemic+%CE%B3-aryl-%CE%B4-oxoesters.+Enantioselective+synthesis+of+3-arylpiperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo025894f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025894f%26sid%3Dliteratum%253Aachs%26aulast%3DAmat%26aufirst%3DM.%26aulast%3DCant%25C3%25B3%26aufirst%3DM.%26aulast%3DLlor%26aufirst%3DN.%26aulast%3DEscolano%26aufirst%3DC.%26aulast%3DMolins%26aufirst%3DE.%26aulast%3DEspinosa%26aufirst%3DE.%26aulast%3DBosch%26aufirst%3DJ.%26atitle%3DDynamic%2520kinetic%2520resolution%2520of%2520racemic%2520%25CE%25B3-aryl-%25CE%25B4-oxoesters.%2520Enantioselective%2520synthesis%2520of%25203-arylpiperidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D5343%26epage%3D5351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">McCabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: an issue of potency</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901188v&amp;key=10.4161%2Fcbt.4.9.2141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901188v&amp;key=16251802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901188v&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=934-936&author=N.+McCabeauthor=C.+J.+Lordauthor=A.+N.+Tuttauthor=N.+M.+Martinauthor=G.+C.+Smithauthor=A.+Ashworth&title=BRCA2-deficient+CAPAN-1+cells+are+extremely+sensitive+to+the+inhibition+of+poly+%28ADP-ribose%29+polymerase%3A+an+issue+of+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: an issue of potency</span></div><div class="casAuthors">McCabe, Nuala; Lord, Christopher J.; Tutt, Andrew N. J.; Martin, Niall M. B.; Smith, Graeme C. M.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">934-936</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">We have previously demonstrated that deficiency of either the BRCA1 or BRCA2 breast cancer susceptibility proteins confers substantial cellular sensitivity to the inhibition of Poly(ADP-Ribose) polymerase (PARP).  PARP is a key enzyme in the repair of single strand DNA damage via the Base Excision Repair pathway.  We suggested that PARP inhibition produces persistent single-strand DNA breaks or gaps which degenerate into stalled replication forks and double-strand breaks, which may be repaired by homologous recombination, a process partially dependent on BRCA1 and BRCA2.  It has recently been suggested that our results might be limited to certain BRCA2 mutations as the CAPAN-1 cell line, which carries a naturally occurring 6174delT mutation in one BRCA2 allele accompanied by loss of the wild-type allele, is apparently insensitive to two PARP inhibitors 3-aminobenzamide (IC50 33 μM) and NU1025 (IC50 400 nM).  Here we show that CAPAN-1 cells are in fact very sensitive to the potent PARP inhibitors KU0058684 (IC50 3.2 nM) and KU0058948 (IC50 3.4 nM).  In contrast, our results reveal much less sensitivity to a chem. related but much less active compd. KU0051529 (IC50 730 nM) and to NU1025.  These results confirm that treatment with potent PARP inhibitors remains an exciting potential therapy for cancers involving BRCA1 or BRCA2 deficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6va3_ljT7XbVg90H21EOLACvtfcHk0lgW1hIjJuJJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVOhsr4%253D&md5=9a15d48249c7fdf0feb573947883bb29</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.9.2141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.9.2141%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DN.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DTutt%26aufirst%3DA.%2BN.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DBRCA2-deficient%2520CAPAN-1%2520cells%2520are%2520extremely%2520sensitive%2520to%2520the%2520inhibition%2520of%2520poly%2520%2528ADP-ribose%2529%2520polymerase%253A%2520an%2520issue%2520of%2520potency%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D934%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span> MK4827 in Patients with Advanced Solid Tumors and BRCA Mutant Ovarian Cancer. <a href="http://clinicaltrial.gov/ct2/show/NCT00749502" class="extLink">http://clinicaltrial.gov/ct2/show/NCT00749502</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK4827+in+Patients+with+Advanced+Solid+Tumors+and+BRCA+Mutant+Ovarian+Cancer.+http%3A%2F%2Fclinicaltrial.gov%2Fct2%2Fshow%2FNCT00749502."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i63"><a href="/doi/suppl/10.1021/jm901188v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56335"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures for the biological assays including protocols for the PARP isoforms and proliferation assays in additional cell lines; general experimental details for the chemistry procedures including synthetic procedures for compounds <b>9</b>−<b>15</b>, <b>17</b>, <b>38</b>−<b>42</b>, <b>44</b>−<b>47</b>, <b>52</b>, and <b>54</b>; purity analysis results of the final compounds; and Mosher’s amide analysis of the stereochemistry of <b>56</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901188v/suppl_file/jm901188v_si_001.pdf">jm901188v_si_001.pdf (154.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901188v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm901188v%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901188v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996e250f073ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
